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ABSTRACT OF DISSERTATION 
 
DAIRY CATTLE HOOF DISEASE COSTS 
AND CONSIDERATIONS FOR PREVENTION 
 
Lameness is considered one of the most important health and welfare issues in the 
dairy industry.  Understanding the total cost per case of disease-specific lameness can help 
producers select better treatment, prevention, and control strategies for their herds.  The 
first objective of our research was to calculate the costs associated with 3 lameness causing 
hoof diseases: digital dermatitis, sole ulcer, and white line disease.  To accomplish this, a 
survey of hoof health professionals (hoof trimmers and veterinarians) was conducted to 
identify treatment related expenditures per case.  Data from the hoof trimmer responses to 
the survey and previously published research were incorporated into a farm-level stochastic 
simulation model to determine the expected costs per case of each disease and the most 
influential factors associated with disease costs.  The cost per case was calculated by 
disease type, severity (mild or severe), incidence timing (0 to 60 days in milk, 61 to 120 
days in milk, 121 to 240 days in milk, or >240 days in milk), and parity group (primiparous 
or multiparous).  The second objective of our research was to determine the economic value 
of investing in different lameness prevention strategies.  Two prevention strategies were 
considered: 1) prevention of infectious hoof diseases and 2) prevention of non-infectious 
hoof diseases.  The total expenditures (therapeutics, outside labor, on-farm labor, and 
prevention costs) and losses (discarded milk, reduced milk production, extended days open, 
increased risk of culling, increased risk of death, and recurrence losses) associated with 
each prevention strategy before and after prevention implementation were calculated and 
compared to find the breakeven investment cost. 
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Abstract 
 Lameness is one of the most costly dairy cow diseases, yet adoption of lameness 
prevention strategies remains low.  Low lameness prevention adoption might be 
attributable to a lack of understanding regarding total lameness costs.  In this review, we 
evaluated the contribution of different expenditures and losses to total lameness costs.  
Evaluated expenditures included labor for treatment, therapeutic supplies, lameness 
detection, and lameness control and prevention.  Evaluated losses included non-saleable 
milk, reduced milk production, reduced reproductive performance, increased animal death, 
increased animal culling, disease interrelationships, lameness recurrence, and reduced 
animal welfare.  The previous literature on total lameness cost estimates was also 
summarized.  The reviewed studies indicated that previous estimates of total lameness costs 
are variable and inconsistent in the expenditures and losses they include.  Many of the 
identified expenditure and loss categories require further research to accurately include in 
total lameness cost estimates.  Future research should focus on identifying costs associated 
with specific lameness conditions, differing lameness severity levels, and differing stages 
of lactation at onset of lameness to provide better total lameness cost estimates that can be 
useful for decision making at both the herd and individual cow level.         
Keywords: disease economics, animal health economics, hoof health, hoof disease, dairy 
health 
Introduction 
Lameness is a prominent issue in the dairy industry.  Adams et al. (2016) estimated 
2014 lameness prevalence in United States herds as 10%, whereas other studies have found 
lameness prevalence to reach as high as 55% (Von Keyserlingk et al., 2012).  Lameness is 
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perceived by producers as one of the top three major health concerns in their herds, with 
the other two being mastitis and fertility (Leach et al., 2010a).  However, understanding of 
the actual cost of lameness is lacking.  Leach et al. (2010a) found that producers cited lack 
of knowledge about lameness costs as one reason less effort was made to prevent lameness 
compared to mastitis.  If producers estimate lameness costs as less than the cost of 
implementing lameness prevention and control strategies, those management practices are 
not likely to be adopted (Leach et al., 2010a). This review aims to 1) identify and discuss 
the individual factors contributing to total dairy cow lameness costs and 2) summarize 
previous estimates of total dairy cow lameness costs. 
Calculating disease costs 
McInerney et al. (1992) defined the total cost of disease as including two 
components: expenditures and losses.  Expenditures focus on disease treatment and 
investment in prevention whereas losses are the indirect result of disease occurrence, 
including reduced milk production, reduced reproductive performance, and other factors 
(McInerney et al., 1992).  Figure 1.1 categorizes common expenditures and losses 
associated with dairy cow lameness, as summarized in this review.   
Given that numeric values change over time with inflation, this review focuses 
more on the contribution of each expenditure and loss category to total lameness costs 
rather than exact price estimates.  However, the relative importance of different factors 
within a study depends on which factors were included in the total cost estimate.  For 
example, treatment expenditures may contribute a large percentage to total lameness costs 
in a study where treatment, reduced milk production, and reduced reproductive 
performance are the only factors included.  In a different study where the increased risk of 
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culling and control and prevention investments are also included, treatment will likely 
contribute a reduced percentage to the total cost.  When dollar values are given, the 
originally reported value was converted to United States dollars and adjusted for inflation 
to represent 2017 values.   
Lameness expenditures 
 Two main types of disease expenditures exist: treatment expenditures and 
prevention expenditures (McInerney et al., 1992).  Treatment expenditures consist of labor 
and supplies necessary for treatment (i.e., therapeutics) which are generally reported as a 
price per case.  These estimates for lameness would be most accurate via surveys of hoof 
trimmers, veterinarians, and producers because they are the individuals charging and 
paying for them.  However, very few large surveys asking for hoof trimmer, veterinary, or 
producer perception of treatment expenditures associated with lameness, and especially 
specific lameness conditions, have been conducted.  Prevention expenditures include 
inputs associated with any control or prevention strategy, including management strategies 
implemented for early detection.  Prevention expenditures could also be thought of as 
investment expenditures because money is spent on prevention with the purpose of 
reducing total lameness costs (via reductions in lameness incidence).  Detection and 
prevention expenditures are rarely included in calculations of the cost per case of lameness.  
Instead, these expenditures are typically, although incorrectly, classified as general 
management costs. 
      Labor for treatment   
On-farm staff, hoof trimmers, or veterinarians most frequently treat lameness.  In a 
survey of 184 farms across the United States, 77% of farms used a professional hoof 
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trimmer for hoof trimming services whereas 16% used a veterinarian or on-farm staff and 
7% used no hoof trimming services at all (Adams et al., 2016).  Bruijnis et al. (2010) 
estimated the likelihood of treatment by a producer, hoof trimmer, or veterinarian for seven 
different lameness conditions, based on experiences in the Netherlands.  According to their 
mathematical model, the probability of a lameness case resulting in labor by the dairy 
producer (i.e., pulling the cow out of the herd to examine or treat her) ranged from 20% of 
cases for interdigital dermatitis with heel erosion, sole hemorrhage, or corns (interdigital 
hyperplasia) to 100% of cases for foot rot.  The probability of treatment by a hoof trimmer 
for each lameness type ranged from 0% of cases for foot rot to 40% of cases for sole ulcers.  
The probability of a veterinarian visit for each lameness type was either 1% of cases 
(interdigital dermatitis with heel erosion, digital dermatitis, sole hemorrhage, white line 
disease, or corns) or 5% of cases (foot rot or sole ulcer).  The estimated involvement by a 
hoof trimmer or veterinarian may seem low, but might result from the difficulty of bringing 
a hoof trimmer or veterinarian to the farm for every detected lameness case.  In other words, 
only the cases that exist when hoof trimmers or veterinarians are already physically present 
are likely to be treated by them.  When the hoof trimmer or veterinarian is not there and 
able to treat a case of lameness, lameness conditions that are difficult to treat (e.g., sole 
ulcers and white line disease) may be left untreated.  For example, Horseman et al. (2013) 
found that if lame cows were only treated by a foot trimmer or veterinarian (not on-farm 
staff) treatment could be delayed anywhere from 1 week to 1 month.   
Table 1.1 includes 7 different studies that calculated total lameness costs per case 
(both non-specific and condition-specific) and provided a breakdown of the costs 
contributed by at least 6 different expenditures or losses.  Within these studies, the 
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contribution of producer labor to total lameness cost estimates ranged from 2% to 16%, 
making it on average the seventh most important cost category of those evaluated.  The 
contribution of outside labor (veterinarian or hoof trimmer fees) to total lameness cost 
estimates ranged from 1% to 43%, making it on average the fifth most important cost 
category of those evaluated.  Some of the variation in these observations can be attributed 
to labor expenditures being dependent on the type of lameness with some treatments being 
more intensive than others.  Kossaibati and Esslemont (1997) surveyed 10 veterinarians in 
the United Kingdom about the cost of veterinary labor and found that sole ulcers resulted 
in the greatest labor charge per affected cow ($66), followed by digital lameness ($49), and 
interdigital lameness ($39).  However, the percentage of the total cost attributed to 
veterinary labor was actually greatest for interdigital lesions (12%) and least for sole ulcers 
(6%).  Sole ulcers are expected to have greater losses (e.g., reduced milk yield, reduced 
reproductive performance, increased culling risk) than infectious diseases because of their 
longer duration (Charfeddine and Pérez-Cabal, 2017); therefore, the percent of costs 
associated with labor is smaller.  Charfeddine and Pérez-Cabal (2017) surveyed Spanish 
hoof trimmers  to estimate the total cost of three different lameness conditions while 
considering severity of lameness as a factor.  In mild lameness cases, they found that the 
condition with the greatest contribution of labor (including labor from both hoof trimmers 
and producers) to the total cost per case was digital dermatitis (49%), followed by white 
line disease (29%), and sole ulcers (25%).  The opposite order was true for severe lesions 
(23%, 19%, and 15% for sole ulcers, white line disease, and digital dermatitis, 
respectively).  For all lameness conditions, the contribution of labor to total costs is less in 
severe cases compared to mild cases because of the increase in losses (e.g., increased 
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chance of culling, greater milk production reduction).  Beyond lameness condition type, 
location of the study could also influence the contribution of labor to total lameness costs.  
For example, involvement by veterinarians is more common, and even required for 
treatment, in some countries.   
Liang et al. (2017) surveyed 19 veterinarians and industry professionals and used 
their estimates to simulate both veterinary and producer labor costs associated with 7 
different diseases (mastitis, metritis, hyperketonemia, left displaced abomasum, retained 
placenta, lameness, and hypocalcemia).  Among all disease, the veterinary and producer 
labor costs associated with non-specific lameness were second highest only behind left 
displaced abomasum.  Therefore, regardless of the percentage of total lameness costs 
attributed to labor, labor expenditures due to lameness are substantial compared to other 
diseases. 
      Therapeutics 
Therapeutic expenditures include any medications or supplies used to treat 
diagnosed cases of lameness.  Therapeutic expenditures vary greatly depending on the 
cause of lameness.  For example, standard treatment of noninfectious hoof lesions like sole 
ulcers and white line disease includes trimming and blocking the hoof to reduce weight 
bearing on the affected claw (Andrews et al., 2008).  Alternatively, digital dermatitis 
treatment often involves cleaning and topical application of antibiotics using a foot wrap.  
In addition to the type of lameness, the severity of lameness when treated can also influence 
therapeutic expenditures (Charfeddine and Pérez-Cabal, 2017).  The farm’s hoof trimmer 
or veterinarian, depending on who is conducting the diagnosis and treatment of lameness 
cases, sets the prices associated with therapeutics.       
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Therapeutic expenditure estimates ranged from 2% to 37% of the total cost per case 
of lameness, making it on average the fourth most important cost category of those 
evaluated in Table 1.1.  Excluding Liang et al. (2017), all therapeutic expenditure estimates 
included in Table 1.1 were 20% or less, with most being 10% or less.  Liang et al. (2017) 
conducted a survey of veterinarians and other industry professionals to identify expected 
therapeutic expenditures.  The considerable variation among respondents ($42 ± 46), likely 
due to a small sample size (n = 19), may have contributed to their difference in findings 
compared to other studies.  The fact that this is the most recent of the studies may also have 
contributed to this finding.  Liang et al. (2017) additionally found that therapeutic 
expenditures associated with lameness were second highest among common dairy diseases, 
only behind left displaced abomasum.   
As expected, lameness conditions that require more supplies to treat had an 
increased contribution of therapeutics to total costs.  Kossaibati and Esslemont (1997) 
found that the cost of interdigital lesions was more dependent on therapeutics (8% of the 
total cost) than either the cost of digital lesions (5% of the total cost) or sole ulcers (4% of 
the total cost).  Charfeddine and Pérez-Cabal (2017) found that white line disease had the 
greatest contribution of therapeutics to the total cost per case (16% and 12% for mild and 
severe lesions, respectively).  Second and third were sole ulcers (15% and 12% for mild 
and severe lesions, respectively) and digital dermatitis (7% and 4% for mild and severe 
lesions, respectively).  Increased lameness severity was again associated with greater losses 
(reduced milk production, reduced reproductive performance, etc.), decreasing the 
therapeutics-associated total cost percentage. 
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      Lameness detection 
When done correctly, monitoring for the presence of disease can lead to detection 
at an early stage and allow for earlier treatment, potentially reducing expenditures and 
losses associated with that case.  Additionally, monitoring disease presence is important 
for recognizing a problem and identifying prevention practices that can reduce overall 
incidence of disease.  Expenditures associated with lameness detection include labor for 
implementation and, in some cases, the cost of supplementary supplies or tools.   
The simplest form of on-farm lameness detection is visual locomotion scoring.  Van 
Nuffel et al. (2015a) identified at least 25 different visual scoring systems for dairy cow 
lameness characteristics.  They noted that although these methods are relatively easy to use 
and inexpensive to implement (i.e., the only expenditure is labor), the amount of time it 
takes to conduct scoring on an entire herd means they are not often executed.  Another 
method of lameness detection is identification of lesions during routine visits by a hoof 
trimmer.  Although no added expenditures are associated with this method, relying on it 
alone can result in missed lameness cases between hoof trimmings, leading to increased 
severity.  This is an especially unreliable lameness detection method in the United States 
where Adams et al. (2016) reported that 7% of dairy herds never trim their cows, 20% only 
trim cows when they are visibly lame, and 36% only trim once per lactation. 
Recently, individual animal monitoring technologies have shown potential for 
lameness detection.  Walk-over or stand-on load cells, pressure-sensitive position mats, 
vision techniques, accelerometers, and other already available sensor data (e.g., milk 
production, activity, rumination time) have all been evaluated for the possibility of 
automated lameness detection (Van Nuffel et al., 2015b).  The economic value of investing 
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in an automated lameness detection system remains unquantified.  One difficulty of 
identifying the value of automated lameness detection is determining what will be done 
when a lameness alert is given (Van Nuffel et al., 2015b).  If a reason for the lameness alert 
is identified, treatment can occur and reduced severity of the condition is beneficial to the 
farm.  However, if a reason for lameness is not found, the value of the early detection is 
negative instead of positive (i.e., labor was used to check the cow and evaluation of the 
hooves for a problem could result in hoof damage).  One possibility is that the technology 
alert occurs before the lameness condition is visibly apparent (i.e., not a false alert, just 
early), but without an actionable response to that alert, it has no value.  Regardless, the 
economic potential of automated estrus detection systems has been quantified (Rutten et 
al., 2014, Dolecheck et al., 2016) and it stands to reason that some of these systems could 
additionally be used for lameness detection with minimal added expenditures (i.e., only 
labor for checking alerted cows). 
Regardless of the available options, lameness diagnosis on dairy herds is generally 
not proactive.  One reason for this may be that producers tend to underestimate the 
prevalence of lameness in their herds (Bell et al., 2006, Espejo et al., 2006, Leach et al., 
2010a).  Additionally, producers perceive lameness management to be more challenging 
to include in daily routines compared to other health issues, like mastitis, which can be 
managed in the parlor (Leach et al., 2010a).  Instead, lame cows are often only identified 
after they become severely lame (Mill and Ward, 1994), completely ignoring mildly lame 
cows that would benefit most from early detection.  Possibly for this reason, no identified 
studies included an estimate for expenditures on lameness diagnosis or detection in their 
calculated total lameness cost.  However, if detection and diagnosis is proactive, an 
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accurate estimate of a herd’s total lameness cost should include the cost of proactive 
diagnostic measures.     
      Lameness control and prevention 
Control and prevention strategies for reducing lameness incidence can be either 
repetitive actions, or one-time, long-term investments.  Examples of repetitive investments 
include preventive hoof trimming (Fjeldaas et al., 2006), footbaths (Laven and Hunt, 2002), 
hoof health feed additives (Bergsten et al., 2003), or even genetic selection (Pritchard et 
al., 2013).  An example of a long-term investment in lameness prevention would be the 
installation of rubber flooring (Vanegas et al., 2006) or the redesigning of poorly 
constructed freestalls (Ito et al., 2010).  Expenditures associated with these different 
strategies might include labor, supplies, and depreciation. 
Although many of these strategies are lameness specific, some lameness control 
and prevention expenditures could overlap with control and prevention of other diseases.  
For example, updating old freestalls could improve more than just lameness incidence (e.g., 
reduced mastitis incidence, improved cow longevity).  Therefore, identifying the 
proportion of prevention costs associated with a specific management change that should 
be attributed to lameness is essential for accurate total lameness cost estimates.  The effects 
of most of these prevention and control strategies are not well studied and are difficult to 
quantify.  Therefore, how best to account for these expenditures when estimating the total 
cost of lameness is unclear.     
Very few estimates of total lameness costs include any allocation to prevention 
strategies.  Kaneene and Hurd (1990) surveyed 60 Michigan (USA) herds to find that, on 
average, $4/cow per year was spent on prevention of lameness as estimated by the 
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producers.  Among 7 other diseases, lameness prevention costs ranked as the third greatest, 
only behind mastitis ($9/cow per year) and fertility problems ($7/cow per year).  Miller 
and Dorn (1990) estimated lameness prevention expenditures (including preventive 
trimming, veterinary services, and labor) using data from 16 Ohio dairy farms (1 304 total 
cows) to be $2/cow per year.  Prevention expenditures for lameness were greater than for 
hypocalcemia, displaced abomasum, or dystocia, but less than mastitis, infertility, 
pneumonia, or “other” diseases.  For both of these studies, prevention cost estimates 
focused on disease-specific costs rather than general management practices like nutrition 
and housing, likely resulting in under-estimation of prevention costs for all diseases.  
Additionally, these estimates of prevention expenditures were all reported as $/cow per 
year rather than $/case.  Although prevention is generally paid in $/cow per year, producers 
should also consider how much they are spending on prevention per case to help determine 
if prevention expenditures are beneficial.  For example, Bennett et al. (1999) estimated 
expenditures on lameness prevention via hoof trimming in the United Kingdom to range 
from $6 to $12 per case of non-specific lameness (4% to 7% of total case costs, depending 
on the assumptions used in their model).   
 Ettema and Østergaard (2006) estimated the value of five lameness prevention 
strategies (footbathing, rubber flooring, pasture access, trimming, and biotin 
supplementation) using a stochastic Monte Carlo model.  The model included reduced milk 
yield, reduced feed intake, weight loss, reduced conception rate, and increased mortality as 
lameness outcomes.  Assuming an average Danish dairy herd, all strategies increased the 
total profit margin per cow-year with rubber flooring providing the greatest increase 
($9/cow-year) and footbathing providing the least increase ($2/cow-year).  However, the 
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cost associated with each prevention strategy was not included.  Therefore, the increase in 
profit margin would only be realized if expenditures on the prevention strategy were less 
than the potential profit.  The expenditures associated with implementation (including 
labor, supplies, etc.), the current herd prevalence of lameness, and the effectiveness of the 
prevention strategy would influence the overall value of each control and prevention 
strategy.     
Lameness losses 
Whereas expenditures involve increased costs, losses revolve around reduced 
returns.  The three categories that most losses will fall under are reduced outputs, reduced 
output quality, and animal welfare effects.  In previous estimates, losses represent 37% to 
93% of total lameness costs, outweighing the expenditures in most cases (Table 1.1). 
Estimates of disease losses typically come from epidemiological or survey studies.  
Commonly, animals are observed over a defined period of time and comparisons (e.g., milk 
production, reproductive performance) are made between those cows that became lame and 
those cows that did not.   Results between studies conducted this way can be difficult to 
compare for many reasons.  First, the definition and identification of lameness are not 
always consistent.  Whereas some studies use periodic visual lameness scoring to define 
lameness, others use lesion presence, and still others rely on farmer or veterinarian 
identified lameness cases.  Second, the losses associated with a disease are specific to both 
the severity of disease and the timing of disease occurrence within the lactation, which 
depends on the disease definition and identification strategy.  Studies using periodic visual 
lameness scoring will likely identify and treat cows before the time a producer generally 
would, resulting in an underestimation of lameness losses because of reduced lameness 
 
14 
 
severity.  On the contrary, cases defined by farmer or veterinarian diagnosis will likely be 
more severe but may mean that mild lameness is entirely overlooked.  Third, the potential 
confounding factors that studies account for can differ.  Some of the losses associated with 
lameness, including reduced milk production and reduced reproductive performance, are 
related to many other factors (e.g., nutrition, other diseases) that need to be considered to 
accurately estimate losses associated with just lameness.  This is different from 
expenditures, which are linked to a specific disease or condition.   
Undoubtedly, other losses beyond those mentioned exist but are hard to define or 
difficult to quantify.  Losses are discussed with emphasis on the general influence of 
lameness on the amount or quality of the product (e.g., milk production, days open) rather 
than the exact value of that amount because market values fluctuate greatly with farm 
location and time.      
      Non-saleable milk 
Milk discarding is required after antibiotic treatment.  Although antibiotic use is 
common for mastitis cases (Rollin et al., 2015), most lameness cases do not require 
antibiotics, resulting in no discarded milk. Stricter antibiotic use guidelines worldwide 
could further reduce discarded milk associated with lameness and other diseases.  Non-
saleable milk loss estimates were consistent between the studies identified, ranging from 
1% to 11% of the total cost per case of non-severe lameness, making it on average the least 
important cost category of those evaluated in Table 1.1. 
Lameness treatments including antibiotic use are more common when lesions are 
severe.  Charfeddine and Pérez-Cabal (2017) found in their survey that no antibiotics, and 
therefore no resulting discarded milk, were needed for mild lesions.  However, survey 
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respondents did use antibiotics for severe lesions, resulting in some discarded milk (258 
kg/treatment, 331 kg/treatment, and 312 kg/treatment for severe digital dermatitis, sole 
ulcer, and white line disease, respectively).  They estimated that milk withholding 
represented the second most important cost for severe lesions (24%, 20%, and 20% of the 
total costs associated with a cow affected by severe digital dermatitis, severe sole ulcers, 
and severe white line disease, respectively).  The specific dollar value of discarded milk is 
dependent on the milk market where a herd is located and the potential alternative uses of 
that milk (i.e., feeding discarded milk to calves). 
      Reduced milk production 
Lameness influences milk production via many different and interrelated factors.  
Huxley (2013) summarized previous studies that estimated a milk yield loss of 270 to 574 
kg per lactation when lameness occurred.  Evidence exists that this milk loss occurs during 
not only clinical lameness, but also pre-diagnosis and post-recovery depending on 
lameness type (Green et al., 2002, Amory et al., 2008, Charfeddine and Pérez-Cabal, 2017).  
Because of this, the point in lactation that a lameness case occurs will influence the total 
milk loss associated with incidence of the disease (i.e., milk loss may continue until the 
end of the lactation).  The relationship between lameness and milk production is two-fold.  
Although lameness incidence decreases milk production, increased milk production is also 
a risk factor for lameness (Barkema et al., 1994, Green et al., 2002, Amory et al., 2008).  
Barkema et al. (1994) estimated that for every 100 kg increase in milk production during 
the first 100 DIM of the previous lactation, cows experienced a 1.1 times greater chance of 
lameness in the current lactation.  Therefore, the effect of lameness incidence on milk 
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production may lead to some high producing cows becoming average producing cows 
rather than average producing cows becoming low producing cows. 
The exact dollar value of reduced milk production is dependent on the estimated 
yield reduction, the value of milk (milk price plus bonuses), and the change in feed costs 
(Charfeddine and Pérez-Cabal, 2017).  Because this milk is never produced, as compared 
to discarded milk, the feed costs savings are especially important to account for.  Reduced 
milk production expenditure estimates have ranged from 9% to 39% of the total cost per 
case of lameness, making it on average the third most important cost category of those 
evaluated in Table 1.1.  Variation in the percentage of total lameness costs contributed to 
reduced milk production may result from some studies considering higher yielding cows 
to be more susceptible to lameness whereas others did not. 
Lameness condition type also influences observed reduced milk production.  
Charfeddine and Pérez-Cabal (2017) estimated reduced milk production to contribute 
between 13% and 18% to total costs per case for mild and severe digital dermatitis, sole 
ulcers, and white line disease.  The only exception was an increased percentage (34%) for 
mild digital dermatitis cases because their shorter duration resulted in reduced expenditures 
and other losses.  Cha et al. (2010) estimated reduced milk production to represent 27% of 
total costs per case for both digital dermatitis and foot rot and an even greater amount (38% 
of the total case cost) for sole ulcers.  The increased percentages of total cost attributed to 
reduced milk production reported by Cha et al. (2010) were likely the result of only 3 
factors being included in their estimates: treatment, reduced milk production, and reduced 
reproductive performance.   
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      Reduced reproductive performance 
Traditionally, lameness has been thought to reduce reproductive performance via 
decreased estrus detection (Lucey et al., 1986).  However, Collick et al. (1989) noted that 
overall days open was affected by lameness more than the time to first service, suggesting 
that reduced estrus detection may not be the only factor contributing to poor reproductive 
performance in lame cows.  Recently, hormone profiles of lame cows have been studied to 
further define the relationship between lameness and reproductive performance (Walker et 
al., 2008, Sood et al., 2009, Morris et al., 2011).  The exact physiological mechanism by 
which lameness affects reproductive performance remains undefined, but is likely a 
combination of multiple factors. 
Huxley (2013) provided a summary of studies that considered the effect of 
lameness on reproductive performance.  In the reported papers, lameness resulted in a mean 
7 d longer time to first service, 30 d increase in days open, 20% lesser conception rate, and 
1.2 more services per conception.  The exact value of these adverse effects depends on the 
cost of a day open or the value of a pregnancy.  Both of these are herd specific, making an 
estimate of the economic influence of lameness on reproduction difficult.  A critical 
contributor to the extent of reduced reproductive performance resulting from lameness is 
the timing of the disease (Lucey et al., 1986).  If lameness occurs in later lactation, after 
pregnancy establishment, its effect on reproduction will likely be lesser than if the 
occurrence is before first breeding.  However, the effect of late lactation lameness on the 
next lactation has not been thoroughly explored.   
The reported percentage of total lameness costs attributed to reduced reproductive 
efficiency ranged from 0% to 48%, making it on average the second most important cost 
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category of those evaluated in Table 1.1.  Parity contributed to some of the variation 
observed.  Liang et al. (2017) found that reproductive losses represented 3% and 25% of 
the total costs per case for primiparous and multiparous cows, respectively, noting that 
unique market conditions assumed in their study resulted in deviations from previous cost 
of days open estimates.  On the other extreme, both Kossaibati and Esslemont (1997) and 
Esslemont (2005) estimated the greatest percentage of total lameness costs attributed to 
reduced reproductive performance (42% and 48%, respectively) when considering 
interdigital lameness.  The actual effect (in days open) of interdigital lameness on 
reproductive performance was assumed less than a sole ulcer in the same studies, but 
because interdigital lameness was assumed to have no effect on culling, the percentage of 
the total cost per case attributed to reduced reproductive performance was greater. 
As with expenditures and other losses, the type of lameness also influences the 
value of reduced reproductive performance.  Cha et al. (2010) found that although the 
percentage of costs attributable to reduced reproductive performance was similar between 
sole ulcers (33%) and digital dermatitis (31%), that percentage was greater (45%) in foot 
rot cases partially because of relatively lesser treatment costs for foot rot.  However, 
Charfeddine and Pérez-Cabal (2017) found a lesser percentage of costs attributable to 
reduced reproductive performance with only around 3% for severe digital dermatitis and 
white line disease ($12 and $19, respectively), but 6% for severe sole ulcers ($38).  Their 
lesser contribution of costs to reduced reproductive performance can be attributed to the 
reduced effects of lameness on days open in their study compared to those summarized by 
Huxley (2013).    
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      Increased death and culling 
Relatively few animals die as a direct result of lameness.  However, welfare 
standards requiring cows to be ambulatory to enter a slaughter facility result in euthanasia 
of some lame cows on-farm rather than them being sold as cull cows.  Thomsen et al. 
(2004) found in interviews with Danish producers that although only 2% of unassisted 
deaths were attributed to lameness, 40% of euthanized cases were.  The USDA (2007) 
National Animal Health Monitoring System Dairy Survey reported that 20% of United 
States dairy cow deaths resulted from euthanasia after either lameness or injury.  McConnel 
et al. (2015), utilizing the same data, noted a relationship between lameness and mortality 
where mortality was predicted to increase by 0.8% for every 1% increase in the proportion 
of lame cows.  However, this could be a result of lameness causing other diseases to occur 
which are ultimately the cause of euthanasia rather than lameness itself.   
The exact percent of lameness cases that result in death remains mostly undefined 
in the literature.  Based on previous veterinary experience in the United States, Guard 
(2008) estimated that 2% of lame cows become disabled to the point that they are not 
accepted for slaughter.  However, this anecdotal estimate may be more accurate for herds 
before the strict non-ambulatory guidelines put into place in the United States in 2004.  
Regardless, for any lameness cases that do result in euthanasia, the cost to the producer is 
the same as a dead cow plus the cost of euthanasia (captive bolt, gunshot, veterinarian, etc.) 
and the emotional toll that does not have a well-defined value.   
Alternatively, the effect of lameness on culling has been extensively explored with 
the general conclusion being that lameness incidence decreases the productive life of a 
dairy cow (Huxley, 2013).  Charfeddine and Pérez-Cabal (2017) found that incidence of 
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either sole ulcer or white line disease decreased the length of productive life between 35 
and 71 d compared to unaffected animals.  No significant effect of digital dermatitis on the 
length of productive life was found.  Similarly, Cramer et al. (2009) identified no effect of 
infectious lameness (foot rot, digital dermatitis, and heel horn erosion) on culling.   In 
studies where culling has not been found to be affected by non-infectious lameness this is 
rationalized because the cows that are more susceptible to culling are also the superior 
producing cows and, therefore, they are not viewed by producers as uneconomical 
(Barkema et al., 1994, Archer et al., 2010).  Additionally, cows might be recorded as 
leaving the herd for low production or reproductive failure when lameness was the root 
cause of removal (Guard, 2008).  This emphasizes the importance of disease incidence 
recording and the proper identification of culling reason to be able to accurately estimate 
the effects of different diseases on culling. 
 Estimates for losses associated with an increased risk of culling or death ranged 
from 0% to 50% of the total cost per case of lameness, making it on average the most 
important cost category of those evaluated in Table 1.1.  The extremely low values (0%) 
were only found in estimates for interdigital lameness, with most estimates falling between 
20% and 40%.  Charfeddine and Pérez-Cabal (2017) found that premature culling was the 
greatest contributor to the cost of a case of mild or severe sole ulcers or white line disease 
and severe digital dermatitis (23% to 40%).  The contribution of culling costs to the cost 
of mild digital dermatitis was less (10%).  Liang et al. (2017) found parity to have little 
effect on the portion of total lameness costs attributable to culling which accounted for 
14% and 16% in primiparous and multiparous cows, respectively.   
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The cost of culling depends greatly on how culling is calculated.  Basic culling 
costs can be calculated as the cost of a replacement minus the slaughter value of the cull 
cow.  However, this method only accounts for the financial cost of culling, ignoring the 
economic costs (Bewley et al., 2010).  More complex and thorough methods, like retention 
pay-off, are better for capturing the difference between the potential future value of a cow 
and the potential future value of her replacement (Groenendaal et al., 2004) and should be 
used for disease culling cost estimates.  
      Disease relationships and recurrence 
Relationships between diseases are complex and not well defined.  When lame and 
non-lame cows have been compared, similar percentages of common diseases (retained 
placenta, metritis, hypocalcemia, left displaced abomasum, and dystocia) have been found 
(Melendez et al., 2003, Booth et al., 2004, Hernandez et al., 2005).  Contradicting results 
exist for hyperketonemia, potentially because of the method of comparison and definitions 
of hyperketonemia used.  Peeler et al. (1994) noted that both dystocia and mastitis 
increased the risk of lameness pre-breeding (odds ratios = 1.5 and 1.5, respectively), 
whereas lameness incidence itself increased the risk of mastitis (odds ratio = 1.4).  
However, other studies have found no link between lameness and mastitis (Melendez et 
al., 2003, Booth et al., 2004, Hernandez et al., 2005).  Another investigated relationship 
that could be related to the reduced reproductive performance of lame cows is the 
connection between ovarian cysts and lameness.  Melendez et al. (2003) found that the 
odds of a lame cow having an ovarian cyst were 2.63 times greater than the odds of a non-
lame cow.  However, given that this was an observational study only, it cannot be 
concluded that a cause-effect relationship exists.   
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In situations where lameness is directly responsible for changing the incidence of 
other diseases, the expenditures and losses associated with those diseases should be 
included in total lameness costs.  Alternatively, if a lameness case is the result of another 
disease, costs associated with that case should not be considered as contributing to total 
lameness costs.  Very few total lameness cost estimates have even attempted to account for 
this source of loss.  When estimating total lameness costs, Enting et al. (1997) did account 
for relationships between lameness and other diseases, finding that the contribution of other 
diseases to total lameness costs (i.e., costs associated with other diseases resulting from 
lameness) was minimal (1% of total lameness costs).   
Not only is the relationship between lameness and other diseases important, but 
also the potential for lameness recurrence.  Costs associated with recurring cases should be 
considered as part of the total cost of the original case, rather than separately.  In previous 
lameness cost estimates, some studies assume lame cows undergo costs associated with 1.4 
cases because of recurrence rates (Kossaibati and Esslemont, 1997, Esslemont, 2005, 
Ettema and Østergaard, 2006).  Using this assumption, Esslemont (2005) found that repeat 
case costs were 3%, 7%, and 3% of total lameness costs per cow affected by digital, 
interdigital, and sole ulcer conditions, respectively.  However, the recurrence rate of 1.4 
appears to be an assumption made by these authors rather than supported by published 
literature.  More recently, Charfeddine and Pérez-Cabal (2017) recorded relapse rates on 
804 Spanish farms, finding a range of 2.0 to 3.1 relapses per case depending on lameness 
condition and parity.  However, accurate recurrence rate estimates alone do not answer the 
question of how much extra cost is attributed to repeat cases.  Although recurrence does 
incur additional costs, those costs are likely not as great as the original case (i.e., total 
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lameness costs do not double with recurrence).  Because data is lacking to know how to 
handle this, some disease models have assumed that recurring disease cases only increase 
direct costs (labor, therapeutics, and non-saleable milk) and have no influence on indirect 
costs (milk loss, reproductive performance, culling, etc.; Kossaibati and Esslemont, 1997, 
Rollin et al., 2015)  .  Estimates for losses associated with lameness case recurrence ranged 
from 3% to 14% of the total cost per case of lameness, making it on average the sixth most 
important cost category of those evaluated in Table 1.1.    
Until we have a better understanding of relationships between other diseases and 
lameness, lameness recurrence rates, and lameness recurrence costs, estimating the 
economic losses associated with these factors is difficult.  Regardless, acknowledging these 
factors highlights that current estimates may not be accounting for every economic loss 
associated with lameness. 
      Reduced animal welfare 
Often, diagnosis of lameness does not occur until the cow is obviously limping 
(Mill and Ward, 1994), indicating a high level of pain (Whay et al., 1998).  In surveys, 
producers have acknowledged the link between lameness and cow pain and suffering (Mill 
and Ward, 1994, Leach et al., 2010b), but they do not always acknowledge a cost associated 
with pain and suffering.  As previously mentioned, the fact that lame cows might also be 
the highest yielding cows may influence a producer’s view on the welfare effects of the 
disease.  In reality, the pain and suffering associated with lameness has at least two 
economic consequences.   
First, some of the previously mentioned losses associated with lameness (i.e., 
reduced milk production, reduced reproductive performance) are likely a result of 
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responses to pain and suffering.  For example, lame cows tend to spend less time feeding 
(González et al., 2008) potentially because they spend more time lying down to relieve 
pressure from their feet (Ito et al., 2010).  The result is reduced milk production and 
economic losses.  The association between lameness and reduced reproductive 
performance might also be related to increased cortisol levels (caused by pain and stress 
that the animal is experiencing from lameness) affecting hormone function (Dobson and 
Smith, 2000).  In these cases, the economic losses associated with pain and suffering during 
lameness are already accounted for within other loss categories.   
 The second economic consequence of poor animal welfare (i.e., pain and suffering) 
is the potential to influence consumer perception.  McInerney (1996) pointed out that one 
mistake farmers make is assuming lameness costs occur only at the farm level.  Recently, 
Leach et al. (2010b) found that this view may be changing.  Seventy-two percent of 
surveyed United Kingdom dairy farms ranked the desire for a good public image as a 
“very” or “extremely” important factor contributing to lameness control.  However, 35% 
of those farmers still felt the risk of lame cows influencing farm accreditation was of “very 
little” or “no” importance.   
In reality, consumer perception of the quality of life of our livestock animals could 
someday result in economic consequences.  If consumers lose faith in the production 
process of a product and reduce their consumption, the market for that product could be 
affected.  This may result in indirect economic consequences to the farmer (i.e., a smaller 
milk market) or direct consequences in the form of new rules and regulations that dictate 
the amount of lameness that can be present on a farm or protocols for handling lameness 
cases.  For example, Version 3 of the United States FARM (Farmers Assuring Responsible 
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Management) program sets the expectation that 95% of the cows on each evaluated dairy 
will score a 2 or less for lameness (on a 1 to 3 scale; NMPF, 2016 ).  Lameness is a critical 
component in farm welfare audits around the world and producers will be (or already are) 
required to follow set guidelines to sell their milk.  To date, no economic estimates of the 
total cost of lameness have included animal welfare.  
Total lameness costs 
      Total lameness cost estimates 
Previously reported total lameness cost estimates (expenditures + losses), adjusted 
to 2017 US dollar values, are listed in Table 1.2 along with which factors each cost estimate 
included.  None of the identified studies considered expenditures associated with lameness 
detection or losses associated with animal welfare when calculating total lameness costs, 
pinpointing these two cost factors as requiring further research to estimate.  Very rarely 
were costs associated with lameness control or prevention, interactions with other diseases, 
or lameness recurrence included.  The few studies that did consider these factors were 
studies mostly conducted in 2006 or earlier.  Although this seems counterintuitive, one 
possibility is that authors of more recent estimates purposely avoided including these 
factors because they understand the difficulty in accurately accounting for them.  
Additionally, some of these factors may be difficult to calculate at the case level rather than 
the herd level (e.g., lameness detection and control or prevention strategies).  Factors 
considered in all or nearly all of the identified studies included labor for treatment (both 
producer and veterinary), therapeutics, non-saleable milk, reduced milk production, 
reduced reproductive performance, and an increased risk of culling.   
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For each study in Table 1.2, cost estimates were calculated as either the cost per 
cow per year or the cost per case.  In studies where the cost per cow per year was calculated, 
lameness costs were spread across all animals in the herd, regardless of which cows 
experienced the disease.  The resulting cost is highly dependent on the individual farm size 
and the prevalence of lameness in the herd.  For this reason, the cost per case is preferred.  
Estimates of the cost per case of non-specific lameness ranged from $76 to $533, depending 
on the location of the study, the calculation method used, and the expenditures and losses 
that were selected for inclusion (Table 1.2).  Liang et al. (2017) estimated that this total 
cost per case of non-specific lameness was less than a case of mastitis or displaced 
abomasum, but more than a case of metritis, retained placenta, ketosis, or hypocalcemia.  
Although more useful than costs per cow per year, these non-specific lameness total cost 
estimates assume all lameness to be identical.   
Often, different lameness disease conditions have been classified into categories 
and costs are evaluated based on those lameness categories.  The most commonly used 
categories include interdigital disease, digital disease, and sole ulcers (Esslemont and 
Peeler, 1993, Kossaibati and Esslemont, 1997, Esslemont, 2005, Willshire and Bell, 2009).  
Among these, sole ulcers are estimated as having the greatest total costs ranging from $232 
to $1 073 per case or affected cow (thereby accounting for recurrence), depending on the 
location of the study, the calculation method used, and the expenditures and losses that 
were selected for inclusion (Table 1.2).  Recently, the total costs of specific lameness 
conditions have been further explored.  Willshire and Bell (2009) added estimates for 
digital dermatitis and white line disease in addition to the aforementioned general 
categories.  Cha et al. (2010) and Charfeddine and Pérez-Cabal (2017) both looked at the 
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total costs associated with digital dermatitis and sole ulcers whereas Charfeddine and 
Pérez-Cabal (2017) alone looked at white line disease and Cha et al. (2010) alone looked 
at foot rot.  Based on these limited studies, digital dermatitis appears to have the least total 
costs of the evaluated conditions whereas sole ulcers have the greatest total costs (Table 
1.2).  Charfeddine and Pérez-Cabal (2017) noted that digital dermatitis generated overall 
lesser costs than noninfectious disorders mainly because of the reduced length of time the 
disease affected the animal, resulting in reduced treatment, labor, discarded milk, and milk 
loss; however, none of the studies considered the possibility of digital dermatitis or other 
infectious diseases transmitting to other animals.  The importance of looking at total 
lameness costs specific to disease type was emphasized by Cha et al. (2010) who noted that 
the top cost contributors differed by disease.  Milk loss contributed the most to the total 
cost of sole ulcers (38%), treatment was the greatest contributor to the total cost of digital 
dermatitis (42%), and decreased fertility was the greatest contributor to the total cost of 
foot rot (50%).   
      Accuracy of total lameness costs 
Although condition-specific lameness costs are an improvement over non-specific 
cost estimates, these estimates are still highly dependent on the assumptions used in the 
model.  In reality, the cost of lameness conditions varies by herd, cow, and lameness case 
characteristics.  At the herd level, variation in market prices and management styles will 
affect lameness incidence, treatment, and recovery.  At the cow level, the cost of a case of 
lameness depends on an individual cow’s milk production potential, pregnancy status, and 
age (Cha et al., 2010).  Finally, characteristics of the lameness case beyond disease type, 
including the point in lactation when a cow becomes lame and the severity of the lameness 
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condition, will affect total lameness costs (Cha et al., 2010, Charfeddine and Pérez-Cabal, 
2017).  Of all these influential factors, only the severity of the lameness condition has been 
considered in any lameness cost estimates and only once by Charfeddine and Pérez-Cabal 
(2017).  They found that although severe lesions were less common, their cost was almost 
3 times greater than the cost of mild lesions because of their effect on the cow’s longevity.  
The ideal scenario would be to provide decision support tools that could use herd, cow, and 
case-specific information to help a producer determine the best individual treatment and 
culling strategies whenever a cow became lame.   
Beyond the definition of lameness used in an economic analysis (i.e., overall, 
disease type, or cow-specific) the accuracy of these estimates depends on many factors.  
First, the correct expenditures and losses for a disease need to be included in the model.  
Our understanding of lameness and all of the factors associated with it continues to 
develop, as emphasized by the variation in factors included in the 14 studies in Table 1.2.  
Likely, past estimates excluded some critical factors and current estimates are still missing 
factors we have yet to consider.   
Even if researchers agreed on which expenditures and losses to include, this does 
not completely solve the problem.  The reliability of cost estimates depends on the 
accuracy, availability, and reliability of the empirical data used to create them (Dijkhuizen 
et al., 1995).  Estimates for some of the factors are lacking (e.g., the expenditures associated 
with detection and the losses associated with animal welfare issues).  Additionally, most 
existing estimates for losses associated with lameness were generated from datasets where 
lameness was defined by a lameness or gait score rather than by the presence or absence of 
specific conditions.  Therefore, the ability to generate further condition-specific lameness 
 
29 
 
cost estimates is limited until this data exists.  Recently, Charfeddine and Pérez-Cabal 
(2017) used a dataset containing over 108,000 records to estimate the effect of three 
specific claw disorders (digital dermatitis, sole ulcer, and white line disease) on milk 
production, fertility performance, and longevity.  More studies of this nature and studies 
including additional lameness disease types, severity, and timing of occurrence would be 
valuable for improving total lameness cost estimates.   
Conclusions 
 Accurate calculations of total lameness costs should include numerous 
expenditures and losses.  Most of these require further empirical research to precisely 
define, especially with regard to specific lameness disease types, severity level, and the 
stage of lactation at occurrence.  Total lameness costs are also influenced by many herd- 
and cow- specific factors.  Regardless of the limitations of current lameness cost estimates, 
having an understanding of the components of total lameness costs can help to guide future 
research and to identify the potential effect of control and prevention strategies, leading to 
more proactive decision making and management.    
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Table 1.1 Contribution of expenditure and loss categories to the total cost of dairy cow lameness across identified studies that 
included at least 6 contribution categories 
Study 
Category contribution to total cost (%) 
Expenditures  Losses 
Producer 
labor 
Outside 
labor1 Therapeutics Total  
Non-
saleable 
milk 
Reduced 
milk 
production 
Reduced 
reproductive 
performance 
Increased risk of 
culling and death 
Repeat 
cases Total 
Kossaibati and Esslemont (1997)                               
 Digital lameness 6.2 8.1 5.4 20  9.0 10.0 14.5 35.3 11.5 80 
 Interdigital lameness 3.8 11.9 8.2 24  11.0 9.2 41.9 0.0 14.0 76 
 Sole ulcer 5.9 6.1 3.5 16  4.0 8.5 31.6 32.6 7.8 84 
Esslemont (2005)                                                                 
 Non-specific lameness 3.2 1.7 3.7 9  0.7 30.9 25.9 30.1 3.7 91 
 Digital lameness 2.5 1.7 3.0 7  0.4 38.8 13.7 36.9 3.0 93 
 Interdigital lameness 5.8 2.7 6.8 15  2.1 27.6 48.1 0.0 7.0 85 
 Sole ulcer 2.9 1.4 3.2 8  0.3 23.1 30.0 36.0 3.1 92 
Guard (2008)                                                                    
 Non-specific lameness 1.7 0.6 4.3 7  0.6 36.0 6.4 50.3 NA 93 
Willshire and Bell (2009)                                            
 Non-specific lameness 2.0 1.0 10.0 13  NA 24.0 39.0 24.0 NA 87 
Bruijnis et al. (2010)                                                  
 Non-specific lameness 17.3 6.7 2.0 26  5.7 28.4 7.4 32.5 NA 74 
Charfeddine and Pérez-Cabal (2017)                
 Digital dermatitis, mild 7.0 42.5 7.0 57  0.0 33.8 0.0 9.6 NA 43 
 Digital dermatitis, severe 8.4 6.3 4.2 19  24.4 16.4 2.9 37.4 NA 81 
 Sole ulcer, mild 14.6 10.9 14.6 40  0.0 18.3 1.5 40.2 NA 60 
 Sole ulcer, severe 10.5 12.4 11.7 35  20.2 15.8 6.1 23.3 NA 65 
 White line disease, mild 16.4 12.3 16.4 45  0.0 13.4 3.0 38.5 NA 55 
 White line disease, severe 10.4 8.7 11.6 31  20.1 16.6 3.2 29.5 NA 69 
Liang et al. (2017)                                                       
 Non-specific lameness, parity 1 7.1 19.2 37.1 63  1.1 12.9 3.1 19.5 NA2 37 
 Non-specific lameness, parity 2+ 4.3 11.6 22.4 38  0.7 12.3 27.2 21.5 NA 62 
Mean 7.2 9.2 9.7   5.9 20.9 23.6 27.6 7.6  
1Veterinarian or hoof trimmer fees, 2NA = not provided
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Table 1.2 Detailed summary of published research estimates of total dairy cow lameness costs, including lameness definition used, 
estimation method, and expenditure and loss categories accounted for within the estimates.    
Study Lameness definition Estimation method Expenditures included
1  Losses included2 Cost estimate3,4 L V T D P  N M F C X O R W 
Harris et al. (1988) Feet problems One-time farm survey  X  X  X  X X  X X    $76/case 
Kaneene and Hurd (1990) Lameness, foot rot, corns Longitudinal farm survey  X X X  X   X  X X    $13/cow/y 
Miller and Dorn (1990) Lameness (nonspecific) Longitudinal farm survey  X X X  X  X X  X X  X  $15/cow-y 
Esslemont and Peeler (1993) Lameness categories Farm surveys and industry 
means X  X   
 
X X X X   X  
$201/case of interdigital disease 
$404/case of digital disease 
$982/case of sole ulcer 
Enting et al. (1997) Clinical digital disease Partial budget model X X X     X X X  X   $174/case 
Kossaibati and Esslemont (1997) Lameness categories Farm and expert opinion 
surveys X X X   
 
X X X X  X X  
$607/cow affected with digital disease 
$331/cow affected with interdigital disease 
$1 073/cow affected with sole ulcer 
Esslemont (2005) Lameness categories Expert surveys and 
published means X X X   
 
X X X X X X X  
$417/cow affected with digital disease 
$176/cow affected with interdigital disease 
$699/cow affected with sole ulcer 
Ettema and Østergaard (2006) Observable lameness 
without inspection of the 
claw or trimming 
Simulation model 
 X X X   
 
 X X  X  X  
$307/affected cow 
Guard (2008) Limping or reluctance to 
move because of  painful 
conditions of the digit(s) 
Partial budget 
X X X   
 
X X X X X    
$533/case 
Willshire and Bell (2009) Lameness categories and 
specific lesion types 
Partial budget 
X X X   
 
X X X X     
$140/digital dermatitis case 
$344/digital lameness case 
$286/interdigital lameness case 
$960/sole ulcer case 
$555/white line disease case 
Bruijnis et al. (2010) Specific lesion types Simulation model 
X X X   
 
X X X X     
$8/cow/y for interdigital phlegmon 
$7/cow/y for interdigital dermatitis and heel erosion 
$22/cow/y for digital dermatitis 
$6/cow/y for sole hemorrhage 
$3/cow/y for white line disease 
$11/cow/y for sole ulcer 
$2/cow/y for interdigital hyperplasia 
Cha et al. (2010) Specific lesion types Simulation model  
 X X   
 
 X X X     
$243/sole ulcer case 
$149/digital dermatitis case 
$136/foot rot case 
Charfeddine and Pérez-Cabal (2017) Specific lesion types Deterministic model 
X X X   
 
X X X X   X  
$53 to $402/cow affected with digital dermatitis 
$232 to $622/cow affected with sole ulcer 
$221 to $590/cow affected with white line disease 
Liang et al. (2017) Undefined Simulation model X X X    X X X X X    $185 to $333/case 
1 L = producer labor; V = veterinary or hoof trimmer labor; T = therapeutics; D = lameness detection; P = lameness control and prevention 
2 N = non-saleable milk; M = reduced milk production; F = reduced reproductive performance; C = increased risk of culling; X = increased risk of death; O = relationships with other diseases; R = 
recurrence of lameness; W = animal welfare   
3 All foreign cost estimates were adjusted from the value reported to United States dollars using the mean exchange rate for the year of publication 
4 All costs were adjusted for inflation from the year of publication to 2017 
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Figure 1.1 Categorization of expenditures and losses that contribute to the total cost of dairy cow lameness 
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Abstract 
The objective of this study was to collect and summarize information on hoof 
disease specific treatment costs charged by hoof trimmers and veterinarians to dairy 
producers.  Additional insight was provided into hoof trimmers’ general billing practices 
and views on the amount and importance of different hoof diseases and the value of 
reducing lameness incidence. Responses were gathered from veterinarians (n = 18) and 
hoof trimmers (n = 116) through both online and paper survey platforms.  Because of the 
limited number of respondents, veterinarian responses were not further analyzed.  Of the 6 
hoof diseases included in the survey, the treatment cost per case was greatest for toe ulcers 
($20.2 ± 8.5), sole ulcers ($19.7 ± 8.6), white line disease ($19.5 ± 8.1), and thin soles 
($18.1 ± 8.1), and least for infectious diseases (foot rot and digital dermatitis; $8.0 ± 7.6 
and $7.5 ± 9.6, respectively).  Of these diseases, digital dermatitis represented most of the 
lameness cases treated by respondents over the past year (43.9 ± 20.4%) whereas toe ulcers 
and thin soles represented the least (5.3 ± 4.1% and 5.3 ± 5.7%, respectively).  Respondents 
that served mostly large herds (> 500 lactating cows) reported a lower prevalence of digital 
dermatitis and a higher prevalence of sole ulcers.  Respondents from the Northeast reported 
a higher prevalence of sole ulcers than other regions outside the Midwest; both were similar 
to the prevalence of sole ulcers reported in the Midwest.     
   When respondents were asked which disease was associated with the greatest total 
cost per case to the producer (treatment and labor costs plus the reduction in milk yield, 
reduced reproductive performance, etc.), hoof trimmers ranked digital dermatitis as having 
the greatest total cost per case and thin soles as having the least total cost per case.  This 
result may have been biased by respondents thinking about the cost of each hoof disease at 
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the herd level rather than at the individual case level.  Finally, respondents indicated that 
the most important benefits of reducing lameness were enhanced animal welfare and 
increased milk production whereas the least important benefit was reduced veterinary and 
hoof trimmer fees.  This survey provided insight into the amount charged by hoof trimmers 
for hoof disease treatment, which can be used to improve the accuracy of hoof disease cost 
estimates and lead to better decision-making regarding both lameness treatment and 
prevention.  
Keywords: lameness, hoof health, disease treatment costs, animal health economics 
Introduction 
The main cause of lameness in dairy cattle is hoof diseases (Van Nuffel et al., 
2015a).  Accurate estimates of the total cost of hoof diseases are essential for identification 
of the best lameness prevention and control strategies to incorporate into herd management 
(Dijkhuizen et al., 1995, Hogeveen et al., 2011).  The total cost of any disease is comprised 
of the expenditures applied to treat and prevent the disease and the losses associated with 
disease occurrence (e.g., reduced milk yield, reduced reproductive performance, increased 
culling; McInerney et al., 1992).  Losses associated with hoof diseases are defined using 
empirical studies that compare cows with and without lameness over time, often throughout 
a lactation.  Many studies have been conducted with the objective of defining these losses 
associated with hoof diseases as summarized by Huxley (2013).  Less emphasis has been 
placed on defining the expenditures associated with a hoof disease case.   
Expenditures are divided between disease prevention and treatment costs 
(McInerney et al., 1992).  Prevention expenditures are commonly ignored in hoof disease 
cost estimates because of their difficulty to calculate (Chapter 1).  Treatment expenditures 
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within hoof disease cost estimates are often based on the author’s opinion or outdated and 
non-specific values.  For example, treatment costs are assumed to be the same regardless 
of the hoof disease causing lameness and are not broken down into labor vs. supplies.  In 
reality, these costs depend on the type of hoof disease, the severity of the condition, the 
treatment used, and the person treating the case (i.e., producer, hoof trimmer, or 
veterinarian).  The best estimate of these costs would come from those that charge the 
producer for them (i.e., hoof trimmers and veterinarians), but limited published data from 
these sources exist.  
 This study aimed to collect and summarize information on hoof disease treatment 
costs charged by hoof trimmers and veterinarians to dairy producers.  Additional insight 
was provided into hoof trimmers’ general billing practices and views on the amount and 
importance of different hoof diseases and the value of reducing lameness incidence.   
Materials and Methods 
      Survey development 
 A survey was drafted with the goal of defining treatment costs for a variety of hoof 
diseases as charged to producers by hoof trimmers and veterinarians.  The drafted survey 
was reviewed by industry veterinarians (n = 2), academic veterinarians (n = 5), academic 
professionals (n = 7), and animal science graduate students (n = 10) to collect feedback on 
content and organization.  Based on collected feedback, revisions were made before the 
survey was sent to survey participants.  The final survey questions are included in 
Appendix Table A1.  The revised survey was also reviewed by the University of Kentucky 
Institutional Review Board and found exempt from human subject protection regulations 
as described in 45 CFR 46.101(b).   
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 Demographic information elicited by the survey included profession (veterinarian, 
hoof trimmer, or other), the location of practice (country or states served, if within the 
United States), herd sizes served, and the mean number of dairy cows trimmed per week 
(broken out into preventive and treatment trimmings).  Respondents selecting “other” for 
their profession were removed from the survey results because they were outside of the 
target audience.  General lameness questions were formulated to evaluate the rate charged 
by hoof trimmers and veterinarians to come to a farm and conduct either preventive or 
treatment trimmings.  These questions included 1) asking respondents if they charged a 
visit, daily, or set-up fee and, if so, how much, 2) the on-farm rate ($/h or $/cow) charged 
for preventive trimming, and 3) the mean number of cows trimmed per hour.   
 Condition-specific lameness questions focused on 6 diseases: digital dermatitis, 
foot rot, sole ulcer, thin sole, toe ulcer, and white line disease.  These diseases were chosen 
based on their expected prevalence and feedback from those who reviewed the first version 
of the survey.  All diseases were defined within the survey according to industry standards 
(Zinpro, 2014; Appendix Figure A1).  Condition-specific questions included the total 
amount charged to the producer for treatment of each disease along with the percent of the 
total cost attributed to labor and the percent of the total cost attributed to supplies.  
Additionally, respondents were asked to estimate the amount of time spent to treat a case 
of each disease, the percent of lameness cases treated in the past year attributed to each 
disease, and milk withhold recommendations following treatment.  Retrospectively, the 
question about milk withhold recommendations was removed from the study results 
because of United States regulations restricting hoof trimmers from prescribing antibiotics. 
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 Finally, respondents were asked to answer two rank order questions.  First, they 
were asked to rank the 6 hoof diseases based on their opinion of the total cost per case to 
the producer (treatment and labor costs plus the reduction in milk yield, reduced 
reproductive performance, etc.) from most expensive (1) to least expensive (6).  Second, 
they were asked to rank the importance to producers of 8 potential benefits (identified by 
the authors) of reducing dairy cow lameness from most important (1) to least important (8).  
The potential benefits included decreased incidence of other diseases (not lameness), 
enhanced animal welfare, increased milk production, increased reproductive performance, 
increased cow longevity, reduced drug and supply costs, reduced producer labor costs, and 
reduced veterinary and hoof trimmer fees.  
      Survey distribution 
 The target audience for the survey was veterinarians and hoof trimmers.  Therefore, 
the American Association of Bovine Practitioners (AABP) and the Hoof Trimmers 
Association (HTA) were identified as potential respondent sources.  Based on the response 
rates from AABP and HTA members to a previous lameness survey (Kleinhenz et al., 
2014), the decision was made to create an online version of the survey for AABP members 
and a paper version of the survey for HTA members.   
 The online survey was created using Qualtrics (Qualtrics Research Suite, Provo, 
UT).  We identified that the best way to distribute the online survey to AABP members 
would be through their member e-mail listserv (n ≈ 2,000 recipients).  A link to the survey 
was first sent to the AABP listserv on June 12, 2017.  Follow-up e-mails were sent to the 
AABP listserv 1 week and again 4 weeks after the original e-mail solicitation to remind 
potential respondents to complete the survey.  The final e-mail to the AABP listserv, sent 
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on August 1st, 2017, indicated that the survey would be closing on August 15th, 2017.  All 
e-mails sent to AABP members and the online survey itself included instructions for 
accessing and returning (via mail at their own expense) a downloadable paper version of 
the survey in case that was the respondent’s preference.  All online surveys submitted by 
and paper surveys received by August 31st, 2017 were included in the analysis.   
 Hoof trimmers identified by the HTA (n = 548) were mailed a paper survey with 
identical questions as the online survey on June 12, 2017, using a third-party mailing 
company selected by the HTA.  The paper survey included pre-paid envelopes to return the 
survey to the University of Kentucky.  The paper survey also included instructions to access 
the online version of the survey in case that was the respondent’s preference.  One week 
after the first paper survey mailing, a follow-up postcard was sent to all original recipients 
to remind them to return the survey.  A difference in postage class resulted in the reminder 
postcards arriving before the originally mailed paper survey.  Because of this, the second 
and final mailing of the paper survey (only sent to non-respondents) was delayed until 5 
weeks after the original mailing (July 17, 2017).  Non-respondents were identified by 
labeling the originally mailed surveys with a number that corresponded to a recipient.  The 
list of recipients was not referenced after the final mailing.  All paper surveys received by 
August 31st, 2017 were included in the analysis. 
 At survey closure, 83 people had started the online survey and 16 completed the 
entire online survey (completion rate = 19%).  One hundred and twenty-three paper surveys 
were returned, and only 1 was from a veterinarian.  Therefore, we obtained a 22% response 
rate from the targeted mailing list.  Nine paper survey respondents indicated that they were 
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retired, 1 respondent indicated that they only trimmed beef cattle, and 1 other indicated that 
they only trimmed for their own herd; these 11 surveys were removed from the dataset.   
      Statistical analysis 
 Responses from paper surveys were manually entered into the online survey to 
standardize data from both sources.  When respondents reported a range for any answer 
(e.g. indicated that they trimmed 10 to 15 cows per hour), the mean of the range was 
calculated for further analysis (e.g. 12.5 cows per hour).  For questions where answers were 
supposed to add up to 100%, (i.e., the percent of each type of hoof disease treated and the 
percent of the total cost attributed to labor and supplies), if the total was not 100% the 
answers were standardized to total 100%.  For rank order questions, if two or more options 
were ranked the same, the tied rankings were removed from the dataset (n = 4 for the rank 
order question about the total cost per case of disease and n = 5 for the rank order question 
about the importance of potential benefits of reducing lameness). Finally, any unanswered 
questions were removed from the dataset.   
Respondents were categorized by profession (veterinarian or hoof trimmer), region 
of practice, herd sizes served, and trimming frequency.   The region of practice was defined 
based on a respondent’s answer to which states they served in the United States.  The region 
classifications included Midwest (states represented included IA, IL, IN, KS, MI, MN, ND, 
NE, OH, SD, and WI), Northeast (states represented included CT, MA, MD, ME, NH, NY, 
PA, RI, and VT), Southeast (states represented included AL, AR, FL, GA, KY, MO, MS, 
TN, and VA), Southwest (states represented included NM and TX), and West (states 
represented included CO, ID, MT, OR, and WA).  If the respondent indicated they served 
herds in more than one region, their region was defined based on the category representing 
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most of the listed states.  Eighty-two percent of respondents were from either the Midwest 
or the Northeast; therefore, the remaining regions were grouped into an “other” region 
category.  Only 3 usable responses were from outside the United States; these responses 
were removed from the dataset because of the inability to distinguish which currency 
answers were given in. 
Herd size served was based on each respondent’s answer to the question, “Estimate 
the number of farms you perform preventive or corrective trimming for each year that 
would fall under each category: small herds (fewer than 100 lactating cows), medium herds 
(between 100 and 500 lactating cows), and large herds (over 500 lactating cows).”  
Respondents were placed into 1 of 3 categories based on which size herds represented most 
of their clientele.  A respondent with most of their clientele classified as small herds was 
categorized as “small” herd size served, a respondent with most of their clientele classified 
as medium herds was categorized as “medium” herd size served, and a respondent with 
most of their clientele classified as large herds was categorized as “large” herd size served.  
In cases where the respondent served the same number of herds in two categories, 
preference was given to the extreme value (i.e. if the same number of small and medium-
sized herds were served, the respondent was classified as “small” herd size served, and if 
the same number of medium and large herds were served, the respondent was classified as 
“large” herd size served; in no cases were the same number of small and large sized herds 
served).   
Trimming frequency was based on the response to the question, “On average, how 
many dairy cows do you conduct preventive trimming for weekly (i.e., routine trimming)?”  
Tertiles were calculated from the responses used in linear regression analysis and were 
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used to classify trimming frequency as either low (≤ 150 trims per week), medium (between 
150 and 250 trims per week), or high (≥ 250 trims per week).     
Statistical analyses were conducted using SAS Version 9.4 (SAS Institute Inc., 
Cary, NC).  For both online and paper surveys, provided answers were included in the 
descriptive statistics even if a respondent did not finish the survey (22% and 78% 
completion rate for online and paper surveys, respectively).  The MEANS procedure was 
used to summarize how many cows were trimmed per hour when conducting preventive 
trims, the rate charged for preventive trimming, the percent of lameness treatments 
attributed to each hoof disease, the time spent treating each hoof disease, the total cost per 
case of each hoof disease, the percent of the total costs of each hoof disease attributed to 
labor, and the percent of the total costs of each hoof disease attributed to supplies.  The 
FREQ procedure was used to summarize if an extra fee was charged (yes or no) and the 
frequency of ranking for both rank-order questions. 
Because very few responses were received from veterinarians (n = 18), only hoof 
trimmer responses were analyzed for statistical difference by demographics.  The GLM 
procedure of SAS was used to analyze the effects of region, herd size served, and trimming 
frequency on the preventive trimming rate, the number of cows trimmed per hour, the 
percent of treated lameness cases attributed to each hoof disease, the amount of time spent 
treating each hoof disease, the total cost charged to producers for treatment of each hoof 
disease, the percent of the total cost of each hoof disease attributed to labor, and the percent 
of the total cost of each hoof disease attributed to supplies: 
𝑦𝑦𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = 𝜇𝜇 + 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑖𝑖 + 𝐻𝐻𝑅𝑅𝑒𝑒𝑒𝑒𝑒𝑒𝑅𝑅𝑒𝑒𝑅𝑅𝑖𝑖 + 𝑇𝑇𝑒𝑒𝑅𝑅𝑇𝑇𝑇𝑇𝑅𝑅𝑅𝑅𝑅𝑅𝑇𝑇𝑒𝑒𝑅𝑅𝑇𝑇𝑇𝑇𝑅𝑅𝑅𝑅𝑇𝑇𝑦𝑦𝑖𝑖 +  𝑅𝑅𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 
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where y is the outcome variable of interest for the lth respondent classified in the kth 
trimming frequency category, the jth herd size served category, and the ith region; µ is the 
intercept; i is Midwest, Northeast, or Other; j is small, medium, or large; k is low, medium, 
or high; and eijkl is residual error.  For all models, differences were considered significant 
when P < 0.05 and all effects were retained regardless of significance.    
Results and Discussion 
  The objective of this study was to gain insight into hoof disease treatment costs 
charged to dairy producers by hoof trimmers and veterinarians.  Table 1 summarizes the 
distribution of respondents used in at least one descriptive statistic calculation by 
profession, survey type returned, region of practice, herd size served, and trimming 
frequency.  The survey distribution methods used in our study (i.e., online surveys for 
veterinarians and mailed surveys for hoof trimmers) were based on results from Kleinhenz 
et al. (2014) who surveyed the same population.  Different from Kleinhenz et al. (2014), 
we received very few completed AABP responses to our online survey.  The low 
completion rate of online surveys could indicate that veterinarians who started the survey 
deemed the topic inapplicable to them.  To support the idea that the veterinarian 
respondents were less involved in lameness treatment than the hoof trimmer respondents, 
all veterinary respondents to the survey were categorized in the low trimming frequency 
group (Table 1).  Additionally, one veterinary respondent stated, “I rarely get asked to work 
on lame cows.”  In agreement, Adams et al. (2016) reported that 77% of United States dairy 
farms used a professional hoof trimmer for hoof health services compared to only 16% 
using a veterinarian or on-farm staff.  Still, one limitation of the current study is that the 
received responses, especially from veterinarians, may not be entirely representative of the 
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target population because of nonresponse bias.  Because of this, veterinarian response 
summary statistics are only included in the Appendix (Tables A2 to A4).  Interpretation of 
veterinarian responses should be conducted carefully, keeping in mind the limited response 
rate.  
      General lameness 
  On average, hoof trimmers reported trimming 10.0 ± 5.0 cows per hour (n = 116).  
The number of cows trimmed per hour differed by trimming frequency with low and 
medium frequency trimmers trimming fewer cows per hour than high frequency trimmers 
(7.66 ± 0.66, 9.34 ± 0.79, and 13.70 ± 0.66 cows/h, respectively; n = 111; P < 0.01).  This 
could be because trimmers who trim more frequently are better practiced or have better 
equipment than trimmers that trim less frequently.  Alternatively, trimmers who trim more 
frequently may have regular clients, making trimming visits quicker (because the cows’ 
hooves are in better shape) than a farm that is not visited by a hoof trimmer regularly. 
Ninety-nine percent (n = 114) of hoof trimmer respondents billed per cow, rarely 
charging an extra fee (visit, daily, or set-up) of any kind (only 12% of respondents, mean 
± SD = 87.9 ± 133.4, n = 14).  The mean ± SD rate charged by hoof trimmers was $12.55 
± 2.38/cow (n = 113).  Trimming rate ($/cow) differed by region and herd size served.  
Hoof trimmers from the Midwest charged a greater fee ($13.21 ± 0.31/cow) than hoof 
trimmers from either the Northeast ($11.73 ± 0.33/cow) or other regions in the United 
States ($10.89 ± 0.47/cow; n = 108; P < 0.01).  A large portion of dairy farms in the United 
States are located in the Midwest (USDA, 2017b), potentially contributing to a greater 
demand for hoof trimmers and the ability to charge an increased fee.  Hoof trimmers 
serving mostly large herds charged a reduced fee ($11.10 ± 0.43) compared to those serving 
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mostly medium sized herds ($12.54 ± 0.33/cow, P = 0.04).  Neither was different from 
hoof trimmers serving mostly small herds ($12.19 ± 0.35/cow).   The effect of herd size on 
fees charged by hoof trimmers could be attributed to economies of scale where large farms 
would be charged less because the fixed costs of hoof trimming (e.g., travel expenses) 
could be spread over more cows.  Although interactions weren’t tested in the model, it was 
noted that the ranking of rates charged to different herd sizes differed numerically by region 
with hoof trimmers in the Midwest charging the most to large herds, hoof trimmers in the 
Northeast charging the most to medium herds, and hoof trimmers in other regions charging 
the most to small herds.  
      Condition-specific lameness 
Prevalence of hoof diseases.  Among treated cases over the past year, respondents 
estimated that digital dermatitis was most prevalent, followed by sole ulcers, white line 
disease, other lameness, foot rot, toe ulcers, and thin soles (Table 2).  Very few studies 
identifying specific lesions have been conducted in the United States, making an estimate 
of actual hoof disease prevalence or incidence difficult.  Bicalho et al. (2007) found in 459 
cows on a New York dairy that the most common hoof diseases were a sole ulcer (52%), 
digital dermatitis (20%), white line disease (15%), other lameness (10%), toe ulcers (3%), 
and foot rot (1%).  Similarly, other studies have identified sole ulcers as the most common 
condition causing lameness in dairy cows, but rarely do studies include identification of 
toe ulcers or thin soles (Amory et al., 2008, Gernand et al., 2012).  Sanders et al. (2009) 
found in a Florida herd of 4,915 cows that 38% of lameness cases were attributed to other 
lameness (including digital dermatitis, foot rot, heel ulcers, leg injuries, sole punctures, and 
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others), 20% to thin sole induced toe ulcers, 16% to sole ulcers, 13% to thin soles, 10% to 
white line disease, and 2% to toe ulcers.   
Inconsistent with previous research, hoof trimmer respondents to this survey 
reported the percentage of treated cases attributed to digital dermatitis as much greater than 
the cases attributed to sole ulcers (44% vs. 16%).  One factor that might contribute to this 
is that hoof trimmers conduct more preventive trimming and are more likely to see both 
lame and non-lame cows, thereby observing both mild and severe conditions.  Additionally, 
the types and prevalence of hoof diseases present in a herd depend on both management 
and the environment (Cook and Nordlund, 2009).   Therefore, variation among herds is 
expected and likely contributed to the variation in reported prevalence of hoof diseases 
seen in our study.  Regardless, the viewpoint of the surveyed hoof trimmers likely does not 
represent the true occurrence of different hoof disease because they do not always examine 
every lame cow.   
 Region, herd size served, and trimming frequency did not influence the percent of 
treatments over the past 12 months classified as foot rot, thin soles, toe ulcers, white line 
disease, or other lameness (P > 0.05).  The percent of digital dermatitis was influenced by 
herd size served (P = 0.02, n = 107) where hoof trimmers serving mostly large herds 
reported less digital dermatitis (31.6 ± 4.2%) than hoof trimmers serving mostly small or 
medium-sized herds (44.4 ± 3.4% and 46.7 ± 3.2%, respectively).  One possible 
explanation for this observation is that large farms may have protocols and consistent labor 
available to prioritize footbath use.  However, the exact reason for this observation cannot 
be extrapolated from the data available in this study.  The percent of sole ulcers reported 
was influenced by region and herd size served (P = 0.03 and P = 0.03, respectively; n = 
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107).  Respondents from the Northeast reported more sole ulcers (22.1 ± 2.3%) than 
respondents from other regions in the United States (12.4 ± 3.3%); neither differed from 
Midwestern respondents (15.2 ± 2.1%).  It is possible that differences in style and age of 
housing contributed to these reported differences, however, an exact reason for this 
observation is not clear.  Respondents serving mostly large herds reported more sole ulcers 
(23.1 ± 3.0%) than respondents serving either medium sized herds (13.3 ± 2.3%) or small 
sized herds (13.4 ± 2.4%).  This could be because large herds from the Midwest and 
Northeastern regions (most respondents) are more likely to house cows on concrete 
(NAHMS, 2014), which is a risk factor for sole ulcer development (Zinpro, 2014).  
Treatment time.  Among all respondents, the mean time to treat a case of lameness 
was longest for toe ulcers, followed by white line disease, sole ulcers, thin soles, foot rot, 
and digital dermatitis (Table 2).  Conditions requiring more remodeling of the foot, like 
ulcers and white line disease (Andrews et al., 2008), required more time to treat.  Region, 
herd size served, and trimming frequency did not influence the time required to treat foot 
rot, sole ulcers, thin soles, toe ulcers, or white line disease (P > 0.05).  The time to treat 
digital dermatitis differed by trimming frequency where hoof trimmers classified as high 
trimming frequency spent less time treating digital dermatitis (1.6 ± 0.3 min) than those 
with a low trimming frequency (3.0 ± 0.3 min; P < 0.01, n = 108).  Hoof trimmers classified 
as medium trimming frequency fell in between the two extremes (2.1 ± 0.3 min).  Although 
numerical differences were minimal, hoof trimmers with a high trimming frequency may 
be quicker because they have had more practice and additionally might have equipment 
that allows for quicker treatments.  
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Cost per case.  The mean total charged per case of each hoof disease was greatest 
for toe ulcers, followed by sole ulcers, white line disease, thin sole, foot rot, and digital 
dermatitis (Table 2).  Previous studies focused on veterinarian and hoof trimmer opinions 
about hoof disease costs are limited.  Similar to our findings, Charfeddine and Pérez-Cabal 
(2017) found in a survey of Spanish hoof trimmers that the cost to treat sole ulcers and 
white line disease were similar to each other, with the treatment of digital dermatitis being 
less.  We observed that many of the respondents indicated that they charged equal amounts 
for the two infectious diseases (digital dermatitis and foot rot) and identical, but larger, 
amounts for non-infectious diseases (sole ulcers, white line disease, thin soles, and toe 
ulcers).  This observation is likely because similar supplies would be used to treat infectious 
(wrap) and non-infectious (block) hoof diseases.  The hoof trimmer reported cost per case 
did not differ by region, herd size served, or trimming frequency for any of the hoof 
diseases (P > 0.05).   
Costs attributed to labor vs. supplies.  The percent of the total cost attributed to 
either labor or supplies by hoof disease is included in Table 2.  The difference in the percent 
of the cost attributed to labor between diseases is likely the result of different treatment 
methods for different diseases.  Traditional infectious lameness treatments often involve 
cleaning and topical application of antibiotics in a foot wrap whereas non-infectious lesions 
involve trimming and blocking the hoof to reduce weight bearing on the affected claw 
(Andrews et al., 2008).  Some paper survey respondents wrote in comments about the cost 
per block or per wrap used.  Mean wrap price was $3.92 ± 1.71 (n = 13) and mean block 
price was $16.00 ± 6.15 (n = 18).  Therefore, it is not surprising that we found a greater 
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percentage of costs attributed to labor for infectious diseases and a greater percentage of 
costs attribute to supplies for non-infectious diseases.   
Region, herd size served, and trimming frequency did not influence the percent of 
total costs attributed to labor or supplies for digital dermatitis, sole ulcers, thin soles, toe 
ulcers, or white line disease (P > 0.05).  The percent of the total cost of foot rot attributed 
to supplies did not differ by region, herd size served, or trimming frequency, but the percent 
of the total cost of foot rot attributed to labor differed by region (P = 0.03, n = 81).  For 
unknown reasons, hoof trimmers from the Midwest attributed more of the foot rot costs to 
labor (75.6 ± 4.2%) than hoof trimmers from the Northeast (60.6 ± 4.2%).      
      Rank order responses 
Hoof disease total costs.  Respondents were asked to rank the selected hoof diseases 
based on the total cost per case to the producer (treatment and labor costs plus the reduction 
in milk yield, reduced reproductive performance, etc.) from most expensive (1) to least 
expensive (6).  The frequency of responses is reported in Table 3.  Hoof trimmer 
respondents most often ranked digital dermatitis total cost per case to the producer as 
greatest.  Conversely, multiple previously published economic estimates of lameness costs 
agree that sole ulcers are the most expensive hoof disease per case whereas infectious 
conditions, including digital dermatitis and foot rot, tend to be the least expensive per case 
(Willshire and Bell, 2009, Cha et al., 2010, Charfeddine and Pérez-Cabal, 2017).  The 
survey question about the cost ranking of different hoof diseases tried to emphasize the 
cost per case component, but the ranking of digital dermatitis total costs per case as first 
by hoof trimmers could indicate that some respondents focused more on the total cost to 
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the herd.  This is especially possible given that respondents reported charging producers 
more to treat either sole ulcers or white line disease than digital dermatitis (Table 2). 
Interestingly, among hoof trimmer respondents that did not rank digital dermatitis 
as first, most ranked the total cost per case of digital dermatitis as last.  This indicates that 
some of the respondents likely did consider the per-case portion of the question more 
seriously than others.  Thin soles were most commonly ranked as the lowest cost per case 
to the producer.   No previous lameness cost estimate studies have included either toe ulcers 
or thin soles and rarely have epidemiological studies included these conditions.  Therefore, 
it is unclear if ranking of thin soles as having the least total cost per case is consistent with 
reality or not; more research on the effects of this condition on cow performance is needed.  
Lameness reduction benefits.  Respondents were asked to rank selected potential 
benefits of reducing lameness from most important (1) to least important (8).  The 
frequency of responses is reported in Table 4.  Among hoof trimmers, enhanced animal 
welfare and increased milk production were the most important benefits identified.  
Chapter 1 summarized that the top contributing categories to the total cost of lameness 
have traditionally been calculated as increased culling and death, reduced reproductive 
performance, and decreased milk yield.  However, no previous literature has considered 
the costs of lameness attributed to negative animal welfare, excluding it from consideration 
in that study.  In agreement with respondents to this survey, recent studies have highlighted 
the connection between animal welfare and lameness (Von Keyserlingk et al., 2009, 
Barkema et al., 2015).   
Reduced veterinary and hoof trimmer fees were ranked as the least important potential 
benefit associated with reducing lameness.  This was in agreement with Chapter 1 which 
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found that previous total cost of lameness estimates have ranked reduced drug and supply 
costs, reduced outside labor, and reduced producer labor as less important cost categories.  
The second least important response was decreased incidence of other diseases.  Evidence 
of the connection between lameness and other diseases is mixed (Chapter 1).  Overall, 
respondent’s answers indicate that hoof trimmers have a good understanding of the 
contribution of different cost categories to the total cost of lameness as defined in currently 
available literature.  However, the voluntary survey strategy may have selected for hoof 
trimmers that are more interested in research and up-to-date on published literature, 
potentially influencing rank order responses. 
Conclusions 
 The goal of this study was to collect information on hoof disease treatment costs 
charged by hoof trimmers and veterinarians to dairy producers.  Low responses rates from 
veterinarians limited our study to hoof trimmer opinions only.  Hoof trimmers reported that 
hoof disease treatment cost per case was greatest for toe ulcers, followed by sole ulcers, 
white line disease, thin sole, foot rot, and digital dermatitis.  Additional insight was 
provided into hoof trimmers’ general billing practices and views on the amount and 
importance of different hoof diseases and the value of reducing lameness incidence.  
Minimal effects of region, herd size served, or trimming frequency were found on 
responses.  The treatment cost estimates found in this study can aid in improving economic 
estimates of the total cost per case of different hoof diseases.  More accurate hoof disease 
total cost per case estimates could help improve decisions regarding the treatment of 
individual hoof disease cases and the adoption of lameness prevention strategies.    
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Table 2.1 Distribution of respondents to a survey1 about dairy hoof disease treatment costs 
by profession, survey type, region, herd size served, and trimming frequency 
Category Profession Total Veterinarian Hoof Trimmer 
Survey type    
 Online 17 5 22 
 Paper 1 111 112 
Region2    
 Midwest 11 55 66 
 Northeast 3 41 44 
 Other 4 20 24 
Herd size served3    
 Small (< 100 cows) 7 45 52 
 Medium (100 to 500 cows) 7 42 49 
 Large (> 500 cows) 0 25 25 
Trimming frequency4    
 Low (< 150 cows/wk) 18 32 50 
 Medium (150 to 250 cows/wk) 0 41 41 
 High (>250 cows/wk) 0 42 42 
Total 18 116  
1An online version of the survey was sent to the American Association of Bovine 
Practitioners listserv (n ≈ 2,000 members) and a paper version of the survey was mailed to 
548 hoof trimmers identified by the Hoof Trimmers Association 
2Midwest states represented included IA, IL, IN, KS, MI, MN, ND, NE, OH, SD, and WI; 
Northeast states represented included CT, MA, MD, ME, NH, NY, PA, RI, and VT; Other 
states represented included AL, AR, FL, GA, KY, MO, MS, TN, VA, NM, TX, CO, ID, 
MT, OR, and WA. 
3Herd size served was categorized based on if the respondent’s clients were mostly small 
herds (fewer than 100 lactating cows), medium herds (between 100 and 500 lactating 
cows), or large herds (over 500 lactating cows). Eight respondents did not provide 
sufficient information to classify them according to herd size served but were still included 
in descriptive statistics. 
4Trimming frequency was categorized based on the calculated tertiles of responses used in 
linear regression analysis; 1 respondent did not provide sufficient information to classify 
hoof trimming frequency but was still included in descriptive statistics   
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Table 2.2 Hoof trimmer responses to a survey regarding dairy hoof disease prevalence, 
time to treat, treatment costs, and the percentage of costs attributed to labor or supplies 
Hoof disease 
Number of responses 
(n) 
 Response 
(mean ± SD) 
Digital dermatitis    
 % of total 112  43.9 ± 20.4† 
 Time to treat (min) 113  2.2 ± 1.9‡ 
 Total charged ($/case) 98  7.5 ± 9.6 
  % attributed to labor 92  65.1 ± 21.8 
  % attributed to supplies 92  34.9 ± 21.8 
Foot rot    
 % of total 112  6.5 ± 7.0 
 Time to treat (min) 111  3.7 ± 2.7 
 Total charged ($/case) 90  8.0 ± 7.6 
  % attributed to labor 85  66.0 ± 21.8⁎ 
  % attributed to supplies 85  32.8 ± 20.8 
Sole ulcer    
 % of total 112  15.9 ± 14.2⁎† 
 Time to treat (min) 114  6.2 ± 3.5 
 Total charged ($/case) 95  19.7 ± 8.6 
  % attributed to labor 90  58.8 ± 19.8 
  % attributed to supplies 90  41.2 ± 19.8 
Thin sole    
 % of total 112  5.3 ± 5.7 
 Time to treat (min) 107  5.1 ± 3.3 
 Total charged ($/case) 89  18.1 ± 8.1 
  % attributed to labor 82  56.7 ± 20.7 
  % attributed to supplies 82  43.3 ± 20.7 
Toe ulcer    
 % of total 112  5.3 ± 4.1 
 Time to treat (min) 111  7.1 ± 3.6 
 Total charged ($/case) 96  20.2 ± 8.5 
  % attributed to labor 91  57.5 ± 20.5 
  % attributed to supplies 91  42.5 ± 20.5 
White line disease    
 % of total 112  14.2 ± 10.2 
 Time to treat (min) 113  6.5 ± 3.1 
 Total charged ($/case) 96  19.5 ± 8.1 
  % attributed to labor 90  57.9 ± 21.2 
  % attributed to supplies 90  42.1 ± 21.2 
Other lameness    
 % of total treatments 112  8.9 ± 9.3 
⁎Indicates a statistical difference between hoof trimmers by region (Midwest, Northeast, or other region of the United 
States; P < 0.05); further details included in the text 
†Indicates a statistical difference between hoof trimmers by herd size served (small, medium, or large; P < 0.05); further 
details included in the text 
‡Indicates a statistical difference between hoof trimmers by trimming frequency (low, medium, or high; P < 0.05); further 
details in the text   
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Table 2.3 Ranking frequency of the estimated total cost per case to the producer (treatment 
and labor costs plus the reduction in milk yield, reduced reproductive performance, etc.) of 
selected hoof diseases as evaluated by a survey of hoof trimmers.  Ranking was from most 
expensive (1) to least expensive (6).  
Disease 
Response frequency (%) 
n 1 2 3 4 5 6 
Digital dermatitis 112 33.9 9.8 4.5 9.8 13.4 28.6 
        
Toe ulcer 109 22.9 19.3 15.6 19.3 12.8 10.1 
        
Foot rot 111 19.8 11.7 9.9 20.7 19.8 18.0 
        
Sole ulcer 111 11.7 27.0 26.1 17.1 13.5 4.5 
        
White line disease 112 7.1 23.2 30.4 20.5 8.9 9.8 
        
Thin sole 111 6.3 7.2 13.5 12.6 30.6 29.7 
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Table 2.4 Ranking frequency of the potential benefits to producers of reducing dairy cow 
lameness as evaluated by a survey of hoof trimmers.  Ranking was from most important 
(1) to least important (8). 
Potential benefit 
Response frequency (%) 
n 1 2 3 4 5 6 7 8 
Enhanced animal welfare 106 36.8 12.3 13.2 17.9 6.6 4.7 2.8 5.7 
          
Increased milk production 105 32.4 24.8 18.1 7.6 6.7 1.0 3.8 4.8 
          
Increased cow longevity 106 20.8 21.7 22.6 15.1 13.2 5.7 0.0 0.9 
          
Reduced veterinary and 
hoof trimmer fees 103 4.9 1.0 2.9 8.7 14.6 17.5 21.4 29.1 
          
Decreased incidence of 
other diseases (not 
lameness) 
105 2.9 7.6 7.6 11.4 20.0 13.3 11.4 25.7 
          
Increased reproductive 
performance 106 2.8 27.4 26.4 20.8 10.4 6.6 4.7 0.9 
          
Reduced drug and supply 
costs 105 1.0 2.9 4.8 12.4 13.3 31.4 21.0 13.3 
          
Reduced producer labor 
costs 106 0.0 3.8 3.8 6.6 14.2 18.9 34.9 17.9 
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Abstract 
 A farm-level stochastic simulation model was modified to estimate the cost per case 
of 3 hoof diseases (digital dermatitis, sole ulcer, and white line disease) by severity, 
incidence timing, and parity group.  Disease expenditures considered within the model 
included therapeutics, outside labor, and on-farm labor.  Disease losses considered within 
the model included discarded milk, reduced milk production, extended days open, an 
increased risk of culling, an increased risk of death (natural or euthanized), and disease 
recurrence.  All estimates of expenditures and losses were defined using data from 
previously published research in stochastic distributions.  Monte Carlo simulation was used 
to account for variation within the farm model; 1,000 iterations were run.  Sensitivity of 
hoof disease costs to selected market prices (milk price, feed price, replacement heifer 
price, and slaughter price) and herd specific performance variables (rolling herd average 
milk production and pregnancy rate) was analyzed.  Using our model assumptions, the cost 
per case of disease over all combinations of severity, incidence timing, and parity group 
was lowest for digital dermatitis (mean ± SD = $137 ± 36), followed by white line disease 
(mean ± SD = $203 ± 33), and sole ulcer (mean ± SD = $227 ± 35).  Disease costs were 
greater in severe vs. mild cases and multiparous vs. primiparous cows and were always 
highest at the beginning of lactation.  The greatest contributing cost categories were 
decreased milk production, an increased risk of culling, disease recurrence, and, in severe 
cases, an increased risk of death.  The contribution of cost categories to the total cost of 
disease varied by disease type, severity, incidence timing, and parity group.  For all 
diseases, the average cost per case of disease increased as milk price, rolling herd average 
milk production, or replacement heifer price increased and decreased as feed price, 
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pregnancy rate, or slaughter price increased.  Understanding how hoof disease costs change 
according to cow-specific conditions (i.e., severity level, DIM at incidence, and parity 
group) and herd-specific conditions (i.e., market prices and performance variables) can 
help improve on-farm decisions about treatment and prevention of hoof diseases.   
Key Words: lameness, disease cost, hoof health, animal health economics   
Introduction 
Lameness is a widespread issue in the dairy industry, with prevalence ranging from 
5.5% to 70.1% (mean = 27.2 ± 11.9%) on United States and Canadian dairy farms (Costa 
et al., 2017).  Although often referred to as a disease itself, lameness is actually a clinical 
sign associated with multiple different hoof diseases.  Each case of lameness, and the 
associated hoof disease that is causing it, is associated with both direct expenditures (e.g., 
on-farm labor, hoof trimmer labor, and therapeutics) and indirect losses (e.g., discarded 
milk, reduced milk production, reduced reproductive performance, increased risk of death, 
increased risk of culling, and disease recurrence; Chapter 1).  Understanding the total cost 
per hoof disease case is valuable for improving management at both the cow and herd level 
by aiding in the selection of lameness treatment strategies, culling strategies, and 
prevention investments.   
Most previous lameness cost estimates have focused on either the cost of lameness 
at the herd level (Kaneene and Hurd, 1990, Miller and Dorn, 1990), the cost per case of 
non-specific lameness (Harris et al., 1988, Guard, 2008, Liang et al., 2017), or the cost per 
case of lameness categorized as interdigital, digital, or sole ulcer (Esslemont and Peeler, 
1993, Kossaibati and Esslemont, 1997, Esslemont, 2005).  More recently, specific hoof 
diseases have been considered when calculating the cost per case of lameness (Willshire 
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and Bell, 2009, Bruijnis et al., 2010, Cha et al., 2010, Charfeddine and Pérez-Cabal, 2017).  
However, Chapter 1 highlighted that these costs often still fail to consider how severity, 
incidence timing relative to calving, or parity affects the cost of the disease even though 
previous literature supports that these differences exist.  Charfeddine and Pérez-Cabal 
(2017) identified differences in both direct (trimmer fees, treatment fees, producer labor, 
and discarded milk) and indirect (milk loss, days open, and length of productive life) 
negative consequences when comparing mild and severe lesions, emphasizing the need to 
account for this factor in cost estimates.  Booth et al. (2004) demonstrated how the effect 
of hoof diseases on survival differed depending on disease diagnosis timing.  Logically, 
incidence timing would also influence discarded milk and reduced milk production because 
of yield changes throughout lactation and reduced reproductive performance, assuming a 
reduced effect of lameness on reproduction after pregnancy is established.  Liang et al. 
(2017) found that the total cost per case of non-specific lameness was 1.8 times greater in 
multiparous cows than primiparous cows.  The authors attributed most of the difference to 
increased multiparous cow losses associated with reduced milk yield, culling, and extended 
days open.  
The objective of this study was to build a stochastic simulation model capable of 
estimating hoof disease costs depending on disease type, severity level, incidence timing, 
and parity group.  Other studies (Ettema and Østergaard, 2006, Bruijnis et al., 2010, Liang 
et al., 2017) have also used stochastic simulation to estimate disease costs which allows 
evaluation of how disease costs change with variation in farm specific and market values.  
To demonstrate usefulness, the model was used to calculate the cost per case of digital 
dermatitis, sole ulcer, and white line disease in an example United States dairy herd.  
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Materials and Methods 
      Model overview 
A pre-existing farm-level, Monte Carlo simulation model was adapted for use in 
this study (Bewley et al., 2010, Liang et al., 2017).  The model was created using Excel 
2016 (Microsoft, Seattle, Washington) and stochastic features were applied using the 
@Risk add-in (Version 7, Palisade Corporation, Ithaca, New York).  As described 
previously by Liang et al. (2017), the model worked by calculating the milk yield 
(estimated via the lactation curve described by Skidmore (1990)), body weight, dry matter 
intake (estimated via equations found in NRC (2001)), and pregnancy status of the average 
cow in the herd every day for 6 parities.  This average cow was assumed to represent all 
cows in the herd and information about the cow was used to calculate disease costs.  
 The Monte Carlo simulation method is a technique that allows re-running of a 
simulation model repeatedly while key variables vary stochastically.  When a variable was 
modeled stochastically, a distribution was defined for that variable based on previously 
published literature or industry averages.  During each iteration of the model, a different 
value from that distribution was selected for use.  For this study, variables assumed to 
influence the cost of lameness were modeled stochastically, resulting in unique cost per 
case estimates for each hoof disease each time the model was run.   
      Disease case definitions 
 For this study, three hoof diseases were selected for modeling: digital dermatitis, 
sole ulcer, and white line disease.  These conditions were selected because they are 
considered the most prevalent lameness causing diseases in United States dairy herds 
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(DeFrain et al., 2013).  Additionally, these 3 hoof diseases have the most published data 
available to be able to specify costs by severity, incidence timing, and parity group. 
 Based on the availability of data for modeling, severity was categorized as mild or 
severe.  Most assumptions about differences between mild and severe cases were taken 
from Charfeddine and Pérez-Cabal (2017).  In that study, severity was classified based on 
how deep or superficial the lesion was, the expected recovery time, and if further treatment 
was needed.  To evaluate how incidence timing affected the cost of disease, 4 incidence 
periods were selected: 0 to 60 DIM, 61 to 120 DIM, 121 to 240 DIM, and >240 DIM.  
These incidence timings were selected from Booth et al. (2004), who reported culling risk 
associated with different hoof diseases by incidence timing.  Two parity groups were 
selected for inclusion: primiparous and multiparous.  In some cases, no differences in 
disease affect by severity level, incidence timing, or parity group was modeled because of 
a lack of data rather than a belief that no difference existed.  
      Calculation of lameness expenditures and losses 
The expenditures and losses associated with lameness were already reviewed in 
Chapter 1.  For this study, only losses and expenditures with enough data to estimate for 
individual hoof diseases were incorporated, as determined by the authors.  Modeled 
expenditures included outside (hoof trimmer) labor, therapeutics, and on-farm labor.  
Modeled losses included discarded milk, reduced milk production, extended days open, an 
increased risk of culling, an increased risk of death (natural or euthanized), and disease 
recurrence.  All expenditure and loss categories were calculated individually for each 
combination of disease type (digital dermatitis, sole ulcer, or white line disease), severity 
level (mild or severe), incidence timing (0 to 60 DIM, 61 to 120 DIM, 121 to 240 DIM, or 
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>240 DIM), and parity group (primiparous or multiparous) for a total of 48 case cost 
estimates.  The total cost per case was the sum of all individual loss and expenditure 
categories.  Separate modules within the model were used to calculate each cost category 
and necessary precursors for those categories. 
Market prices module.  Current market prices (milk price, feed price, replacement 
heifer price, slaughter price, heifer calf price, and bull calf price) were necessary to 
accurately calculate many of the disease-related losses.  Historical price variation and 
future price baseline data were used to create stochastic predicted prices for 2017, identical 
to the process described by Bewley et al. (2010) and Liang et al. (2017).  To summarize, 
the historical prices were used to create simulated error terms that could be added to the 
expected 2017 price to account for variation in the prediction.  Additionally, a correlation 
matrix between historical values over the past 10 years was implemented to prevent 
unrealistic price combinations (e.g., high corn price and low soybean price).   
Annual historical United States prices for milk, alfalfa, corn, soybean, slaughter, 
and replacement heifers from the previous 10 years (2007 to 2016) were collected from the 
Understanding Dairy Markets website (Gould and Bozic, 2017).  Heifer and bull calf prices 
for 2007 to 2016 were collected from the USDA Agricultural Market Service website 
(USDA, 2017a).  The expected 2017 prices for milk, alfalfa, corn, soybean, and slaughter 
price were collected from the Food and Agricultural Policy Research Institute’s 2017 U.S. 
Baseline Briefing Book: Projections for Agricultural and Biofuel Markets (FAPRI, 2017).  
Feed price was subsequently estimated from corn, soybean, and alfalfa prices using the 
equation published by Bailey and Ishler (2007).   
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Expected 2017 replacement heifer, heifer calf, and bull calf prices were calculated 
using regression analysis between historical values for each variable and other historical 
prices, similar to Bewley et al. (2010) and Liang et al. (2017).  For our model, regressions 
were calculated using the REG procedure in SAS (version 9.4, SAS Institute, Inc., Cary, 
NC).  Historical replacement heifer price records were found back to 1971 (Gould and 
Bozic, 2017); therefore, data from 1971 to 2016 was included in the regression equation.  
Historical calf price (bull and heifer) records were found back to 1991 (Robin L. Cusato-
Wood, USDA Agricultural Marketing Service, Moses Lake, WA, personal 
communications and USDA (2017a)); therefore, data from 1991 to 2016 was included in 
those regression equations.  All historical prices for slaughter, feed (calculated using alfalfa 
price, corn price, and soybean price), and milk that were included in each regression 
equation were collected from the Understanding Dairy Markets website 
(http://future.aae.wisc.edu/; Gould and Bozic, 2017).   
Regression equations were built by offering each model the following variables: 
slaughter price, feed price, milk price, lag of slaughter price, lag of feed price, lag of milk 
price, and year where lag indicates the previous year’s price for the specific variable.  The 
regression equation for replacement heifer price was also offered the lag of heifer calf price 
and the lag of bull calf price.  The regression equation for heifer calf price was also offered 
the lag of replacement heifer price and the lag of bull calf price.  The regression equation 
for bull calf price was also offered the lag of replacement heifer price and the lag of heifer 
calf price.  Year was forced into all models to account for time.  Other covariates were 
removed when non-significant (P ≥ 0.05) via backward step-wise elimination.  The final 
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equations generated adjusted R2 values of 0.97, 0.78, and 0.85 for replacement heifer price, 
heifer calf price, and bull calf price, respectively: 
 
Replacement heifer price ($) = -23,161 (± 4,644.29) – 47.56 (± 11.79) × feed price ($/cwt) 
+ 48.79 (± 6.87) × milk price ($/cwt) + 482.68 (± 95.55) × slaughter price lag ($/lb) – 53.13 
(± 14.23) × feed price lag ($/cwt) + 37.52 (± 7.38) × milk price lag ($/cwt) + 0.78 (± 0.10) 
× heifer calf price lag ($) + 11.72 (± 2.37) × year 
 
Heifer calf price ($) = 6,447.10 (± 8,551.59) + 33.88 (± 8.67) × milk price ($/cwt) – 59.99 
(± 9.35) × feed price lag ($/cwt) + 0.47 (± 0.10) × replacement price lag ($) – 3.51 (± 4.38) 
× year 
 
Bull calf price ($) = 2,645.27 (± 1,213.77) + 442.60 (± 41.86) × slaughter price ($/lb) – 
15.31 (± 4.02) × feed price ($/cwt) – 12.60 (± 5.03) × feed price lag ($/cwt) + 8.50 (± 2.72) 
× milk price lag ($/cwt) – 1.35 (± 0.62) × year 
 
Retention pay-off module.  The stochastic market prices and the daily simulated 
cow data (i.e., milk yield, body weight, dry matter intake, and pregnancy status) were 
combined to calculate the retention pay-off (RPO) value for every day over the lifetime of 
the average cow.  Retention pay-off compares the value of the current cow with her 
potential replacement, considering both cows’ expected future profits based on daily 
revenues (milk sales, calf value, and slaughter value) and costs (feed costs, veterinary costs, 
breeding costs, and disposal losses).  The RPO value represents a cow’s worth beyond her 
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slaughter value and can be used to estimate losses resulting from early or non-optimal 
culling and death (Groenendaal et al., 2004).  For additional details regarding how RPO is 
calculated, see Groenendaal et al. (2004).  In this model, the RPO value was used in the 
calculation of losses associated with extended days open and an increased risk of culling. 
Treatment module.  The treatment module calculated expenditures associated with 
outside labor, on-farm labor, and therapeutics, and the losses associated with discarded 
milk.  Expenditures on outside labor and therapeutics were disease-specific, expenditures 
on on-farm labor were disease and severity specific, and losses associated with discarded 
milk were disease, severity, incidence timing, and parity group specific.  Estimates used in 
the model for outside labor and therapeutics were taken from a survey of hoof trimmers 
and veterinarians (Chapter 2; Table A5).  The responses from hoof trimmers (n = 90 for 
digital dermatitis; n = 88 for sole ulcer and white line disease) to questions about the 
amount charged to a producer for labor and supplies per case by disease type were used to 
create stochastic distributions for disease-specific outside labor and therapeutic costs per 
case.  This dataset was evaluated using the “distribution fitting” feature in @Risk and the 
best distribution was identified using the AIC value.  An extreme values distribution, 
related to the Weibull distribution, was chosen to represent therapeutic costs associated 
with sole ulcer treatment.  All other distributions for both outside labor and therapeutics 
were log logistic distributions.  Log-logistic distributions are similar in shape to log-normal 
distributions, but have thicker tails.  All distributions were truncated at a minimum of 0, 
meaning if a value less than 0 was drawn from the distribution, the distribution was 
resampled assuming there would never be decreased costs associated with outside labor or 
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therapeutics resulting from a hoof disease case.  Outside labor and therapeutic expenditures 
were assumed to be identical regardless of severity, incidence timing, and parity group.   
 Charfeddine and Pérez-Cabal (2017) reported the mean cost of on-farm labor per 
mild and severe case of digital dermatitis, sole ulcer, and white line disease.  These means 
and corresponding standard deviations, calculated as a 10% coefficient of variation from 
the mean, were used in normal distributions to create stochastic disease and severity 
specific on-farm labor cost estimates (Table A5).  All values drawn from these distributions 
were truncated at a minimum of 0, meaning if a value less than 0 was drawn from the 
distribution, the distribution was resampled assuming there would never be decreased costs 
associated with on-farm labor resulting from a hoof disease case.  The cost associated with 
on-farm labor was assumed identical regardless of incidence timing and parity group.     
Data from the survey conducted in Chapter 2 were also used to define discarded 
milk per case, as required after treatment with antibiotics.  It was assumed that only digital 
dermatitis would result in discarded milk because antibiotic use was reported as rare for 
both sole ulcers and white line disease cases.  Survey respondents were asked to indicate 
the number of days required for milk discard (on-average) for a case of digital dermatitis 
(n = 22 responses).  The digital dermatitis days to discard milk data was fit to a single 
stochastic distribution using the “distribution fitting” feature in @Risk (Table A5).  That 
stochastic distribution was chosen to represent severe digital dermatitis cases; an 
assumption was made that mild digital dermatitis cases would not require antibiotic 
treatment and, therefore, would require no milk discard.  The fitted distribution for days to 
discard milk following a severe case of digital dermatitis was an exponential distribution.  
To account for differences in milk production, discarded milk losses associated with digital 
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dermatitis were made both parity group and incidence timing specific.  This was 
accomplished by multiplying the stochastic number of days of milk discard by the average 
milk production per day for a cow with digital dermatitis in the appropriate parity group 
(primiparous or multiparous) and time period (0 to 60 DIM, 61 to 120 DIM, 121 to 240 
DIM, and >240 DIM).  Lastly, the resulting pounds of milk lost per case was multiplied by 
the stochastic milk price to calculate the value of discarded milk associated with each 
lameness event.  In this study, we assumed discarded milk was not fed to calves.  If 
discarded milk were fed to calves, losses associated with discarded milk would be reduced, 
therefore reducing the cost of a severe case of digital dermatitis. 
Milk loss module.  The milk loss module calculated the losses associated with the 
reduced production potential of cows experiencing hoof diseases.  Milk losses were 
disease, severity, incidence timing, and parity group specific.  Charfeddine and Pérez-
Cabal (2017) reported the mean and SE ECM loss (kg/d) associated with a case of mild 
and severe digital dermatitis, sole ulcer, and white line disease for 4 weeks before and after 
disease occurrence for primiparous and multiparous cows separately.  Those reported 
values were chosen for use in our model because other studies have not considered severity 
when calculating milk loss associated with specific hoof diseases.  However, that study did 
not account for culling bias (i.e., culled cows were not included in all milk loss calculations) 
or the increased likelihood that a higher producing cow would get a hoof disease; therefore, 
the estimates for reduced milk production are likely biased low.  As a result, we may have 
underestimated the losses associated with reduced milk production in our disease cost 
estimates and, therefore, underestimated the cost per case of each hoof disease.  
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The mean and SE ECM loss (kg/d) for each disease, severity, and parity 
combination from Charfeddine and Pérez-Cabal (2017) was used to calculate the expected 
2.5th and 97.5th percentiles which were used in program evaluation and review technique 
(PERT) distributions to create stochastic estimates for milk loss associated with each hoof 
disease combination for each of the 4 weeks before and after occurrence (Table A6).  The 
PERT distribution is a type of β distribution adjusted for skewness by defining the 
minimum, mean, and maximum values or, alternatively, the 5th and 95th percentile can be 
defined (Bewley et al., 2010).  If the distribution parameters were positive, they were 
adjusted to zero, assuming this was because higher producing cows are more susceptible 
to disease rather than the disease actually increases milk production (Bewley et al., 2010).  
For all disease cases, an assumption was made that all weeks post-disease incidence ≥ 4 
were identical.  This meant that milk production potential was reduced for the remainder 
of the lactation after lameness incidence, making losses associated with reduced milk 
production incidence timing specific.  Altogether, the total milk loss per case of hoof 
disease was the sum of milk loss for every week from 4 weeks before disease occurrence 
until the end of the lactation.   
Milk loss per case for each incidence timing (0 to 60 DIM, 61 to 120 DIM, 121 to 
240 DIM, and >240 DIM) was calculated by summing the milk loss associated with a case 
occurring every day within that incidence timing and taking the average of all of those 
cases.  Milk loss per case was multiplied by the 2017 stochastic milk price to calculate 
reduced milk revenues.  The feed costs associated with producing that milk were subtracted 
from the total reduced milk revenue losses to account for the fact that the cow responds to 
reduced milk production by eating less.  Reduced feed costs were calculated by multiplying 
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the estimated reduction in dry matter intake (calculated as the average cow’s daily intake 
over the lactation divided by the average cow’s daily production over the lactation) by the 
stochastic feed price.  
Days open module.  The days open module calculated the losses associated with 
extended days open resulting from cows experiencing hoof diseases.  Extended days open 
losses were disease, severity, incidence timing, and parity-specific.  Charfeddine and 
Pérez-Cabal (2017) reported the mean and SE increase in days open associated with mild 
and severe digital dermatitis, sole ulcer, and white line disease for primiparous and 
multiparous cows combined.  Similar to the milk loss module parameters, these reported 
values were chosen for use in our model because other studies have not considered severity 
when calculating days open losses associated with specific hoof diseases.  However, 
culling bias also affected these estimates because Charfeddine and Pérez-Cabal (2017) only 
considered those cows that became pregnant within their analysis (i.e., the impact of cows 
who did not become pregnant was not included).  As a result, we may have underestimated 
the losses associated with extended days open in our disease cost estimates and, therefore, 
further underestimated the cost per case of each hoof disease. 
The mean and SE increase in days open for each disease and severity combination 
from Charfeddine and Pérez-Cabal (2017) was used to calculate the expected 2.5th and 
97.5th percentiles which were used in PERT distributions to create stochastic estimates for 
the number of extended days open associated with each hoof disease and severity 
combination (Table A7).  For each distribution, if the mean or 2.5th percentile were negative 
(indicating a decrease in days open) they were adjusted to zero, assuming no positive effect 
of disease on days open. 
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The losses associated with extended days open were calculated separately for 
parities 1, 2, and 3 using RPO values.  For each parity, the RPO of an average cow in the 
herd on the first day of that parity was compared to the RPO of a diseased cow on the first 
day of that parity.  The only difference between the two cows was the difference in days 
open during that parity, so the difference in RPO represented the total loss in the cow’s 
value associated with extended days open for that case.  For example, if the RPO of the 
average cow without any disease on day 1 of lactation 1 was $825 and the RPO of the 
average cow with a severe sole ulcer (+ 17 days open) on day 1 of lactation 1 was $800, 
then the total losses associated with extended days open for a parity 1 cow experiencing a 
severe sole ulcer were $25.  This method has previously been described by Dolecheck et 
al. (2016) and was applied in the model by Liang et al. (2017). 
The multiparous parity group extended days open cost per case was a weighted 
average of the calculated cost of extended days open per case for parity 2 cows and parity 
3 cows, based on the assumed distribution of cows among parities (Table 3.1).  To calculate 
costs by incidence timing, an assumption was made that disease cases occurring before the 
average cow became pregnant resulted in all losses associated with extended days open 
and disease cases occurring after the average cow became pregnant resulted in no losses 
associated with extended days open.  For incidence timings that contained the average 
cow’s DIM at conception, a portion of the losses associated with extended days open were 
included to account for some cases occurring before the average cow becomes pregnant 
and some cases occurring after the average cow becomes pregnant.  For example, if the 
average cow’s days open is 150 d and the days open losses per case are $20, then the losses 
per case associated with days open for the incidence timing 121 to 240 DIM would be $5 
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($20 x (150-121)/(240-121)).  The DIM at conception for the average cow was calculated 
using the equation by Pecsok et al. (1994) with the voluntary waiting period and days in 
milk do not breed set deterministically at 60 and 250 DIM, respectively, and pregnancy 
rate calculated using stochastic distributions for estrus detection rate and conception rate 
defined by data from DairyMetrics (Dairy Records Management Systems, Raleigh, NC; 
Table 3.1 and Table 3.2).   
Culling and death module.  The culling and death module calculated the losses 
associated with an increased risk of culling and death resulting from hoof diseases.  The 
losses associated with an increased risk of culling and death were disease, severity, 
incidence timing, and parity group specific.  Mean, 5th percentiles, and 95th percentiles 
culling hazard ratios associated with digital dermatitis and sole ulcers were reported by 
Booth et al. (2004), specifically considering how the incidence of disease in one period (0 
to 60 DIM, 61 to 150 DIM, 151 to 240 DIM, or > 240 DIM) influenced culling in both that 
time period and future time periods.  These values were used to create stochastic 
distributions for disease-specific culling risk ratios, assuming white line disease culling 
risk ratios were identical to sole ulcers (Table A8).  The assumption about similarities 
between sole ulcer and white line disease were made because they are both non-infectious 
hoof diseases and Charfeddine and Pérez-Cabal (2017) reported similar effects of both 
diseases on the length of productive life.   
To account for severity, two different stochastic distributions were created for each 
disease using PERT distributions.  For the “mild” distributions, a mean 0.5 times that of 
the mean reported by Booth et al. (2004) was used whereas for the “severe” distributions, 
a mean 1.5 times that of the reported mean was used.  The same 5th and 95th percentiles 
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were used in both mild and severe distributions for each disease.  This method allowed for 
the same minimum and maximum values, regardless of severity, but skewed the 
distributions to the lower or upper ends for mild and severe cases, respectively.  All 
distributions were truncated at a minimum of 1.0, meaning if a value less than 1.0 was 
drawn from the distribution (indicating a decreased risk of culling) the distribution was 
resampled, assuming no positive effect of disease on culling.  The culling risk ratios were 
used to calculate the number of extra culls resulting from each hoof disease case, as 
previously described by Bewley et al. (2010).  To calculate losses associated with the extra 
culls, the RPO value of the average cow for each combination of parity and incidence 
timing was multiplied by the number of extra culls per case in that parity and incidence 
timing.  Culling losses per case were calculated separately for parities 1, 2, 3, 4, 5, and 6.  
The weighted average of parities ≥ 2, based on the distribution of cows among parities 
(Table 3.1), was used to represent culling losses associated with the multiparous parity 
group.  
An assumption was made in this model that only severe lameness cases would have 
the potential to result in death and that no cases of digital dermatitis would result in death.  
Therefore, losses associated with an increased risk of death for all mild conditions and 
severe digital dermatitis cases were $0.  No previous research has estimated the percentage 
of hoof disease cases resulting in death so for other severe conditions (sole ulcer and white 
line disease) an assumption was made that 5% of cases occurring at any incidence timing 
would result in death.  Disease related death losses were calculated for each incidence 
timing and parity (1, 2, 3, 4, 5, or 6).  To summarize, the number of deaths per case for 
each incidence timing and parity was multiplied by the mean slaughter value (calculated 
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as the body weight of the cow multiplied by the stochastic slaughter price) for that specific 
time period in that specific lactation.  Death losses per case for multiparous cows were the 
weighted average of each parity, based on the assumed distribution of cows among parities 
(Table 3.1). 
Disease recurrence module.  The disease recurrence module calculated losses 
linked to cases recurring in the same animal.  Disease recurrence losses were disease, 
severity, incidence timing, and parity group specific.  Charfeddine and Pérez-Cabal (2017) 
reported mean relapse rates (episodes per infected cow) for both primiparous and 
multiparous cows experiencing either mild or severe digital dermatitis, sole ulcers, and 
white line disease.  Each of these assumptions was modeled stochastically using a PERT 
distribution (Table A9) with minimum and maximum values assumed identical for all hoof 
diseases using the general lameness relapse rate values reported by Ettema and Østergaard 
in 2006 (min = 1.5, max = 4.0).  The stochastic relapse rate minus 1 was the number of 
repeat cases expected per original case.  However, incidence timing and disease length 
logically influence how many repeat cases per original case can occur within the same 
lactation.  Therefore, disease length estimates were incorporated into the model.   
Bruijnis et al. (2010) reported mean, 5th percentile, and 95th percentile disease 
length for subclinical and clinical digital dermatitis, sole ulcer, and white line disease.  An 
assumption was made that subclinical would represent mild cases and clinical would 
represent severe cases.  These values were used in PERT distributions to create stochastic 
estimates for disease length for each hoof disease (Table A9).  By multiplying the disease 
length by the relapse rate, the length of time (d) required for all cases (original plus relapse 
cases) to occur was calculated.  
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To make losses associated with disease recurrence incidence timing specific, a 
comparison was made between the length of time required for all cases (original and 
relapse) to occur and the number of days remaining in the lactation.  An assumption was 
made that a new case occurring within each incidence timing occurred at the midpoint of 
that period (e.g., for incidence timing 0 to 60 DIM, incidence occurred at 30 DIM).  The 
remaining days left in the lactation were calculated by subtracting the incidence timing 
from the average cow’s length of lactation, as determined by the calving interval.  For 
example, if the average cow’s length of lactation was 375 days, then there would be 345 d 
left in the lactation for the incidence timing 0 to 60 DIM (375 to 30).  By comparing this 
to the time required for all lameness cases (original and relapse) to occur, we could 
calculate the number of actual recurrences that would happen within a lactation.  Using this 
method, more recurring cases were assumed for a case of lameness occurring in early 
lactation than a case occurring in later lactation, simply because the days remaining in the 
lactation would not permit the case to recur at the same rate.  We assumed no adverse 
effects of hoof diseases occurring in late lactation on the subsequent lactation because of 
lacking published data on this relationship.   
For recurring cases, treatment, labor, and discarded milk costs were assumed to 
reoccur at 100% of the price of the first episode whereas no extra losses were associated 
with reduced milk production, extended days open, an increased risk of culling, or an 
increased risk of death.  This assumption is likely conservative but was necessary 
considering the lack of data available to show how recurring cases influence a cow’s milk 
yield, reproductive performance, risk of culling, and risk of death.  As a result of this 
assumption, we may have underestimated the losses associated with disease recurrence in 
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our disease cost estimates and, therefore, underestimated the cost per case of each hoof 
disease. 
      Model demonstration 
To demonstrate model usefulness, 1,000 iterations of the model were run using Latin 
Hypercube sampling. The mean ± SD cost per case of hoof disease across all disease type, 
severity level, incidence timing, and parity group combination was reported.  Default 
deterministic variable assumptions used to define the herd and the average cow were 
collected from Dairy Records Management Systems (Raleigh, NC) using limitations of 
only Holstein herds with ≥ 200 cows, published literature, or the authors’ expertise (Table 
3.1).  The resulting distributions of herd-level stochastic variables can be found in Table 
3.2.  Inputs used in the model for this study were meant to represent a United States dairy 
herd.  However, model inputs could be adjusted to herd-specific values to calculate the cost 
of hoof diseases for a specific herd.   
      Sensitivity analysis 
 As described for each module, many variables were stochastic within the model 
including labor costs, therapeutic costs, days of discarded milk, expected milk loss, 
extended days open, culling risk ratios, disease recurrence rates, and disease length.  
However, only selected market prices and herd specific performance variables were 
included in a sensitivity analysis to test how they affected the disease costs because these 
variables are either more controllable by or more readily available to the producer.  The 
selected variables included: milk price, feed price, replacement heifer price, slaughter 
price, rolling herd average milk production, and pregnancy rate (calculated as the 
multiplication of estrus detection rate and conception rate).  Using the @Risk sensitivity 
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analysis function, a multivariate regression analysis was conducted between these 
stochastic variables and the mean total cost per case of each hoof disease across all 
combinations of severity level, incidence timing, and parity group.  The results of this 
analysis show how the cost per case of disease changes with a 1 standard deviation increase 
in each stochastic factor.  
Results and Discussion 
 The objective of this study was to build a stochastic simulation model capable of 
estimating hoof disease costs per case depending on disease, severity level, incidence 
timing, and parity group.  This was accomplished by incorporating modules to account for 
outside (hoof trimmer) labor, therapeutics, on-farm labor, discarded milk, reduced milk 
production, extended days open, an increased risk of culling, an increased risk of death 
(natural or euthanized), and disease recurrence into a pre-existing stochastic simulation 
model.  Model accuracy may be limited by the fact that few previous studies have 
considered hoof disease expenditure and loss estimates specific to disease, severity level, 
incidence timing, and parity group.  In particular, estimates used in this study for reduced 
milk production, extended days open, and disease recurrence may underestimate the total 
effects of hoof diseases.  Additionally, little data exists on the effects of hoof diseases 
beyond the current lactation.  Therefore, our hoof disease cost estimates only included 
expenditures and losses within the same lactation as disease occurrence. The disease cost 
estimates from our model demonstration should be interpreted carefully while keeping 
these limitations in mind.  
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      Disease cost estimates 
Digital dermatitis.  The simulated mean ± SD cost per case of digital dermatitis by 
severity, incidence timing, and parity group is presented in Table 3.3 and patterns among 
results are presented in Figure 3.1a.  Over all combinations, the mean ± SD cost per case 
of digital dermatitis was $137 ± 36, ranging from a low of $30 ± 21 for a mild case in a 
post-peak lactation (121 to 240 DIM), primiparous cow to a high of $399 ± 116 for a severe 
case in an early lactation, multiparous cow.  Previous estimates of the cost of digital 
dermatitis have been similar to the mean found in this study ($133 and $149/case after 
adjustment to 2017 USD; Willshire and Bell, 2009; Cha et al., 2010); although those 
estimates did not differentiate by severity or parity and did not include the cost of recurring 
cases within the same cow.   
Charfeddine and Pérez-Cabal (2017) estimated a mild and severe case of digital 
dermatitis to be $53 and $402 (adjusted to 2017 USD), respectively, including the cost of 
recurrence.  The mean ± SD mild or severe cost per case of digital dermatitis in our study, 
regardless of parity group or incidence timing, was $59 ± 40 and $215 ± 117, respectively.  
It is difficult to compare estimates from Charfeddine and Pérez-Cabal (2017) to the current 
study because 1) our study breaks costs down by not only severity but also incidence timing 
and parity group and 2) Charfeddine and Pérez-Cabal (2017) included recurrence costs 
within the other cost categories whereas recurrence costs were a separate category within 
our estimates.  However, some major differences in calculations likely contributed to our 
difference in severe case cost estimates.  First, our study did not differentiate expenditures 
on therapeutics or outside labor by severity level, whereas Charfeddine and Pérez-Cabal 
(2017) did.  Additionally, the estimates for therapeutics and outside labor assumed in this 
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study (from Chapter 2) were lesser than those found by Charfeddine and Pérez-Cabal 
(2017), likely because of differences in study location (United States vs. Spain) and the 
increased likelihood of veterinary involvement in Spain as compared to the United States.  
Second, discarded milk was assumed to be minimal in our study compared to Charfeddine 
and Pérez-Cabal (2017) who reported that antibiotic use was standard for all severe lesions.  
Third, our study assumed that the cost of a recurring case only included direct costs 
(therapeutics, outside labor, on-farm labor, and discarded milk) because minimal evidence 
exists to differentiate milk loss, extended days open, risk of culling, and risk of death 
associated with the first vs. second case of a hoof disease.  Comparatively, Charfeddine 
and Pérez-Cabal (2017) assumed recurring cases to have the same cost as the first case.   
As shown in Figure 3.1a, cases in primiparous cows were less expensive than 
comparable cases (same severity level and incidence timing) in multiparous cows.  
Compared to multiparous cows, primiparous cows experienced less milk production losses, 
losses associated with extended days open, losses associated with an increased risk of 
culling, and recurrence losses (Table 3.3).  Within parity group, severe cases were more 
expensive than mild cases, regardless of incidence timing.  Mild cases were associated with 
less on-farm labor, less milk production losses (from both discarded milk and reduced 
yield), lower costs associated with extended days open, lower losses associated with an 
increased risk of culling, and fewer recurrence costs.  Across incidence timing, mean severe 
case costs decreased over the lactation of the cow whereas mean mild case costs were 
bimodal, peaking at the beginning and end of the lactation but with minimal variation 
among incidence timings (Figure 3.1a).  All variable cost categories decreased as DIM at 
incidence increased except for culling losses.  Losses associated with culling were bimodal, 
 
80 
 
peaking in both early and late lactation.  Our assumptions about the effects of hoof diseases 
on culling were taken from Booth et al. (2004), who found that the 95% confidence interval 
for the risk of culling when hoof diseases occurred in later lactation was wider than the 
95% confidence interval for the risk of culling when hoof diseases occurred in earlier 
lactation.  This resulted in our model estimating an increased risk of culling for cases 
occurring in later lactation, which may be overestimated.  More research is needed to 
accurately estimate the effects of hoof disease timing on culling.      
For mild digital dermatitis cases, losses associated with an increased risk of culling 
represented the greatest contribution to the total cost per case (mean = 55% of the total 
cost) in both parities and at all incidence timings except for multiparous cows in the post-
peak period (121 to 240 DIM).  During that period, losses associated with decreased milk 
production represented the largest portion of the total cost (mean = 39% of the total cost).  
For severe digital dermatitis cases, regardless of parity group, losses associated with 
decreased milk production represented the greatest contribution to the total cost per case at 
all incidence timings except late lactation (mean = 43% of the total cost).  During late 
lactation, losses associated with an increased risk of culling contributed the most to the 
total cost per case (mean = 38% of the total cost).  The remaining contributions of each 
cost category varied by severity, parity group, and incidence timing (Table 3.3).  
Charfeddine and Pérez-Cabal (2017) found that expenditures on outside labor and losses 
associated with reduced milk production contributed the most to the cost per affected cow 
in mild digital dermatitis cases (43% and 34%, respectively) and losses associated with an 
increased risk of death and culling and discarded milk contributed the most to the cost per 
affected cow in severe digital dermatitis cases (37% and 24%, respectively).  As previously 
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mentioned, recurrence losses were not considered as their own category by Charfeddine 
and Pérez-Cabal (2017), making direct comparisons difficult.      
It is worth noting that none of the current cost estimates for digital dermatitis, 
including those in this study, have included the cost of transmission.  Digital dermatitis is 
a contagious disease and ignoring the costs of additional cases of digital dermatitis resulting 
from one original case ignores the full economic losses of the disease.  Döpfer et al. (2012) 
estimated the reproductive ratio of digital dermatitis to be between 0.5 and 3.3, depending 
on the prevention strategy used.  Therefore, this cost category could make up a large portion 
of the cost per case of digital dermatitis, depending on herd level prevention strategies in 
place.  Modeling of contagious diseases is complex, which is why this cost category is 
typically not included in digital dermatitis case cost estimates. 
Sole ulcer.  The simulated mean ± SD cost per case of a sole ulcer by severity, 
incidence timing, and parity group is presented in Table 3.4 and patterns among results are 
presented in Figure 3.1b.  Over all combinations, the mean cost per case of sole ulcers was 
$227 ± 35, ranging from a low of $111 ± 41 for a mild case in a late lactation, primiparous 
cow to a high of $486 ± 87 for a severe case in an early lactation, multiparous cow.  Our 
reported mean was similar to the sole ulcer cost estimate of $243 (adjusted to 2017 USD) 
by Cha et al. (2010).  The mean ± SD mild or severe cost per case of sole ulcer in our study, 
regardless of parity group or incidence timing, was $170 ± 65 and $283 ± 109, respectively.  
Charfeddine and Pérez-Cabal (2017) estimated the cost per case of a mild and severe sole 
ulcer to be $232 and $622, respectively (adjusted to 2017 USD).  The lower cost estimates 
found in our study, especially for severe cases, may be for similar reasons as the differences 
found for digital dermatitis.  
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Unlike digital dermatitis, parity group appeared to minimally affect the cost per 
case of mild sole ulcer (Figure 3.1b).  In fact, mild cases occurring at any incidence timing 
except early lactation were within $15 of each other (Table 3.4).  Parity group did affect 
the cost per case of severe sole ulcers with severe sole ulcers in multiparous cows resulting 
in greater losses associated with decreased milk production throughout lactation and 
greater losses associated with increased culling or death in early lactation.  Within parity 
group, severe cases were always more expensive than mild cases occurring at the same 
incidence timing.  Mild cases were associated with less on-farm labor and fewer losses 
associated with extended days open, disease recurrence, and an increased risk of culling or 
death.  Milk production losses were greater in severe cases compared to mild cases for 
multiparous cows, but in primiparous cows, mild cases resulted in greater (though 
numerically similar) decreased milk production losses than severe cases.  This was because 
milk production losses for week 4 post-diagnosis were estimated by Charfeddine and 
Pérez-Cabal (2017) to be greater in mild cases than severe cases, and week 4 post-diagnosis 
losses were assumed to continue until the end of lactation.  Unfortunately, no alternative 
literature sources were identified that considered milk loss associated with hoof diseases 
while also considering severity of the disease and parity group of the affected animal.  
However, it is possible that a mild case of lameness might go undetected (and untreated) 
longer than a severe case of lameness, potentially increasing losses associated with reduced 
milk production.  
Across incidence timing, both mild and severe case costs decreased over the 
lactation of the cow (Figure 3.1b).  The decrease in mild case costs for sole ulcers over the 
lactation of the cow was more apparent than the decrease in mild case costs for digital 
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dermatitis over the lactation of the cow.  Compared to digital dermatitis, sole ulcers were 
associated with more extreme effects on reduced milk yield, extended days open, and an 
increased risk of culling or death, which were all influenced by stage of lactation.  Similar 
to digital dermatitis, all variable cost categories decreased further in lactation except for 
those associated with an increased risk of culling or death.  The peak in losses associated 
with an increased risk of death differed by parity group, but was bimodal in both cases with 
losses being highest at the beginning and end of lactation.  This resulted from the slaughter 
value of the cow being highest at the beginning and end of lactation, following body weight 
patterns.  
Across all sole ulcer cases, regardless of severity, the losses associated with reduced 
milk production, an increased risk of culling, and disease recurrence made up most of the 
total cost per case (mean = 24%, 24%, and 23% of the total cost, respectively).  In severe 
sole ulcer cases, losses associated with an increased risk of death were also a top contributor 
to the total cost per case (mean = 18% of the total cost).  The remaining contributions of 
each cost category varied by parity group (Table 3.4).   Similarly, Kossaibati and Esslemont 
(1997) and Esslemont (2005) estimated that the combined costs of culling and death 
contributed most to the total cost of sole ulcers (33% to 36%).  However, they estimated 
reduced reproductive performance to contribute the second most to total sole ulcer costs 
(30% to 32%).  Losses associated with extended days open in this study were based on the 
assumption that mild and severe sole ulcers resulted in 2.1 ± 1.1 and 17.4 ± 6.0 extended 
days open, respectively, whereas both Kossaibati and Esslemont (1997) and Esslemont 
(2005) assumed sole ulcers resulted in 40 extended days open, which partially explains our 
difference in findings.  Additionally, our method of calculating the cost per day open tends 
 
84 
 
to be more conservative than other estimates (Dolecheck et al., 2016).  Charfeddine and 
Pérez-Cabal (2017) estimated that the losses associated with an increased risk of culling 
contributed most (40% and 23% for mild and severe cases, respectively) to the total cost 
of a sole ulcer, followed by discarded milk (20% in severe cases) and reduced milk yield 
(18% and 16% for mild and severe cases, respectively).   
White line disease.  The simulated mean ± SD cost per case of white line disease 
by severity, incidence timing, and parity group is presented in Table 3.5 and patterns among 
results are presented in Figure 3.1c.  Over all combinations, the mean cost per case of white 
line disease was $203 ± 33, ranging from a low of $97 ± 39 for a mild case in a late 
lactation, primiparous cow to a high of $471 ± 90 for a severe case in an early lactation, 
multiparous cow.  Willshire and Bell (2009) estimated costs associated with white line 
disease to be greater ($555/case after adjustment to 2017 USD), but assumed 30 extended 
days open resulting from the disease, whereas our assumed mean extended days open for 
a mild and severe case of white line disease was 3.3 ± 1.5 d and 10.3 ± 5.0 d, respectively.  
The mean ± SD mild or severe cost per case of white line disease in our study, regardless 
of parity group or incidence timing, was $135 ± 55 and $271 ± 106, respectively.  These 
estimates are less than those of Charfeddine and Pérez-Cabal (2017), who found a mild 
case of white line disease to cost $221 and a severe case to cost $590 assuming greater 
therapeutic and supply costs, as well as the possibility of discarded milk losses, which were 
not included in our study.   
Similar to sole ulcers, parity group appeared to minimally affect the cost per case 
of mild white line disease while having greater effects on severe white line disease.  In 
severe cases, multiparous cows had increased losses associated with reduced milk 
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production throughout lactation and increased losses associated with an increased risk of 
culling or death in early lactation.  Within parity group, severe cases were always more 
expensive than mild cases.  Losses associated with decreased milk production were greater 
in severe cases compared to mild cases regardless of parity group, but within mild cases 
were greater for primiparous cows than multiparous cows for similar reasons as for our 
sole ulcers estimates.  Across incidence timing, both mild and severe case costs generally 
decreased over the lactation of the cow (Figure 3.1c).   
For mild cases of white line disease, regardless of parity group, the cost categories 
that contributed the most to the total cost per case were losses associated with an increased 
risk of culling (mean = 33% of the total cost) and disease recurrence (mean = 23% of the 
total cost).  For severe cases of white line disease, losses attributed to disease recurrence 
and an increased risk of culling contributed most to the cost per case in primiparous cows 
(mean = 22% and 21% of the total cost, respectively) whereas losses attributed to decreased 
milk production and an increased risk of culling contributed most to the cost per case in 
multiparous cows (mean = 27% and 22% of the total cost, respectively).  Losses associated 
with an increased risk of death were also a large contributor to the total cost per case of 
severe white line disease (mean = 18% of the total cost).  The remaining contributions of 
each cost category varied by parity group (Table 3.5).  Only Charfeddine and Pérez-Cabal 
(2017) have previously broken down cost categories for white line disease, with very 
similar estimates to sole ulcers (30% to 39% increased risk of culling or death, 13% to 17% 
reduced milk production, and 20% discarded milk in severe cases).   
Sensitivity Analysis.  The change in the mean (across all severity level, incidence 
timing, and parity group combinations) total cost per case of each disease as selected 
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market prices and herd specific performance variables increased by 1 standard deviation is 
displayed in Figure 3.2.  Across all diseases, the cost per case of hoof disease increased in 
response to a 1 standard deviation increase in milk price, rolling herd average milk 
production, or replacement heifer price.  As either milk price or rolling herd average milk 
production increased the cost per case increased because there was more potential income 
from milk production being lost through both discarded milk and reduced milk yield.  Milk 
price and the rolling herd average milk production level influenced the cost per case more 
in higher milk production potential situations: multiparous cows, severe cases, and earlier 
incidence timing (because milk loss would continue throughout lactation).  As replacement 
price increased, the cost to replace an animal that was culled or died increased, thereby 
increasing the cost of disease.  The change in the cost per case in response to changing 
replacement price was greatest in severe cases when culling or death was more likely.   
Across all diseases, the cost per case of hoof disease decreased in response to a 1 
standard deviation increase in feed price, pregnancy rate, or slaughter price.  In response 
to disease and the resulting lower milk production, cows were assumed to eat less.  
Therefore, a cow with a disease would have lower feed costs and the cost of disease would 
be lowered when feed costs are high.  As with milk price, the feed price influenced the cost 
per case more in higher milk production potential situations.  As pregnancy rate increased, 
the adverse effects of disease on reproduction became less detrimental, therefore lowering 
the cost of disease.  In other words, if a herd was already getting cows pregnant quickly, 
adding a few more days open would be less detrimental than in a herd that was already 
struggling to get cows pregnant.  Finally, as slaughter price increased, the cost of culling a 
cow decreased, therefore lowering the cost of disease.  
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 The two most important of the selected market prices and herd specific performance 
variables appeared to be the milk price and replacement price.  Changing milk price 
resulted in the largest change in the mean cost of either digital dermatitis or sole ulcer 
($15.3 and $17.1 increase, respectively) whereas changing replacement price resulted in 
the largest change in the mean cost of white line disease ($13.5 increase).  The reason these 
two market prices had the greatest influence on the cost of hoof diseases is likely linked to 
their heavy involvement in calculating losses associated with reduced milk production, an 
increased risk of culling, and an increased risk of death; these 3 cost categories were among 
the largest contributors in all cost per case estimates.  
Hoof disease cost estimates summary.  Across all 3 hoof diseases considered in this 
study, severity had the largest effect on the total cost per case.  The percent increase from 
mild to severe cases within the same incidence timing and parity group ranged from 45% 
to 364%.  Understanding the differences between the cost of a mild and severe hoof disease 
highlights the need for early intervention when a cow becomes lame.  For digital dermatitis, 
parity group had a greater effect on the total cost per case than incidence timing.  For sole 
ulcers and white line disease, both incidence timing and parity group affected the total cost 
per case of disease.  Understanding the cost per case of disease for different categories of 
animals (e.g., parity group, DIM) can help guide treatment and culling decisions at the 
individual animal level.  Understanding how incidence timing influences the cost of a 
disease can additionally help focus prevention strategies on certain groups of animals 
within a herd (i.e., early vs. late lactation) if prevention is not implemented across the whole 
herd.  Based on results using the assumptions in this study, implementing hoof disease 
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prevention strategies would be most beneficial in early lactation.  Additionally, this might 
indicate that prevention in the dry and close-up periods would also be beneficial.   
The results from the sensitivity analysis highlight the importance of considering the 
cost of hoof diseases at the herd level as changes in market prices and herd performance 
can change the cost of disease.  In the future, models like this one could aid in the 
construction of decision support tools to improve herd and cow level decisions regarding 
lameness treatment and prevention. 
Conclusions 
 The ability to estimate the cost per case of 3 hoof diseases (digital dermatitis, sole 
ulcer, and white line disease) was incorporated into a pre-existing stochastic simulation 
model.  Through this process, missing data in the literature was identified, indicating 
potential areas for future research.  In particular, expenditures and losses specific to 
individual hoof diseases, severity of disease, timing of disease, and parity group affected 
by the disease should be considered. 
Using assumptions meant to represent a United States dairy herd, disease cost estimates 
calculated using the model varied by not only disease type, but also severity, incidence 
timing, and parity group.  These differences indicate that the cost per case of hoof disease 
differs by cow.  This knowledge could help guide on-farm decisions about hoof disease 
treatment, culling strategies, and investment in lameness prevention.  Hoof disease costs 
were also influenced by market prices and herd specific performance variables, indicating 
that hoof disease costs should be considered at the individual herd level.    
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Table 3.1 Deterministic farm performance and financial inputs used in a stochastic model 
to estimate the cost of 3 different dairy cow hoof diseases  
Input Value Source1 
Age at first calving (m) 24.3 DairyMetrics 
Baseline culling rate (%) 13.0 Bewley et al. (2010) 
Breeding costs ($/insemination) 15.512 VanRaden and Cole (2014) 
Butterfat yield (%) 3.7 DairyMetrics 
Calf birth weight (kg) 41.7 Kertz et al. (1997) 
Close up dry cow feed price ($/kg DM) 0.22 Authors’ expertise 
Close up dry period length (d) 21 Authors’ expertise 
 Days dry 56.2 NAHMS (2014) 
Days in milk designated do not breed 250 Bewley et al. (2010) 
Discount rate (%) 8.0 Hyde and Engel (2002) 
Disposal losses ($) 652 Groenendaal et al. (2004) 
Far off dry cow feed price ($/kg DM) 0.15 Authors’ expertise 
Gestation length (d) 280 Norman et al. (2007) 
Mature cow live weight (kg) 723 NRC (2001) 
Percent heifer calves 46.7 Del Río et al. (2007) 
Percent of herd in 1st parity 36.1 Dhuyvetter et al. (2007) 
Percent of herd in 2nd parity 26.0 Dhuyvetter et al. (2007) 
Percent of herd in 3rd parity 17.7 Dhuyvetter et al. (2007) 
Percent of herd in 4th parity 11.0 Dhuyvetter et al. (2007) 
Percent of herd in 5th parity 5.8 Dhuyvetter et al. (2007) 
Percent of herd in 6th (or greater) parity 3.4 Dhuyvetter et al. (2007) 
Protein yield (%) 3.1 DairyMetrics 
Voluntary waiting period (d) 59.3 DairyMetrics 
1DairyMetrics information was collected on October 1, 2017 from Dairy Records 
Management Systems (Raleigh, NC).  Values gathered from DairyMetrics included 1,987 
United States Holstein herds with at least 200 cows. 
2Adjusted for inflation to 2017 prices 
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Table 3.2 Simulated market price and farm performance inputs used in a stochastic model 
to estimate the cost of 3 different dairy cow hoof diseases 
Input 
Simulated range 
(min – max) 
Simulated     
mean ± SD Source1 
Calf value ($/bull) 72.35 – 224.25 130.74 ± 41.27 Regression model 
Calf value ($/heifer) 234.00 – 674.92 395.16 ± 143.51 Regression model 
Slaughter value ($/kg) 1.03 – 1.78 1.43 ± 0.20 FAPRI (2017) 
Milk price ($/kg) 0.29 – 0.50 0.40 ± 0.06 FAPRI (2017) 
Lactating feed price ($/kg DM) 0.21 – 0.38 0.29 ± 0.04 FAPRI (2017) 
Replacement heifer price ($)      1,437 – 2,122    1,718 ± 216 Regression model  
RHA milk production (kg)      4,899 – 18,113  11,459 ± 2,002 DairyMetrics 
Pregnancy rate (%)          2.8 – 74.7      22.5 ± 11.4 DairyMetrics 
1DairyMetrics information was collected on October 1, 2017 from Dairy Records 
Management Systems (Raleigh, NC).  Values gathered from DairyMetrics included 1,987 
United States Holstein herds with at least 200 cows.   
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Table 3.3 Mean ± SD expenditures, losses, and total cost per case of digital dermatitis by severity, incidence timing, and parity group 
as estimated using a stochastic simulation model (n = 1,000 iterations).  Bolded values indicate the cost category contributing most to 
the total cost per case for each combination of severity, incidence timing, and parity group. 
  Expenditures 
($/case) 
 Losses1 
($/case) Total 
($/case)   Therapeutics Outside labor On-farm labor 
 Discarded 
milk 
Decreased milk 
production 
Extended days 
open Recurrence Culling 
Primiparous (mild)           
 0 to 60 DIM 1.98 ± 2.41 4.91 ± 8.99 1.73 ± 0.43          NA 0.59 ± 0.35 0.67 ± 0.70 10.41 ± 13.77 27.10 ± 18.33 47.39 ± 28.42 
 61 to 120 DIM 1.98 ± 2.41 4.91 ± 8.99 1.73 ± 0.43          NA 0.59 ± 0.35 0.61 ± 0.62 9.88 ± 12.93 26.84 ± 23.47 46.55 ± 31.71 
 121 to 240 DIM 1.98 ± 2.41 4.91 ± 8.99 1.73 ± 0.43          NA 0.59 ± 0.35 0.12 ± 0.18 7.54 ± 9.05 12.71 ± 11.23 29.57 ± 21.23 
 >240 DIM 1.98 ± 2.41 4.91 ± 8.99 1.73 ± 0.43          NA 0.55 ± 0.33 0.00 ± 0.00 2.58 ± 3.11 31.77 ± 27.21 43.52 ± 29.61 
Primiparous 
(severe) 
          
 0 to 60 DIM 1.98 ± 2.41 4.91 ± 8.99 20.81 ± 5.20  14.99 ± 16.57 81.34 ± 50.81 11.31 ± 9.66 53.15 ± 35.66 28.95 ± 18.93 217.45 ± 76.73 
 61 to 120 DIM 1.98 ± 2.41 4.91 ± 8.99 20.81 ± 5.20  14.78 ± 16.33 67.53 ± 40.36 10.56 ± 9.18 50.30 ± 32.31 27.07 ± 20.81 197.95 ± 67.36 
 121 to 240 DIM 1.98 ± 2.41 4.91 ± 8.99 20.81 ± 5.20  12.46 ± 13.75 45.95 ± 24.96 2.17 ± 3.38 36.70 ± 21.90 12.14 ± 10.04 137.11 ± 47.65 
 >240 DIM 1.98 ± 2.41 4.91 ± 8.99 20.81 ± 5.20  9.02 ± 10.02 17.43 ± 7.19 0.00 ± 0.00 11.54 ± 6.82 41.48 ± 25.94 107.17 ± 33.38 
Multiparous (mild)           
 0 to 60 DIM 1.98 ± 2.41 4.91 ± 8.99 1.73 ± 0.43          NA 31.47 ± 14.58 0.97 ± 0.70 11.81 ± 14.20 66.36 ± 33.51 119.23 ± 44.11 
 61 to 120 DIM 1.98 ± 2.41 4.91 ± 8.99 1.73 ± 0.43          NA 27.56 ± 12.02 0.91 ± 0.66 10.97 ± 12.86 27.91 ± 17.97 75.96 ± 31.94 
 121 to 240 DIM 1.98 ± 2.41 4.91 ± 8.99 1.73 ± 0.43          NA 20.13 ± 8.07 0.20 ± 0.28 8.07 ± 9.01 13.97 ± 11.41 50.98 ± 23.40 
 >240 DIM 1.98 ± 2.41 4.91 ± 8.99 1.73 ± 0.43          NA 10.15 ± 3.26 0.00 ± 0.00 2.75 ± 3.12 39.92 ± 28.35 61.42 ± 31.30 
Multiparous 
(severe) 
          
 0 to 60 DIM 1.98 ± 2.41 4.91 ± 8.99 20.81 ± 5.20  19.60 ± 21.31 194.33 ± 76.00 15.00 ± 12.22 74.72 ± 47.56 67.96 ± 31.66 399.30 ± 115.94 
 61 to 120 DIM 1.98 ± 2.41 4.91 ± 8.99 20.81 ± 5.20  17.98 ± 19.54 162.85 ± 62.21 14.07 ± 11.63 65.83 ± 40.55 28.58 ± 14.97 316.99 ± 94.36 
 121 to 240 DIM 1.98 ± 2.41 4.91 ± 8.99 20.81 ± 5.20  12.10 ± 13.10 110.66 ± 41.56 3.06 ± 4.67 41.50 ± 23.32    13.42 ± 9.42 208.43 ± 62.76 
 >240 DIM 1.98 ± 2.41 4.91 ± 8.99 20.81 ± 5.20  5.80 ± 6.32 41.57 ± 14.81 0.00 ± 0.00 11.83 ± 6.42 51.99 ± 26.00 138.88 ± 36.66 
1NA indicates a cost category that was assumed not applicable to the total cost for that specific severity, incidence timing, and parity 
group combination  
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Table 3.4 Mean ± SD expenditures, losses, and total cost per case of sole ulcer by severity, incidence timing, and parity group as 
estimated using a stochastic simulation model (n = 1,000 iterations).  Bolded values indicate the cost category contributing most to the 
total cost per case for each combination of severity, incidence timing, and parity group. 
  Expenditures 
($/case)  
Losses1 
($/case) Total 
($/case)   Therapeutics Outside labor 
On-farm 
labor  
Decreased milk 
production 
Extended days 
open Recurrence Culling Death 
Primiparous (mild)           
 0 to 60 DIM 8.01 ± 4.69 12.01 ± 6.16 13.88 ± 3.48  75.30 ± 30.68   1.98 ± 1.33 51.03 ± 21.18 45.47 ± 33.00        NA 207.68 ± 50.60 
 61 to 120 DIM 8.01 ± 4.69 12.01 ± 6.16 13.88 ± 3.48  62.96 ± 25.18 1.84 ± 1.27 50.35 ± 20.43 40.23 ± 30.59        NA 189.29 ± 46.76 
 121 to 240 DIM 8.01 ± 4.69 12.01 ± 6.16 13.88 ± 3.48  42.72 ± 16.94 0.38 ± 0.53 43.74 ± 17.50 18.02 ± 15.35        NA 138.77 ± 33.80 
 >240 DIM 8.01 ± 4.69 12.01 ± 6.16 13.88 ± 3.48  15.82 ± 5.97 0.00 ± 0.00 16.58 ± 7.65 44.20 ± 37.30        NA 110.51 ± 40.57 
Primiparous (severe)           
 0 to 60 DIM 8.01 ± 4.69 12.01 ± 6.16 20.81 ± 5.20  55.92 ± 35.06  21.59 ± 11.03 80.91 ± 25.67 62.16 ± 38.73 39.25 ± 5.68 300.66 ± 60.58 
 61 to 120 DIM 8.01 ± 4.69 12.01 ± 6.16 20.81 ± 5.20  49.42 ± 28.42  20.07 ± 10.55 77.90 ± 24.58 58.18 ± 34.68 40.12 ± 5.80 286.53 ± 53.97 
 121 to 240 DIM 8.01 ± 4.69 12.01 ± 6.16 20.81 ± 5.20  36.42 ± 18.35  3.99 ± 4.70 62.95 ± 22.07 21.87 ± 16.76 41.70 ± 6.04 207.76 ± 39.63 
 >240 DIM 8.01 ± 4.69 12.01 ± 6.16 20.81 ± 5.20  18.85 ± 6.81 0.00 ± 0.00 22.32 ± 9.26 53.17 ± 35.76 46.63 ± 6.84 181.81 ± 39.76 
Multiparous (mild)           
 0 to 60 DIM 8.01 ± 4.69 12.01 ± 6.16 13.88 ± 3.48  70.72 ± 22.99   2.77 ± 1.69 52.67 ± 21.14 99.59 ± 52.71        NA 259.65 ± 66.11 
 61 to 120 DIM 8.01 ± 4.69 12.01 ± 6.16 13.88 ± 3.48  61.12 ± 19.64 2.60 ± 1.66 51.69 ± 20.09 43.33 ± 25.41        NA 192.64 ± 43.50 
 121 to 240 DIM 8.01 ± 4.69 12.01 ± 6.16 13.88 ± 3.48  43.43 ± 14.08 0.57 ± 0.80 44.24 ± 16.53 19.19 ± 14.99        NA 141.34 ± 32.34 
 >240 DIM 8.01 ± 4.69 12.01 ± 6.16 13.88 ± 3.48  19.89 ± 6.20 0.00 ± 0.00 16.72 ± 7.37 53.25 ± 36.20        NA 123.76 ± 40.08 
Multiparous (severe)           
 0 to 60 DIM 8.01 ± 4.69 12.01 ± 6.16 20.81 ± 5.20  114.67 ± 45.21 27.35 ± 13.96 81.51 ± 26.66 137.67 ± 51.36 84.38 ± 12.20 486.41 ± 87.49 
 61 to 120 DIM 8.01 ± 4.69 12.01 ± 6.16 20.81 ± 5.20  100.30 ± 37.88 25.54 ± 13.61 78.53 ± 25.05 62.33 ± 23.93 41.63 ± 6.02 349.15 ± 63.35 
 121 to 240 DIM 8.01 ± 4.69 12.01 ± 6.16 20.81 ± 5.20  72.41 ± 26.12 5.30 ± 6.46 62.91 ± 21.64 22.65 ± 14.13 41.91 ± 6.08 246.02 ± 46.45 
 >240 DIM 8.01 ± 4.69 12.01 ± 6.16 20.81 ± 5.20  35.08 ± 10.91 0.00 ± 0.00 22.27 ± 9.06 64.41 ± 34.06 44.10 ± 6.41 206.70 ± 41.52 
1NA indicates a cost category that was assumed not applicable to the total cost for that specific severity, incidence timing, and parity 
group combination
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Table 3.5 Mean ± SD expenditures, losses, and total cost per case of white line disease by severity, incidence timing, and parity group 
as estimated using a stochastic simulation model (n = 1,000 iterations).  Bolded values indicate the cost category contributing most to 
the total cost per case for each combination of severity, incidence timing, and parity group. 
  Expenditures 
($/case)  
Losses1 
($/case) Total 
($/case)   Therapeutics Outside labor 
On-farm 
labor  
Decreased milk 
production 
Extended days 
open Recurrence Culling Death 
Primiparous (mild)           
 0 to 60 DIM 8.20 ± 6.74 11.86 ± 5.85 13.88 ± 3.47  36.63 ± 20.87 3.09 ± 1.76 46.96 ± 17.59 45.10 ± 32.12 NA 165.72 ± 45.78 
 61 to 120 DIM 8.20 ± 6.74 11.86 ± 5.85 13.88 ± 3.47  31.32 ± 16.90 2.88 ± 1.69 40.99 ± 15.30 40.05 ± 30.08 NA 149.19 ± 39.75 
 121 to 240 DIM 8.20 ± 6.74 11.86 ± 5.85 13.88 ± 3.47  21.99 ± 10.89 0.57 ± 0.71 28.45 ± 11.09 18.39 ± 16.81 NA 103.34 ± 27.65 
 >240 DIM 8.20 ± 6.74 11.86 ± 5.85 13.88 ± 3.47  9.60 ± 4.11 0.00 ± 0.00 9.60 ± 4.11 43.90 ± 37.13 NA 97.03 ± 39.01 
Primiparous (severe)           
 0 to 60 DIM 8.20 ± 6.74 11.86 ± 5.85 20.81 ± 5.20  56.68 ± 38.89 11.30 ± 7.35 71.58 ± 26.16 62.60 ± 39.74 39.25 ± 5.68 282.28 ± 62.39 
 61 to 120 DIM 8.20 ± 6.74 11.86 ± 5.85 20.81 ± 5.20  50.60 ± 31.52 10.53 ± 6.98 66.67 ± 25.34 58.09 ± 35.37 40.12 ± 5.80 266.88 ± 56.01 
 121 to 240 DIM 8.20 ± 6.74 11.86 ± 5.85 20.81 ± 5.20  37.63 ± 20.26 2.15 ± 2.91 52.29 ± 23.37 22.12 ± 16.55 41.70 ± 6.04 196.76 ± 40.57 
 >240 DIM 8.20 ± 6.74 11.86 ± 5.85 20.81 ± 5.20  20.20 ± 7.44 0.00 ± 0.00 18.92 ± 10.22 53.73 ± 36.74 46.63 ± 6.84 180.35 ± 40.95 
Multiparous (mild)           
 0 to 60 DIM 8.20 ± 6.74 11.86 ± 5.85 13.88 ± 3.47  23.34 ± 11.42 4.23 ± 2.27 48.97 ± 17.49 99.60 ± 51.62 NA 210.09 ± 60.89 
 61 to 120 DIM 8.20 ± 6.74 11.86 ± 5.85 13.88 ± 3.47  22.06 ± 9.63 3.96 ± 2.24 42.37 ± 15.16 42.85 ± 24.44 NA 145.19 ± 35.66 
 121 to 240 DIM 8.20 ± 6.74 11.86 ± 5.85 13.88 ± 3.47  17.24 ± 6.61 0.83 ± 1.04 29.17 ± 11.17 19.31 ± 15.78 NA 100.50 ± 26.63 
 >240 DIM 8.20 ± 6.74 11.86 ± 5.85 13.88 ± 3.47  10.74 ± 3.18 0.00 ± 0.00 9.85 ± 4.23 53.32 ± 36.38 NA 107.85 ± 39.08 
Multiparous (severe)           
 0 to 60 DIM 8.20 ± 6.74 11.86 ± 5.85 20.81 ± 5.20  120.36 ± 51.15 14.70 ± 9.51 73.16 ± 25.32 137.65 ± 53.18 84.38 ± 12.20 471.13 ± 89.89 
 61 to 120 DIM 8.20 ± 6.74 11.86 ± 5.85 20.81 ± 5.20  104.92 ± 42.39 13.74 ± 9.04 67.76 ± 24.50 62.44 ± 24.64 41.63 ± 6.02 331.36 ± 65.46 
 121 to 240 DIM 8.20 ± 6.74 11.86 ± 5.85 20.81 ± 5.20  75.33 ± 28.62 2.92 ± 4.02 52.58 ± 22.16 22.72 ± 13.91 41.91 ± 6.08 236.33 ± 47.55 
 >240 DIM 8.20 ± 6.74 11.86 ± 5.85 20.81 ± 5.20  35.91 ± 11.56 0.00 ± 0.00 19.12 ± 10.25 64.62 ± 34.40 44.10 ± 6.41 204.62 ± 43.17 
1NA indicates a cost category that was assumed not applicable to the total cost for that specific severity, incidence timing, and parity 
group combination 
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Figure 3.1 Variation in the total cost per case of a) digital dermatitis, b) sole ulcer, and c) 
white line disease by severity, incidence timing, and parity group as estimated using a 
stochastic simulation model (n = 1,000 iterations).  Incidence timing represents the timing 
of diseases occurrence.  Open squares (     ) represent mild cases in primiparous cows, solid 
squares (    ) represent severe cases in primiparous cows, open circles (    ) represent mild 
cases in multiparous cows, and solid circles   (    ) represent severe cases in multiparous 
cows.   
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Figure 3.2 Tornado graphs indicating the change ($) in digital dermatitis (a), sole ulcer (b), 
and white line disease (c) mean total cost per case with a 1 SD increase in selected 
stochastic market prices and herd specific performance variables (RHAM = rolling herd 
average milk production, PR = pregnancy rate) as estimated using a stochastic simulation 
model (n = 1,000 iterations).  
a) 
 
b) 
 
c) 
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Abstract 
 A farm-level stochastic simulation model was adapted to estimate the value of 
implementing lameness prevention on a dairy farm by calculating the change in the herd-
level total cost of lameness from pre- to post- lameness prevention implementation.  Two 
potential lameness prevention strategies were tested: strategy 1 was prevention focused on 
reducing the infectious hoof diseases in the model (digital dermatitis) and strategy 2 was 
prevention focused on reducing the non-infectious hoof diseases in the model (sole ulcer 
and white line disease).  For each strategy, the effect of the pre-prevention investment hoof 
disease incidence on prevention value was evaluated by setting pre-prevention incidence 
of hoof diseases at 3 different levels.  For strategy 1, digital dermatitis incidence level pre-
prevention investment was 20%, 40%, or 60% while the incidence level of the non-
infectious hoof diseases in the model were held constant.  For strategy 2, sole ulcer and 
white line disease incidence level pre-prevention investment were both 5%, 15%, or 25% 
while the incidence level of the infectious hoof diseases included in the model were held 
constant.  Overall, 6 different scenarios were run; 1 scenario for each prevention strategy 
and pre-prevention investment hoof disease incidence rate combination.  To evaluate how 
the effectiveness of each prevention strategy would influence the investment value, the 
effectiveness of prevention was allowed to vary from a disease incidence risk ratio of 0.0 
(100% reduction in disease incidence) to 1.0 (0% reduction in disease incidence).  For both 
prevention strategies, the value of prevention (i.e., change in the herd-level total cost of 
lameness) increased as the pre-prevention incidence rate of hoof diseases and the 
effectiveness of prevention increased (i.e., the disease incidence risk ratio became smaller).  
However, the profitability of investing in lameness prevention would depend on the cost 
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of the prevention strategy and the other benefits association with the selected prevention 
strategy.  If a herd manager knows the current herd-level incidence of hoof diseases and 
the expected effectiveness of a potential lameness prevention strategy, this model could be 
used as a decision support tool to help identify the amount that could be paid to implement 
that prevention strategy.   
Key words: lameness, hoof health, decision support, animal health economics 
Introduction 
Lameness is considered one of the most important animal welfare issues in the dairy 
industry today (Von Keyserlingk et al., 2009) and is also estimated to be one of the most 
expensive dairy diseases per case (Liang et al., 2017).  In North American herds, reported 
lameness prevalence has ranged from 10% (Adams et al., 2016) to 55% (Von Keyserlingk 
et al., 2012) between 2012 and 2017.   
There are many lameness prevention strategies available for dairy herds to use, 
including footbaths (Speijers et al., 2012) and preventive hoof trimming (Manske et al., 
2002).  Yet a recent survey of 184 United States dairies indicated that producers are not 
consistently using recommended lameness prevention and control strategies (Adams et al., 
2016).  Thirty-five percent of surveyed farms never used a footbath and 13% of farms only 
used a footbath seasonally or occasionally.  Additionally, 7% of herds never performed 
preventive hoof trimming, 20% of farms only conducted trimming when cows were visibly 
lame, and 36% of farms only performed preventive hoof trimming once per lactation.   
Leach et al. (2010a) found that the reasons producers did not focus on lameness 
prevention included a false perception that no lameness problem existed in their herd, a 
lack of time, or a lack of understanding surrounding the economic consequences of 
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lameness.  Further, when producers were asked what could motivate other farms to reduce 
lameness, the most frequent response was to provide more information on lameness costs 
(Leach et al., 2010b).  Disease costs are difficult to understand because the total cost is 
composed of 2 different components: expenditures and losses (McInerney et al., 1992).  
Expenditures are the direct costs associated with treatment (i.e., labor and therapeutics) and 
prevention of disease.  These are the costs producers often recall because they are obvious.  
Losses are the indirect costs associated with existing disease.  For example, reduced milk 
yield, reduced reproductive performance, increased risk of culling, increased risk of death, 
and risk of disease recurrence are all disease losses.   
Morris (1969) defined optimum disease management as increasing disease 
prevention expenditures only to the point that the additional money spent would be equal 
to the resulting additional returns (i.e., reduced losses).  In this study, we used a pre-existing 
farm-level stochastic simulation model to estimate the change in the herd-level total cost 
of lameness when prevention strategies were implemented.  By doing this, the model could 
be used to calculate the amount a producer should be willing to spend on prevention, given 
the expected returns (i.e., reduced hoof disease losses). Our objective was to estimate the 
value of infectious or non-infectious lameness prevention strategies when pre-prevention 
hoof disease incidence rates and prevention effectiveness varied.       
Materials and Methods 
      Model overview 
 The herd-level stochastic simulation model used in this study was previously 
described in Chapter 3.  The deterministic portion of the model was created using Excel 
2016 (Microsoft, Seattle, Washington) and was supplemented with stochastic features 
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using the @Risk add-in (Palisade Corporation, Ithaca, New York).  The model calculates 
the revenues (milk sales, calf value, and slaughter value) and expenses (feed costs, 
veterinary costs, breeding costs, and disposal losses) associated with the average cow in 
the herd every day for 6 lactations.  Information about the average cow is used to estimate 
the herd-level revenues and expenses over a year-long period. 
 Within the model, the cost per case of 3 hoof diseases (digital dermatitis, sole ulcer, 
and white line disease) was calculated based on assumed changes in cow performance in 
response to disease, as collected from previously published research (Chapter 3).  The cost 
per case of hoof disease varied by not only disease type, but also severity level (mild or 
severe), incidence timing (0 to 60 DIM, 61 to 120 DIM, 121 to 240 DIM, or >240 DIM), 
and parity group (primiparous or multiparous).  The total cost per case of each hoof disease 
included the current lactation expenditures associated with outside (hoof trimmer) labor, 
therapeutics, and on-farm labor, and losses associated with discarded milk, reduced milk 
production, extended days open, an increased risk of culling, an increased risk of death 
(natural or euthanized), and disease recurrence (within the same animal).  Variables 
assumed to influence the cost of hoof diseases were modeled stochastically to account for 
variation among herds or uncertainty in their values.  For stochastically modeled variables, 
a distribution was defined using previously published literature or industry averages (Table 
4.1).  Each time the model was run, a value from that distribution was selected and used in 
the model to calculate a unique cost per case of hoof disease.   
      Lameness prevention assumptions 
In this study, the pre-existing model was adapted to estimate the economic outcome 
associated with implementing lameness prevention strategies on a dairy farm.  As an 
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example, we focused on two potential lameness prevention methods: strategy 1 was 
assumed to reduce infectious hoof diseases only (i.e., digital dermatitis) and strategy 2 was 
assumed to reduce both non-infectious hoof diseases only (i.e., sole ulcer and white line 
disease).  To calculate the value of implementing strategies which prevented each type of 
lameness, the herd-level total cost of lameness would need to be calculated pre- and post- 
lameness prevention implementation.  To calculate the herd-level total cost of lameness 
from the cost per case of lameness estimates already provided by the model, the following 
additional information was needed in the model: pre- and post- lameness prevention 
implementation hoof disease incidence rates and the distribution of hoof diseases among 
different classifications (i.e., mild vs. severe cases, the distribution of disease occurrence 
across the lactation, and the distribution of cases among parities).  
Hoof disease incidence rates.  For the base scenario, when no lameness prevention 
was used, an estimate of the incidence of each hoof disease was needed.  No United States 
studies were identified that evaluated incidence levels of specific hoof diseases while 
reporting the prevention strategies used on the evaluated herds.  Additionally, incidence 
rates will vary across farms.  Therefore, in this study we tested 3 possible pre-prevention 
implementation incidence rates of hoof diseases within each strategy to see how variation 
would influence the investment outcome.  Each different pre-prevention incidence rate was 
run as a separate simulation within the model.  For strategy 1, the incidence of digital 
dermatitis was assumed to be 20%, 40%, or 60%, while the incidence of sole ulcer and 
white line disease were held constant (15%).  For strategy 2, the incidence of both sole 
ulcers and white line disease was assumed to be 5%, 15%, or 25%, while the incidence of 
digital dermatitis was held constant (30%).  To summarize, 6 different scenarios were 
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tested: in 3 scenarios the economic effect of implementing infectious hoof disease 
prevention was tested, assuming 3 different pre-prevention incidence rates for digital 
dermatitis and in 3 scenarios the economic effect of implementing non-infectious hoof 
disease prevention was tested, assuming 3 different pre-prevention incidence rates for sole 
ulcers and white line disease.  The values chosen to represent pre-prevention 
implementation incidence rates for all diseases were selected to represent variation around 
the mean prevalence rates reported by DeFrain et al. (2013), but do not necessary represent 
the true incidence rates found on farms in the United States. 
 When lameness prevention strategies were used, we assumed that lameness 
incidence would be affected.  Disease incidence risk ratios (RR) were used to adjust the 
base incidence of each hoof disease as prevention strategies were implemented.  Limited 
published data on how different lameness prevention strategies change hoof disease 
incidence exists.  Therefore, instead of assuming a particular prevention strategy, we 
allowed the effect of prevention strategies on hoof disease incidence (disease risk ratios) 
to vary stochastically.  Hoof disease risk ratios were modeled using a triangle distribution 
with the minimum, most likely, and maximum values set to 0.0, 0.5, and 1.0, respectively, 
for all simulations.  The hoof disease risk ratio distributions were truncated at a minimum 
of 0.0 and a maximum of 1.0, meaning the model input was re-drawn from the distribution 
if a value outside of that range was selected, assuming that lameness prevention strategy 
implementation would never increase the risk of diseases incidence.  To summarize, the 
effect of prevention in all 6 scenarios varied from no effect (risk ratio = 1.0) to 100% 
reduction in the selected hoof diseases (risk ratio = 0.0).  For the first 3 scenarios, this risk 
ratio was applied to the incidence of digital dermatitis (to allow analysis of the value of 
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infectious hoof disease prevention) and for the remaining 3 scenarios, this risk ratio was 
applied to the incidence of sole ulcers and white line disease (to allow analysis of the value 
of non-infectious hoof disease prevention).  Allowing variation in the disease incidence 
risk ratios allowed us to evaluate the value of lameness prevention strategies with varying 
levels of effectiveness. 
Hoof disease case classification.  The model calculated the cost per case of hoof 
disease by disease type, severity level, incidence timing, and parity.  Therefore, the 
distribution of occurring hoof disease cases among these combinations was needed for an 
accurate estimation of herd-level lameness costs.  The same hoof disease incidence rates 
were assumed for primiparous and multiparous cows and parities 1, 2, 3, 4, 5, and 6 were 
modeled to represent 36.1%, 26.0%, 17.7%, 11.0%, 5.8%, and 3.4% of the herd, 
respectively (Table 4.1; Dhuyvetter et al., 2007).  The percent of severe vs. mild cases was 
defined by observations from Charfeddine and Pérez-Cabal (2017) who estimated severe 
cases to represent 6%, 14%, and 16% of primiparous digital dermatitis, sole ulcer, and 
white line disease, and 6%, 13%, and 14% of multiparous digital dermatitis, sole ulcer, and 
white line disease, respectively.  Disease incidence timing was modeled to match timing 
as reported by Booth et al. (2004), assuming white line disease to follow a similar pattern 
to sole ulcer because both are non-infectious diseases.  The percentage of digital dermatitis 
cases occurring at ≤ 60 DIM, 61 to 120 DIM, 121 to 240 DIM, and >240 DIM was 27%, 
31%, 30%, and 12%, respectively.  The percentage of sole ulcer and white line disease 
cases occurring at ≤ 60 DIM, 61 to 120 DIM, 121 to 240 DIM, and >240 DIM was 26%, 
32%, 31%, and 10%, respectively.   
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      Calculation of lameness prevention value 
In both pre- and post- lameness prevention implementation simulations, hoof 
disease incidence rates were multiplied by the number of cows in each parity to calculate 
the number of cases of each hoof disease occurring in one year.  To find the number of 
cows in each parity, the percent of cows in each parity (Table 4.1) was multiplied by the 
milking herd size.  Milking herd size was modeled stochastically using a PertAlt 
distribution with the 5th percentile, mean, and 95th percentile set to 50, 250, and 1,000 cows 
to represent a wide range of herd sizes (Table 4.2).  These calculations resulted in the total 
number of cases of each hoof disease in each parity per year in both the pre- and post- 
lameness prevention implementation scenarios.  The number of cases within each parity 
per year were then classified by severity and incidence timing using model assumptions, 
and a cost was assigned to each case by calculating the lameness associated expenditures 
and losses as described in Chapter 3. 
In each scenario, the herd-level total cost of lameness was calculated as the sum of 
all expenditures (outside labor, therapeutics, on-farm labor, and prevention) and losses 
(discarded milk, reduced milk production, increased days open, an increased risk of culling, 
an increased risk of death, and disease recurrence) for all 3 hoof diseases over a one-year 
period.  This value was converted to the total cost of lameness per lactating cow-year by 
dividing the herd-level total cost of lameness by the lactating herd size.  Within this cost 
of lameness, we did not include the cost of prevention since we were not attempting to 
model specific prevention strategies.  Instead, by comparing the herd-level total cost of 
lameness per cow-year pre- and post - lameness prevention implementation, the change in 
the herd-level total cost of lameness per cow-year can be calculated, which would represent 
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the maximum amount that could be spent on the lameness prevention strategy in each 
scenario to breakeven.  How this value varied with varying pre-prevention incidence rate 
of hoof diseases and effectiveness of the implemented prevention strategy was also 
considered. 
      Simulation methods 
  For this study, 12 simulations of the model were run as described in Table 4.3.  In 
6 simulations, the value of infectious hoof disease prevention was estimated (strategy 1) 
assuming varying pre-prevention implementation digital dermatitis incidence levels (20%, 
40%, and 60% for simulations 1 and 2, 3 and 4, and 5 and 6, respectively, where odd 
numbered simulations were pre-prevention implementation and even numbered 
simulations were post-prevention implementation) .  In the remaining 6 simulations, the 
value of non-infectious hoof disease prevention was estimated (strategy 2) assuming 
varying pre-prevention implementation sole ulcer and white line disease incidence levels 
(5%, 15%, and 25% for simulations 7 and 8, 9 and 10, and 11 and 12, respectively, where 
odd numbered simulations were pre-prevention implementation and even numbered 
simulations were post-prevention implementation).  For each simulation, 300 iterations 
were run using Latin Hypercube sampling.  To confirm that all simulations used the same 
drawn stochastic variables for each iteration (making them comparable) a static seed was 
set to 31,517.  Default deterministic variable assumptions used to define the herd and the 
average cow were collected from Dairy Records Management Systems (Raleigh, NC) 
using limitations of only Holstein herds with ≥ 200 cows, published literature, or the 
authors’ expertise (Table 4.2).  The resulting distributions of herd-level stochastic variables 
can be found in Table 4.1.  Inputs used in the model for this study were meant to represent 
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a United States dairy herd.  However, model inputs could be adjusted to herd-specific 
values to calculate the cost of hoof diseases for a specific herd.   
Results and Discussion 
 The objective of this study was to use an existing stochastic simulation model to 
estimate the value of lameness prevention strategies when pre-prevention hoof disease 
incidence rates and prevention effectiveness varied.  The mean ± SD total herd-level cost 
of lameness per cow-year for each simulation is presented in Table 4.3.  Over the 12 
simulations, the herd-level total cost of lameness varied depending on the assumed pre-
prevention disease incidence rates, if lameness prevention was used or not, and how 
effective the lameness prevention method was.  The change in the herd-level total cost of 
lameness per cow-year between simulations using and not using prevention could be used 
to identify the maximum amount a producer should be willing to pay for implementing a 
prevention strategy.  
      Infectious hoof disease prevention 
 Figure 4.1 shows the change in the herd-level total cost of lameness per cow-year 
when infectious hoof disease prevention was implemented as affected by prevention 
effectiveness across the 3 different pre-prevention digital dermatitis incidence rates.  
Regardless of pre-prevention digital dermatitis incidence rate, the value of prevention (i.e., 
change in the herd-level total cost of lameness) increased as the effectiveness of prevention 
increased (i.e., the disease incidence risk ratio became smaller) because less lameness cases 
were occurring and, therefore, there were less expenditures and losses associated with 
lameness.  Additionally, as the pre-prevention incidence rate of digital dermatitis increased, 
the value of prevention (i.e., change in the herd-level total cost of lameness between pre- 
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and post- lameness prevention implementation) increased.  The mean ± SD change in the 
herd-level total cost of lameness per cow-year when digital dermatitis was original 20%, 
40%, or 60% was $6.9 ± 3.3, $13.8 ± 6.5, and $20.6 ± 9.8, respectively.  In this example, 
we assumed prevention focused on infectious hoof diseases would reduce the incidence of 
digital dermatitis only so changes in the herd-level total cost of lameness per cow-year 
were not affected by changes in the cost of other hoof diseases included in the model (i.e., 
sole ulcer and white line disease).  The pre-prevention incidence rate of digital dermatitis 
influences the value of prevention because as pre-prevention incidence increases, the 
potential to reduce lameness costs increases. 
 Although the herd-level total cost of lameness per cow-year always decreased when 
infectious hoof disease prevention was implemented, this is only beneficial to the herd if 
the decrease in costs is greater than or equal to the cost of prevention.  In the simulation 
where pre-prevention incidence of digital dermatitis was 20%, the maximum decrease in 
the herd-level total cost of lameness per cow-year was $17 when the digital dermatitis 
incidence risk ratio associated with prevention was 0.20 and the minimum decrease in the 
herd-level total cost of lameness per cow-year was $0.1 when the digital dermatitis 
incidence risk ratio associated with prevention was 0.99.  This indicates that, using our 
model assumptions, the most that could be spent on prevention per cow-year when your 
herd has a pre-prevention incidence rate of 20% is $17, but only if the prevention strategy 
is highly effective (reduces digital dermatitis incidence by > 80%).  If the prevention 
strategy is not very effective, a herd in this scenario could only spend up to $0.1 per cow-
year before the benefits of prevention are not paying for the prevention strategy itself.  
Similarly, if pre-prevention incidence rate of digital dermatitis was 40%, the maximum that 
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could be paid for prevention was $34, but if the effectiveness of prevention was low then 
the maximum that could be paid for prevention was only $0.3.  Finally, if pre-prevention 
incidence rate of digital dermatitis was 60%, the maximum that could be paid for 
prevention was $51, but if the effectiveness of prevention was low then the maximum that 
could be paid for prevention was only $0.4.   
 The most common infectious lameness disease prevention strategy in the United 
States dairy industry is footbaths.  Multiple options exist for footbath solutions, with the 2 
most common being 5% copper sulfate and formalin.  If we assume that a 5% copper sulfate 
solution footbath costing $50 per bath is utilized 1 time per day, 3 times per week, and 
changed after 200 cow passes, 0.78 baths would be needed per cow-year, for a total cost of 
prevention of $39/cow-year.  In our model, the mean change in the herd-level total cost of 
lameness per cow-year was not enough to pay for using this prevention strategy, regardless 
of the pre-prevention incidence level of digital dermatitis.  Even if copper sulfate footbath 
use was highly effective at reducing digital dermatitis, the maximum change in the herd-
level total cost of lameness per-cow year was only high enough to pay for prevention if 
pre-prevention incidence rate of digital dermatitis was 60%; there were no scenarios when 
pre-prevention incidence of digital dermatitis was 20% or 40% that the value of prevention 
was enough to offset the cost of this prevention strategy, regardless of prevention 
effectiveness.  However, reduced footbath frequency or a less expensive supply of copper 
sulfate could change these results if no negative effects on footbath effectiveness were 
seen.  Additionally, if more benefits beyond digital dermatitis reduction are seen after 
footbath implementation (e.g., reduced foot rot) the footbath could still be profitable.  
Alternatively, if we assume a formalin footbath costing $12 per bath and utilized at the 
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same rate as we assumed for the 5% copper sulfate bath, the total cost of prevention would 
be $9/cow-year.  In our model, the mean change in the herd-level total cost of lameness 
per cow-year would cover the cost of this prevention method if pre-prevention incidence 
of digital dermatitis was 40% or 60%.  Additionally, implementation of this prevention 
strategy would be economically beneficial when pre-prevention digital dermatitis 
incidence was only 20% if prevention effectiveness was high.  
      Non-infectious hoof disease prevention 
 Figure 4.2 shows the change in the herd-level total cost of lameness per cow-year 
when non-infectious hoof disease prevention was implemented, as affected by prevention 
effectiveness across the 3 different pre-prevention non-infectious hoof disease incidence 
rates.  Similar to the infectious hoof disease prevention scenario, the value of prevention 
(i.e., change in the herd-level total cost of lameness from pre- to post- lameness prevention 
implementation) increased as the effectiveness of prevention increased (i.e., the disease 
incidence risk ratio became smaller) and as the pre-prevention incidence rate of non-
infectious diseases increased.  The mean ± SD change in the herd-level total cost of 
lameness per cow-year when non-infectious hoof disease incidence levels were original 
5%, 15%, or 25% was $8.7 ± 3.9, $26.2 ± 11.6, and $43.6 ± 19.3, respectively.  Compared 
to when infectious hoof disease prevention was used, the value of prevention was greater 
in this scenario even though the pre-prevention incidence rate of selected disease was 
lower.  This resulted from non-infectious diseases costing more per case (Table 4.1) and 
the prevention strategy impacting the incidence of more than just 1 disease.     
 Using our model assumptions in the simulation where pre-prevention incidence of 
non-infectious hoof diseases was 5%, the most that could be spent on prevention per cow-
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year was $20, but only if the prevention strategy was highly effective (risk ratio = 0.05).  
If the prevention strategy effectiveness was poor (risk ratio = 0.99) then the most that could 
be spent on prevention per cow-year was only $0.2.  Similarly, if pre-prevention incidence 
rate of non-infectious diseases was 15%, the maximum that could be paid for prevention 
was $59, but if the effectiveness of prevention was low then the maximum that could be 
paid for prevention was only $0.7.  Finally, if the pre-prevention incidence rate of non-
infectious hoof diseases was 25%, the maximum that could be paid for prevention was $98, 
but if the effectiveness of prevention was low then the maximum that could be paid for 
prevention was only $1.   
 Multiple non-infectious hoof disease prevention strategies exist; for example, 
preventive hoof trimming, biotin supplementation, and rubber flooring (Ettema and 
Østergaard, 2006).  An estimated cost of preventive hoof trimming could be taken from the 
survey of hoof trimmers in Chapter 2 where the mean ± SD charged for trimming per cow 
was $12.55 ± 2.39 (n = 113 survey respondents).  Assuming the implementation of one 
additional trimming per cow-year, the mean value of this prevention strategy would be 
positive if pre-prevention incidence of non-infectious diseases was either 15% or 25%.  
Only in cases where this prevention strategy was highly effective was the change in the 
herd-level total cost of lameness per cow-year enough to pay for implementation if pre-
prevention incidence of non-infectious hoof diseases was only 5%.  Other non-infectious 
hoof disease prevention strategies are more difficult to calculate the cost of because they 
are typically not charged per cow.  For example, reduction in lameness may be seen after 
installing rubber flooring (Vanegas et al., 2006) or redesigning poorly constructed freestalls 
(Ito et al., 2010), but the cost of doing so is a long-term investment that will also have 
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benefits beyond lameness incidence reduction (e.g., reduced mastitis incidence, improved 
cow longevity).  Correctly identifying what portion of this cost should be considered 
expenditures on lameness prevention will influence if the prevention investment is 
beneficial or not.  
      Interpretation of results 
Within this study we focused on estimating the value of implementing either 
infectious or non-infectious lameness prevention.  Based on the results in this study, the 
value of lameness prevention strategies depends on the pre-prevention incidence rate of 
hoof diseases, the effectiveness of the prevention strategy implemented, and the cost of the 
prevention strategy implemented.   
This model could be useful as a decision support tool to help guide decisions about 
investment in lameness prevention strategies.  However, some limitations exist within the 
model.  First, the model only accounted for 3 hoof diseases.  These hoof diseases were 
selected because they are the most prevalent lameness causing diseases in United States 
dairy herds (DeFrain et al., 2013) and have had their effects on cow productivity studied 
more extensively than other hoof diseases.  However, by not including other hoof diseases 
(e.g., foot rot, toe ulcers, thin soles) we may be underestimating the herd-level total cost of 
lameness and, therefore, the value of lameness prevention strategies. 
Secondly, we did not account for the possibility that the proportion of mild and 
severe cases could change with lameness prevention implementation.  If prevention 
strategies do reduce the proportion of severe hoof diseases, we may have underestimated 
the value of prevention.  Third, the model did not account for a herd potentially improperly 
implementing prevention strategies.  In reality, a positive response to prevention 
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implementation will only be seen in herds with correct stocking density, appropriate time 
budgets, and proper implementation of the prevention strategies.  Poor implementation, 
including improper hoof trimming practices or footbath design, could lead to increased 
rather than decreased hoof disease incidence.  
Finally, the accuracy of model results is limited by the accuracy of the information 
provided to it.  To accurately calculate the value of lameness prevention strategies, correct 
estimates are needed for the cost of hoof diseases, the pre-prevention hoof disease 
incidence rates within a herd, and the effectiveness of prevention.  Although our cost 
estimates were taken from Chapter 3, those did not account for the animal welfare impact 
of lameness, which could be an economic contributor in the future.  Improved on-farm 
records of hoof disease incidence at the cow level, further research considering the effects 
of specific hoof diseases on cow performance, and further research on the effects of 
prevention strategies on hoof disease incidence is needed.     
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Table 4.1 Simulated market price and herd performance inputs used in a stochastic model 
to estimate the value of infectious and non-infectious lameness prevention strategies 
Input 
Simulated range 
(min – max) 
Simulated     
mean ± SD Source1 
Calf value ($/bull)         72 – 224       131 ± 41 Chapter 3 
Calf value ($/heifer)       234 – 675       395 ± 144 Chapter 3 
Milking herd size (c)         68 – 968        434 ± 205 
Authors’ 
expertise 
 Slaughter value ($/kg)      1.03 – 1.78      1.43 ± 0.20 FAPRI (2017) 
Milk price ($/kg)      0.29 – 0.50      0.40 ± 0.06 FAPRI (2017) 
Lactating cow feed price ($/kg)      0.21 – 0.37      0.29 ± 0.04 FAPRI (2017) 
Replacement heifer price ($)    1,437 – 2,122    1,718 ± 217 Chapter 3 
RHA milk production (kg)    5,993 – 17,136  11,461 ± 1,994 DairyMetrics 
Pregnancy rate (%)        3.3 – 72.6      22.1 ± 11.0 DairyMetrics 
Cost of digital dermatitis 
($/case)1         64 – 248       137 ± 31 Chapter 3 
Cost of sole ulcer ($/case)1       130 – 325       227 ± 37 Chapter 3 
Cost of white line disease 
($/case)1       138 – 435       202 ± 33 Chapter 3 
Prevention effect on hoof 
diseases (risk ratio)      0.01 – 0.99      0.50 ± 0.20   
Authors’ 
expertise 
1Mean cost per case across all combinations of severity level, incidence timing, and parity 
group 
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Table 4.2 Deterministic herd performance and financial inputs used in a stochastic model 
to estimate the value of infectious and non-infectious lameness prevention strategies 
Input Value Source1 
Age at first calving (m) 24.3 DairyMetrics 
Baseline culling rate (%) 13.0 Bewley et al. (2010) 
Breeding costs ($/insemination) 2 15.51 VanRaden and Cole (2014) 
Butterfat yield (%) 3.7 DairyMetrics 
Calf birth weight (kg) 41.7 Kertz et al. (1997) 
Close up dry cow feed price ($/kg DMI) 0.22 Model input 
Close up dry period length (d) 21 Model input 
 Days dry 56.2 NAHMS (2014) 
Days in milk designated do not breed 250 Bewley et al. (2010) 
Discount rate (%) 8.0 Hyde and Engel (2002) 
Disposal losses ($)2 65 Groenendaal et al. (2004) 
Far off dry cow feed price ($/kg DMI) 0.15 Model input 
Gestation length (d) 280 Norman et al. (2007) 
Mature cow live weight (kg) 723 NRC (2001) 
Percent heifer calves 46.7 Del Río et al. (2007) 
Percent of herd in 1st parity 36.1 Dhuyvetter et al. (2007) 
Percent of herd in 2nd parity 26.0 Dhuyvetter et al. (2007) 
Percent of herd in 3rd parity 17.7 Dhuyvetter et al. (2007) 
Percent of herd in 4th parity 11.0 Dhuyvetter et al. (2007) 
Percent of herd in 5th parity 5.8 Dhuyvetter et al. (2007) 
Percent of herd in 6th (or greater) parity 3.4 Dhuyvetter et al. (2007) 
Protein yield (%) 3.1 DairyMetrics 
Voluntary waiting period (d) 59.3 DairyMetrics 
1DairyMetrics information was collected on October 1, 2017 from Dairy Records 
Management Systems (Raleigh, NC).  Values gathered from DairyMetrics included 1,987 
United States Holstein herds with at least 200 cows. 
2Adjusted for inflation to 2017 prices  
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Table 4.3 Outline of simulations run to estimate the value of either infectious or non-infectious hoof disease prevention strategies, as 
influenced by pre-prevention hoof disease incidence rates and prevention effectiveness.  The mean ± SD total herd-level total cost of 
lameness per cow-year as estimated using a stochastic simulation model is reported for each simulation (n = 300 iterations).  
Simulation 
number Prevention focus 
Pre-prevention disease incidence rate (%) Prevention 
implemented 
(Yes or No) 
Herd-level total               
cost of lameness                       
(mean ± SD $/cow-year) 
Digital 
dermatitis Sole ulcer 
White line 
disease 
1 Infectious diseases 20 15 15 No 66.3 ± 10.5 
2 Infectious diseases 20 15 15 Yes 59.5 ± 9.9 
3 Infectious diseases 40 15 15 No 80.2 ± 66.4 
4 Infectious diseases 40 15 15 Yes 66.4 ± 12.3 
5 Infectious diseases 60 15 15 No 94.0 ± 16.4 
6 Infectious diseases 60 15 15 Yes 73.4 ± 9.8 
7 Non-infectious diseases 30 5 5 No 38.3 ± 7.1 
8 Non-infectious diseases 30 5 5 Yes 29.5 ± 7.3 
9 Non-infectious diseases 30 15 15 No 73.3 ± 11.8 
10 Non-infectious diseases 30 15 15 Yes 47.1 ± 13.9 
11 Non-infectious diseases 30 25 25 No 108.2 ± 17.1 
12 Non-infectious diseases 30 25 25 Yes 64.6 ± 21.3 
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Figure 4.1 Change in the total herd-level total cost of lameness per cow-year when 
infectious hoof disease prevention was implemented, as calculated using a stochastic 
simulation model (n = 300 iterations).  Three pre-prevention herd-level digital dermatitis 
incidence rates were tested: 20% (a), 40% (b), and 60% (c).  The prevention effect on 
digital dermatitis incidence (risk ratio) was allowed to vary between 0.0 and 1.0.   
a) 
 
b) 
 
 
c)  
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Figure 4.2 Change in the total herd-level total cost of lameness per cow-year when non-
infectious hoof disease prevention was implemented, as calculated using a stochastic 
simulation model (n = 300 iterations).  Three pre-prevention herd-level non-infectious hoof 
disease (sole ulcer and white line disease) incidence rates were tested: 5% (a), 15% (b), 
and 25% (c).  The prevention effect on non-infectious hoof disease incidence (risk ratio) 
was allowed to vary between 0.0 and 1.0.   
a) 
 
b)  
 
c) 
 
 
0
20
40
60
80
100
0.00 0.20 0.40 0.60 0.80 1.00
C
ha
ng
e 
in
 th
e 
he
rd
-le
ve
l 
to
ta
l c
os
t o
f l
am
en
es
s p
er
 
co
w
-y
ea
r (
$)
Prevention effect on non-infectious hoof disease incidence 
(risk ratio)
0
20
40
60
80
100
0.00 0.20 0.40 0.60 0.80 1.00
C
ha
ng
 e
in
 th
e 
he
rd
-le
ve
l 
to
ta
l c
os
t o
f l
am
en
es
s p
er
 
co
w
-y
ea
r (
$)
Prevention effect on non-infectious hoof disease incidence 
(risk ratio)
0
20
40
60
80
100
0.00 0.20 0.40 0.60 0.80 1.00
C
ha
ng
e 
in
 th
e 
he
rd
-le
ve
l 
to
ta
l c
os
t o
f l
am
en
es
s p
er
 
co
w
-y
ea
r (
$)
Prevention effect on non-infectious hoof disease incidence 
(risk ratio)
 
118 
 
CHAPTER 5  
 
Research Summary 
Two objectives were focused on throughout this research.  The first was to calculate 
the costs associated with hoof diseases causing lameness in dairy cattle.  To accomplish 
this, we had to collect estimates for all disease associated expenditures (therapeutics, 
outside labor, and on-farm labor) and losses (discarded milk, reduced milk production, 
extended days open, increased risk of culling, increased risk of death, and disease 
recurrence) from previously published epidemiological studies.  Many gaps in the literature 
were identified through our search.  In particular, very few studies have focused on the 
expenditures and losses associated with lameness at the hoof disease level.  Originally we 
had planned to estimate the costs per case for 6 different hoof diseases (digital dermatitis, 
foot rot, sole ulcer, thin sole, toe ulcer, and white line disease), but missing data narrowed 
our focus to 3 hoof diseases (digital dermatitis, sole ulcer, and white line disease).  Further 
research considering the many different conditions classified as lameness, rather than 
lameness as a disease itself, is needed.  This area of focus is especially necessary given the 
prevalence of lameness reported in many recent studies and the increasing animal welfare 
concerns for the dairy industry.     
One hole identified in the literature was a lack of estimates for disease-specific 
therapeutic and outside labor costs (fees charged by hoof trimmers or veterinarians to visit 
and treat lameness cases) in the United States.  Therefore, a survey of hoof trimmers and 
veterinarians was conducted to estimate those costs for the 3 hoof diseases of interest, along 
with additional hoof diseases (foot rot, toe ulcers, and thin soles).  Answers from 116 hoof 
trimmers and 18 veterinarians were obtained through both online and paper survey 
methods.  Because of the low response rates from veterinarians, our analysis focused on 
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hoof trimmer respondents only.  Hoof trimmers indicated that digital dermatitis, sole ulcer, 
and white line disease were the most commonly treated hoof diseases, confirming our 
decision to focus our research on those 3 diseases.  However, toe ulcers were identified as 
the most expensive hoof disease to treat.  This is interesting given the lack of published 
literature on toe ulcers.  Further research into less understood hoof diseases, like toe ulcers 
and thin soles, could increase understanding of those diseases and potentially reduce their 
treatment costs.    
Survey estimates for therapeutics and outside labor were combined with other 
literature-derived values in a stochastic simulation model used to estimate cost of 3 specific 
hoof diseases.  To improve on previous studies, costs per case were differentiated not only 
by disease, but also by severity (mild vs. severe), incidence timing (0 to 60 DIM, 61 to 120 
DIM, 121 to 240 DIM, or >240 DIM), and parity group (primiparous or multiparous).  Our 
results indicate similar mean costs per case to previous hoof disease cost estimates, but 
provide beneficial insight into how costs vary by severity, incidence timing, and parity 
group.  Having an understanding of how disease costs differ by cow (depending on parity, 
DIM, etc.) could help producers make cow specific treatment decisions.  Additionally, this 
knowledge can help prioritize investment in prevention to focus on cases that are most 
costly to the producer.  The sensitivity of hoof disease costs to market prices (milk price, 
feed price, replacement price, and slaughter price) and herd performance factors (rolling 
herd average milk production and pregnancy rate) highlights the need to consider lameness 
costs at the herd level rather than the industry level.  In other words, a good treatment or 
prevention decision for one herd may be a poor treatment or prevention decision for another 
herd.  Future efforts could be made to incorporate our hoof disease cost estimates into 
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decision support tools that could be used at the herd level to aid in treatment and prevention 
investment decisions.   
A variety of lameness prevention recommendations are made to dairy producers with 
little scientific evidence supporting their economic benefits.  Therefore, the second 
objective of this research was to estimate the economic value of investing in different 
lameness prevention strategies.  For our study, we chose to focus on 2 broad categories of 
lameness prevention: infectious hoof disease prevention and non-infectious hoof disease 
prevention. The same stochastic simulation model used for estimating hoof disease costs 
was used to calculate the herd-level total cost of digital dermatitis, sole ulcer, and white 
line disease with and without prevention implementation.  We also evaluated how changes 
in pre- lameness prevention implementation hoof disease incidence and the effectiveness 
of the prevention strategy changed the estimated value of lameness prevention.   
Overall, the greater the incidence of hoof diseases and the more effective the prevention 
strategy, the greater the value of implementing lameness prevention strategies.  However, 
each lameness prevention strategy would only be economically beneficial if the change in 
the herd-level total cost of lameness was enough to offset the cost of the selected prevention 
strategy or if non-economic factors (like improved animal welfare) could be used to justify 
implementation.   Individual farm managers could use this model to help identify the 
potential value of different lameness prevention strategies if they know the current herd-
level incidence of hoof diseases and the expected effectiveness of the lameness prevention 
strategy of interest.     
 Compared to other dairy diseases, hoof diseases are understudied.  Many 
opportunities exist for further research in this area; particularly field trials focused on the 
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direct effect of individual hoof diseases on cow performance and on how prevention 
strategies effect specific hoof diseases, including those beyond digital dermatitis, sole 
ulcers, and white line disease.   
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Table A1.  Questions included in a survey of hoof trimmers and veterinarians aimed at 
collecting and summarizing information on hoof disease treatment costs 
Question 
number Question 
Q1 What role do you serve for dairy farmers? (hoof trimmer, veterinarian, other) 
Q2 If in the United States, which states do you practice in?  If outside the United States, in which 
country/countries do you practice? 
Q3 Estimate the number of farms you perform preventative or corrective trimming for each year 
that would fall under each category: 
Small herds (fewer than 100 lactating cows): __________  
Medium herds (between 100 and 500 lactating cows): __________ 
Large herds (over 500 lactating cows): __________ 
Q4 What is the smallest herd size for which you perform preventative or corrective trimming?  
___________ lactating cows 
Q5 What is the largest herd size for which you perform preventative or corrective trimming?  
____________ lactating cows 
Q6 On average, how many dairy cows do you conduct preventative trimming for weekly (i.e. 
routine trimming)?  __________  
Q7 On average, how many dairy cows do you treat for lameness weekly (i.e. treatment of existing 
lameness)?  __________  
Q8 Do you charge a set-up fee, visit fee, or set daily rate to come to a dairy farm?  Circle one: 
NO 
YES   If yes, what is your rate: $__________ set-up fee (on average)   
         $__________ visit fee (on average) 
         $__________ set daily rate (on average) 
Q9 What is your on-farm rate for dairy preventative trimming (i.e. routine trimming)?   
_________ $/hour   OR   _________ $/cow 
Q10 On average, how many dairy cows do you trim per hour when conducting preventative trims?  
__________ 
Q11 In your opinion, rank the following dairy lameness diseases from (1) most costly to (6) least 
costly in terms of total costs per case to the producer (treatment and labor costs plus reduction 
in milk yield, reduced reproductive performance, etc.).  Use each number only once. 
_______ Digital Dermatitis 
_______ Foot Rot 
_______ Sole Ulcer 
_______ Thin Sole 
_______ Toe Ulcer 
_______ White Line Lesion 
Q12 In your opinion, rank the following potential benefits of reducing dairy cow lameness to dairy 
producers from (1) most important to (8) least important.  Use each number only once. 
____ Decreased incidence of other diseases (not lameness) 
____ Enhanced animal welfare  
____ Increased milk production 
____ Increased reproductive performance 
____ Increased cow longevity 
____ Reduced drug and supply costs 
____ Reduced producer labor costs 
____ Reduced veterinary/hoof trimmer fees 
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Table A1.  Continued 
Q13 Of all dairy cow lameness cases that you have treated in the past 12 months, what is your best 
estimate of the percent that would fall under each of the following classifications (the total 
should equal 100%).   
_________% Digital Dermatitis 
_________% Foot Rot 
_________% Sole Ulcer 
_________% Thin Sole 
_________% Toe Ulcer 
_________% White Line Lesion 
_________% Other (For example: corkscrew, axial wall cracks, overgrowth, and corns) 
100 % = TOTAL OF ALL 
Q14 Approximately how much time do you spend per hoof to treat a case of: 
Digital Dermatitis:   _________ minutes 
Foot Rot:    _________ minutes 
Sole Ulcer:     _________ minutes 
Thin Sole:   _________ minutes 
Toe Ulcer:   _________ minutes 
White Line Lesion:    _________ minutes 
Q15 Do you generally recommend milk withholding following treatment of each of the following 
diseases (mark “Yes” or “No”)?  If “Yes”, indicate for how many days milk withholding is 
recommended: 
Disease No Yes If yes, days withhold is recommended after treatment: 
Digital Dermatitis    
Foot Rot    
Sole Ulcer    
Thin Sole    
Toe Ulcer    
White Line Lesion    
 
Q16 In the first blank column, list how much you charge a dairy producer to treat one case of each 
of the diseases listed. 
 
Then indicate what percent of the total charge of each case is for labor vs. supplies.  The total 
of “% Labor” and “% Supplies” for each row should equal 100%. 
Disease 
Total amount 
charged to the 
producer  
$ 
% 
Labor 
% 
Supplies 
Total 
% 
Digital 
Dermatitis 
   100% 
Foot Rot    100% 
Sole Ulcer    100% 
Thin Sole    100% 
Toe Ulcer    100% 
White Line 
Lesion 
   100% 
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Table A2. Veterinarian responses to a survey regarding dairy hoof disease prevalence, time 
to treat, treatment costs, and the percentage of costs attributed to labor or supplies 
Hoof disease 
Number of 
responses 
(n) 
 Response 
(mean ± SD) 
Digital dermatitis    
 % of total 16  24.7 ± 12.7 
 Time to treat (min) 12  11.4 ± 6.8 
 Total charged ($/case) 12  46.3 ± 26.5 
  % attributed to labor 12  75.6 ± 16.7 
  % attributed to supplies 12  24.4 ± 16.7 
Foot rot    
 % of total 16  17.0 ± 10.4 
 Time to treat (min) 12  11.4 ± 6.1 
 Total charged ($/case) 12  65.1 ± 38.1 
  % attributed to labor 12  57.5 ± 23.6 
  % attributed to supplies 12  42.5 ± 23.6 
Sole ulcer    
 % of total 16  27.4 ± 14.3 
 Time to treat (min) 12  21.3 ± 10.1 
 Total charged ($/case) 12  69.8 ± 30.8 
  % attributed to labor 12  73.4 ± 18.3 
  % attributed to supplies 11  26.6 ± 18.3 
Thin sole    
 % of total 16  3.3 ± 5.0 
 Time to treat (min) 12  9.6 ± 6.2 
 Total charged ($/case) 10  53.1 ± 35.8 
  % attributed to labor 12  64.8 ± 37.1 
  % attributed to supplies 12  18.5 ± 23.1 
Toe ulcer    
 % of total 16  2.8 ± 3.0 
 Time to treat (min) 12  16.9 ± 8.0 
 Total charged ($/case) 11  78.2 ± 48.9 
  % attributed to labor 12  66.7 ± 27.1 
  % attributed to supplies 12  25.0 ± 18.8 
White line disease    
 % of total 16  18.3 ± 14.8 
 Time to treat (min) 12  18.8 ± 7.6 
 Total charged ($/case) 12  65.3 ± 33.6 
  % attributed to labor 12  77.1 ± 17.2 
  % attributed to supplies 12  22.9 ± 17.2 
Other lameness    
 % of total treatments 16  6.6 ± 6.7 
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Table A3. Ranking frequency of the estimated total cost per case to the producer (treatment 
and labor costs plus the reduction in milk yield, reduced reproductive performance, etc.) of 
selected hoof diseases as evaluated by a survey of veterinarians.  Ranking was from most 
expensive (1) to least expensive (6). 
Disease 
Response frequency (%) 
n 1 2 3 4 5 6 
Sole ulcer 16 31.3 31.3 6.3 18.8 12.5 0.0 
        
Digital dermatitis 16 25.0 37.5 25.0 6.3 0.0 6.3 
        
Foot rot 16 18.8 0.0 43.8 12.5 12.5 12.5 
        
Toe ulcer 16 12.5 12.5 0.0 25.0 18.8 31.3 
        
White line disease 16 6.3 18.8 18.8 25.0 18.8 12.5 
        
Thin sole 16 6.3 0.0 6.3 12.5 37.5 37.5 
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Table A4. Ranking frequency of the potential benefits to producers of reducing dairy cow 
lameness as evaluated by a survey of veterinarians.  Ranking was from most important (1) 
to least important (8). 
Potential benefit 
Response frequency (%) 
n 1 2 3 4 5 6 7 8 
Enhanced animal welfare 16 50.0 18.8 6.3 6.3 6.3 0.0 0.0 12.5 
          
Increased milk production 16 37.5 25.0 25.0 6.3 6.3 0.0 0.0 0.0 
          
Increased cow longevity 16 12.5 25.0 6.3 18.8 31.3 63.0 0.0 0.0 
          
Increased reproductive 
performance 16 0.0 18.8 37.5 37.5 6.3 0.0 0.0 0.0 
          
Decreased incidence of 
other diseases (not 
lameness) 
16 0.0 6.3 18.8 18.8 31.3 18.8 6.3 0.0 
          
Reduced veterinary and 
hoof trimmer fees 16 0.0 6.3 0.0 0.0 12.5 0.0 25.0 56.3 
          
Reduced drug and supply 
costs 16 0.0 0.0 6.3 0.0 6.3 75.0 12.5 0.0 
          
Reduced producer labor 
costs 16 0.0 0.0 0.0 12.5 0.0 0.0 56.3 31.3 
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Table A5. Input assumptions and resulting simulated distributions of values used in the treatment module of a stochastic simulation 
model developed to estimate the cost per case of 3 hoof diseases.    
Variable 
Input assumption 
(mean ± SD) Input source 
Simulation 
distribution type 
Simulated data1 
(mean ± SD) 
Outside labor ($/case)     
 Digital dermatitis 4.67 ± 4.61 
 
Survey of hoof trimmers (Chapter 2) Log logistic 4.91 ± 8.99 
 Sole ulcer 11.81 ± 6.74 Survey of hoof trimmers (Chapter 2) Log logistic 12.01 ± 6.16 
 White line disease 11.60 ± 6.49 Survey of hoof trimmers (Chapter 2) Log logistic 11.86 ± 5.85 
Therapeutics ($/case)     
 Digital dermatitis 2.74 ± 8.92 Survey of hoof trimmers (Chapter 2) Log logistic 1.98 ± 2.41 
 Sole ulcer 8.13 ± 5.07 Survey of hoof trimmers (Chapter 2) Extreme values 8.01 ± 4.69 
 White line disease 8.16 ± 5.47 Survey of hoof trimmers (Chapter 2) Log logistic 8.19 ± 6.74 
On-farm labor ($/case)2     
 Mild digital dermatitis 1.73 ± 0.43 Charfeddine and Pérez-Cabal (2017) Normal 1.73 ± 0.43 
 Severe digital dermatitis 20.81 ± 5.20 Charfeddine and Pérez-Cabal (2017) Normal 20.81 ± 5.20 
 Mild sole ulcer 13.88 ± 3.47 Charfeddine and Pérez-Cabal (2017) Normal 13.88 ± 3.48 
 Severe sole ulcer 20.81 ± 5.20 Charfeddine and Pérez-Cabal (2017) Normal 20.81 ± 5.20 
 Mild white line disease 13.88 ± 3.47 Charfeddine and Pérez-Cabal (2017) Normal 13.88 ± 3.47 
 Severe white line disease 20.81 ± 5.20 Charfeddine and Pérez-Cabal (2017) Normal 20.81 ± 5.20 
Days of discarded milk (per case)3   
 Severe digital dermatitis 0.95 ± 1.86  Survey of hoof trimmers (Chapter 2) Exponential 0.91 ± 0.96 
1n = 1,000 iterations 
2Input source only reported a mean; the SD was calculated as a 10% coefficient of variation from the mean 
3An assumption was made that only severe cases of digital dermatitis would result in discarded milk; no discarded milk was assumed 
for mild digital dermatitis cases or cases of other diseases 
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Table A6. Input assumptions and resulting simulated distributions of values used in the 
milk loss module of a stochastic simulation model developed to estimate the cost per case 
of 3 hoof diseases.  Input assumptions were taken from Charfeddine and Pérez-Cabal 
(2017) and used in PERT (program evaluation and review technique) distributions to 
calculate the simulated data (n = 1,000 iterations). 
Variable 
Input 
assumption1           
(mean ± SE) 
Simulated 
data      
(mean ± SD) 
Primiparous mild digital dermatitis  (ECM kg lost/d)   
 28 to 15 d before incidence NA  
 14 to 1 d before incidence NA  
 1 to 14 d after incidence -0.07 ± 0.25 -0.20 ± 0.15 
 ≥ 15 d after incidence NA  
Primiparous severe digital dermatitis  (ECM kg lost/d)   
 28 to 15 d before incidence NA  
 14 to 1 d before incidence -0.37 ± 1.27 -1.03 ± 0.77 
 1 to 14 d after incidence -0.56 ± 1.34 -1.20 ± 0.86 
 ≥ 15 d after incidence -0.64 ± 1.14 -1.14 ± 0.77 
Multiparous mild digital dermatitis  (ECM kg lost/d)   
 28 to 15 d before incidence -0.52 ± 0.19 -0.52 ± 0.20 
 14 to 1 d before incidence -0.77 ± 0.18 -0.77 ± 0.19 
 1 to 14 d after incidence -0.90 ± 0.20 -0.90 ± 0.21 
 ≥ 15 d after incidence -0.39 ± 0.18 -0.39 ± 0.19 
Multiparous severe digital dermatitis  (ECM kg lost/d)   
 28 to 15 d before incidence -1.52 ± 1.08 -1.71 ± 0.97 
 14 to 1 d before incidence -2.22 ± 0.95 -2.22 ± 1.00 
 1 to 14 d after incidence -0.54 ± 1.07 -1.03 ± 0.71 
 ≥ 15 d after incidence -2.77 ± 0.90 -2.77 ± 0.94 
Primiparous mild sole ulcer  (ECM kg lost/d)   
 28 to 15 d before incidence -0.72 ± 0.30 -0.72 ± 0.31 
 14 to 1 d before incidence -0.42 ± 0.29 -0.47 ± 0.26 
 1 to 14 d after incidence -0.63 ± 0.31 -0.63 ± 0.32 
 ≥ 15 d after incidence -1.07 ± 0.35 -1.07 ± 0.37 
Primiparous severe sole ulcer  (ECM kg lost/d)   
 28 to 15 d before incidence -1.16 ± 0.82 -1.30 ± 0.74 
 14 to 1 d before incidence -0.87 ± 0.80 -1.09 ± 0.65 
 1 to 14 d after incidence -1.80 ± 0.83 -1.80 ± 0.87 
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Table A6. Continued   
 ≥ 15 d after incidence 
 
 
-0.23 ± 0.86 -0.69 ± 0.52 
Multiparous mild sole ulcer  (ECM kg lost/d)   
 28 to 15 d before incidence -1.14 ± 0.14 -1.14 ± 0.15 
 14 to 1 d before incidence -1.52 ± 0.14 -1.52 ± 0.15 
 1 to 14 d after incidence -1.04 ± 0.15 -1.04 ± 0.16 
 ≥ 15 d after incidence -0.93 ± 0.17 -0.93 ± 0.18 
Multiparous severe sole ulcer  (ECM kg lost/d)   
 28 to 15 d before incidence -2.48 ± 0.44 -2.48 ± 0.46 
 14 to 1 d before incidence -2.28 ± 0.43 -2.28 ± 0.45 
 1 to 14 d after incidence -2.36 ± 0.44 -2.36 ± 0.46 
 ≥ 15 d after incidence -1.47 ± 0.50 -1.47 ± 0.52 
Primiparous mild white line disease  (ECM kg lost/d)   
 28 to 15 d before incidence -0.36 ± 0.34 -0.46 ± 0.27 
 14 to 1 d before incidence -0.68 ± 0.32 -0.68 ± 0.33 
 1 to 14 d after incidence -0.41 ± 0.35 -0.50 ± 0.29 
 ≥ 15 d after incidence -0.38 ± 0.38 -0.49 ± 0.30 
Primiparous severe white line disease  (ECM kg lost/d) 
 28 to 15 d before incidence -1.24 ± 1.02 -1.48 ± 0.86 
 14 to 1 d before incidence -1.29 ± 0.93 -1.46 ± 0.83 
 1 to 14 d after incidence -1.71 ± 0.92 -1.74 ± 0.93 
 ≥ 15 d after incidence -0.07 ± 1.02 -0.68 ± 0.56 
Multiparous mild white line disease  (ECM kg lost/d)   
 28 to 15 d before incidence -1.16 ± 0.16 -1.16 ± 0.17 
 14 to 1 d before incidence -1.02 ± 0.16 -1.02 ± 0.17 
 1 to 14 d after incidence -0.65 ± 0.17 -0.65 ± 0.18 
 ≥ 15 d after incidence -0.20 ± 0.19 -0.25 ± 0.15 
Multiparous severe white line disease  (ECM kg lost/d) 
 28 to 15 d before incidence -2.37 ± 0.58 -2.37 ± 0.61 
 14 to 1 d before incidence -2.66 ± 0.54 -2.66 ± 0.57 
 1 to 14 d after incidence -2.07 ± 0.57 -2.07 ± 0.60 
 ≥ 15 d after incidence -1.56 ± 0.61 -1.56 ± 0.64 
1NA indicates that the value reported by the input source was positive (indicating an 
increase in milk yield); positive values were adjusted to 0 (i.e. no change in milk 
production) 
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Table A7. Input assumptions and resulting simulated distributions of values used in the 
days open module of a stochastic simulation model developed to estimate the cost per case 
of 3 hoof diseases.  Input assumptions were taken from Charfeddine and Pérez-Cabal 
(2017) and used in PERT (program evaluation and review technique) distributions to 
calculate the simulated data (n = 1,000 iterations).    
Variable 
Input assumption1                      
[mean (min – max)] 
Simulated data              
(mean ± SD) 
Increase in days open (d)   
 Mild digital dermatitis 0.0 (0.0 – 3.6) 0.6 ± 0.5 
 Severe digital dermatitis   5.4 (0.0 – 39.5) 10.2 ± 6.6 
 Mild sole ulcer 1.6 (0.0 – 6.3) 2.1 ± 1.1 
 Severe sole ulcer 17.4 (1.4 – 33.3) 17.4 ± 6.0 
 Mild white line disease 3.0 (0.0 – 7.7) 3.3 ± 1.5 
 Severe white line disease   8.6 (0.0 – 27.4) 10.3 ± 5.0 
1If parameters (mean, min, or max) reported by the input source were positive (indicating 
an improvement in reproductive performance) they were adjusted to 0 (i.e. no change in 
days open) 
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Table A8. Input assumptions and resulting simulated distributions of values used in the 
culling module of a stochastic simulation model developed to estimate the cost per case of 
3 hoof diseases.  Input assumptions were taken from Booth et al. (2004)1 who reported 
culling hazard ratios based on both time of disease incidence and time of culling.  Input 
assumptions were used in PERT (program evaluation and review technique) distributions2 
to calculate the simulated data (n = 1,000 iterations).    
  Time interval of culling 
Disease and data type 
Incidence 
timing ≤60 61 to 120 121 to 240 >240 
Digital dermatitis 
input assumptions 
[HR (95% CI)] 
≤ 60 0.4 (0.0 – 2.5) 0.9 (0.3 – 2.8) 1.4 (0.6 - 2.9) 0.8 (0.3 – 2.1) 
61 to 120  2.7 (1.3 – 6.0) 1.5 (0.8 – 3.0) 1.9 (1.0 – 3.6) 
121 to 240   1.5 (0.8 – 3.5) 1.1 (0.5 – 2.5) 
> 240    2.2 (0.7 – 7.1) 
 
Mild digital 
dermatitis simulated 
data  
(mean ± SD) 
≤ 60 1.7 ± 0.6 1.8 ± 0.7 1.8 ± 0.7 1.5 ± 0.5 
61 to 120  2.9 ± 1.5 1.4 ± 0.4 1.5 ± 0.4 
121 to 240   1.6 ± 0.5 1.5 ± 0.4 
> 240    2.7 ± 1.3 
 
Severe digital 
dermatitis simulated 
data 
(mean ± SD) 
≤ 60 1.7 ± 0.6 1.9 ± 0.6 2.0 ± 0.6 1.5 ± 0.4 
61 to 120  2.9 ± 1.4 1.4 ± 0.3 1.5 ± 0.3 
121 to 240   1.6 ± 0.5 1.4 ± 0.3 
> 240    3.2 ± 1.2 
 
Sole ulcer and white 
line disease input 
assumptions   
[HR (95% CI)] 
≤ 60 2.0 (0.9 – 4.3) 2.4 (1.2 – 5.0) 2.6 (1.4 – 4.9) 1.3 (0.5 – 3.1) 
61 to 120  2.7 (1.3 – 6.0) 1.5 (0.8 – 3.0) 1.9 (1.0 – 3.6) 
121 to 240   1.5 (0.8 – 3.5) 1.1 (0.5 – 2.5) 
> 240    2.2 (0.7 – 7.1) 
 
Mild sole ulcer and 
white line disease 
simulated data  
(mean ± SD) 
≤ 60 1.8 ± 0.6 2.6 ± 1.2 2.7 ± 1.1 1.9 ± 0.7 
61 to 120  3.0 ± 1.5 1.8 ± 0.7 2.0 ± 0.8 
121 to 240   2.0 ± 0.8 1.7 ± 0.6 
> 240    3.5 ± 1.9 
 
Severe sole ulcer and 
white line disease 
simulated data  
(mean ± SD) 
≤ 60 2.4 ± 0.5 3.3 ± 1.1 3.4 ± 1.0 2.1 ± 0.6 
61 to 120  3.9 ± 1.3 2.1 ± 0.6 2.6 ± 0.7 
121 to 240   2.3 ± 0.7 1.8 ± 0.5 
> 240    4.0 ± 1.8 
1White line disease culling hazard ratio inputs were assumed identical to sole ulcers 
2 To account for severity, two different stochastic distributions were created for each 
disease.  For the mild distributions, a mean 0.5 times that of the mean reported by Booth et 
al. (2004) was used whereas for the severe distributions, a mean 1.5 times that of the 
reported mean was used.  The same 5th and 95th percentiles were used in both mild and 
severe distributions for each disease.  
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Table A9. Input assumptions and resulting simulated distributions of values used in the 
disease recurrence module of a stochastic simulation model developed to estimate the cost 
per case of 3 hoof diseases.  Input assumptions for relapse rates were collected from 
Charfeddine and Pérez-Cabal (2017) and used in PERT (program evaluation and review 
technique) distributions to calculate the simulated data (n = 1,000 iterations).  Input 
assumptions for disease length were collected from Bruijnis et al. (2010) and used in PERT 
(program evaluation and review technique) distributions to calculate the simulated data (n 
= 1,000 iterations). 
Variable Input assumption 
Simulated data     
(mean ± SD) 
Relapse rate (episodes per infected cow) Mean1  
 Primiparous mild digital dermatitis 1.97 2.23 ± 0.43 
 Primiparous severe digital dermatitis 2.02 2.26 ± 0.44 
 Multiparous mild digital dermatitis 2.24 2.41 ± 0.46 
 Multiparous severe digital dermatitis 2.60 2.65 ± 0.47 
 Primiparous mild sole ulcer 2.38 2.50 ± 0.46 
 Primiparous severe sole ulcer 3.13 3.00 ± 0.46 
 Multiparous mild sole ulcer 2.46 2.56 ± 0.47 
 Multiparous severe sole ulcer 3.14 3.01 ± 0.46 
 Primiparous mild white line disease 2.50 2.58 ± 0.47 
 Primiparous severe white line disease 2.89 2.84 ± 0.47 
 Multiparous mild white line disease 2.65 2.68 ± 0.47 
 Multiparous severe white line disease 2.98 2.90 ± 0.47 
Disease length (months)2 Mean  
(5th – 95th percentile) 
 
 Mild digital dermatitis 3.65 (2.68 – 4.78) 3.68 ± 0.40 
 Severe digital dermatitis 3.54 (2.38 – 5.00) 3.59 ± 0.49  
 Mild sole ulcer 2.50 (1.37 – 4.00)3 2.56 ± 0.50 
 Severe sole ulcer 2.50 (1.37 – 4.00) 2.56 ± 0.50 
 Mild white line disease 4.43 (2.50 – 6.42) 4.44 ± 0.74 
 Severe white line disease 2.90 (1.00 – 6.33) 3.16 ± 0.99 
1The input assumption source only reported mean relapse rates.  Relapse rate minimum 
and maximum values were assumed the same for all diseases and severity levels for 
stochastic modeling purposes.  Minimum and maximum were set to 1.50 and 4.00 based 
on results from Ettema et al. (2010). 
2The input assumption source reported disease length for subclinical and clinical cases of 
each disease.  For this study, subclinical cases were assumed to represent mild cases and 
clinical cases were assumed to represent severe cases. 
3The input assumption source did not report disease length for subclinical sole ulcers; an 
assumption was made that this length would be identical to clinical sole ulcers. 
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Figure A1. Hoof disease definitions provided to respondents in a survey of hoof trimmers 
and veterinarians aimed at collecting and summarizing information on hoof disease 
treatment costs 
 
Lesion Descriptions: For the remaining questions, please consider the below dairy lameness 
disease definitions and refer to the “Claw Zones” indicated in the figure: 
 
Digital Dermatitis (also called Hairy Heel Warts or Mortellaro Disease) 
Claw Zones affected: any zones along the coronary band including zones 0, 9, and 10 
Common signs include: 
• Typically located at the end of the interdigital cleft 
• Acute cases have bright-red lesions > 0.75 inches (2 cm) that are painful and raw 
• Chronic cases have lesions with lots of skin/hair around them, but are not painful 
Foot Rot (also called Foot Foul, Interdigital Phlegmon, or Interdigital Necrobacillosis) 
Claw Zones affected: 9 
Common signs include: 
• Symmetrical hard swelling of tissue above the claws (acute onset, “overnight”) 
• Can occur with dead, smelly skin between the claws 
Sole ulcer (also called Pododermatitis Circumscripta, Rusterholz Disease) 
Claw Zones affected: 4 
Common signs include: 
• Localized defect in sole horn that exposes corium 
• Can also be a hemorrhage that is painful to hoof test 
• Typically occurs on the inner side of the sole on the outer claw, but can occur in 
the heel 
Thin Sole 
Claw Zones affected: 4, 5 
Common signs include: 
• Sole moves when thumb pressure is applied at the toe 
• Dorsal wall length is < 3 inches (7.5 cm) 
Toe Ulcer 
 Claw Zones affected: 1 
 Common signs include: 
• Penetration or separation of the horn in the toe triangle that results in exposure or 
infection of the corium 
White line lesion (also called White Line Separation or White Line Disease) 
Claw Zones affected: 1, 2, 3 
Common signs include: 
• Separation of the white line, which may result in abscesses (pus filled cavity) in 
the white line region 
If severe this can be accompanied by swelling of the affected claw 
 
135 
 
REFERENCES 
 
Adams, A., J. Lombard, C. Fossler, I. Román-Muñiz, and C. Kopral. 2016. Associations 
between housing and management practices and the prevalence of lameness, hock 
lesions, and thin cows on US dairy operations. J. Dairy Sci. 100:2119-2136. 
Amory, J., Z. Barker, J. L. Wright, S. Mason, R. Blowey, and L. E. Green. 2008. 
Associations between sole ulcer, white line disease and digital dermatitis and the 
milk yield of 1824 dairy cows on 30 dairy cow farms in England and Wales from 
February 2003–November 2004. Prev. Vet. Med. 83:381-391. 
Andrews, A. H., R. Blowey, H. Boyd, and R. Eddy. 2008. Bovine medicine: diseases and 
husbandry of cattle. John Wiley & Sons, Hoboken, NJ. 
Archer, S. C., M. J. Green, and J. Huxley. 2010. Association between milk yield and 
serial locomotion score assessments in UK dairy cows. J. Dairy Sci. 93:4045-
4053. 
Bailey, K. and V. Ishler. 2007. Tracking milk prices and feed costs. Department of 
Agricultural Economics and Rural Sociology.  Penn State University, Park City, 
PA. 
Barkema, H., J. Westrik, K. Van Keulen, Y. Schukken, and A. Brand. 1994. The effects 
of lameness on reproductive performance, milk production and culling in Dutch 
dairy farms. Prev. Vet. Med. 20:249-259. 
Barkema, H. W., M. A. G. von Keyserlingk, J. P. Kastelic, T. J. G. M. Lam, C. Luby, J. 
P. Roy, S. J. LeBlanc, G. P. Keefe, and D. F. Kelton. 2015. Invited review: 
Changes in the dairy industry affecting dairy cattle health and welfare. J. Dairy 
Sci. 98:7426-7445. 
Bell, N., D. Main, H. Whay, T. Knowles, M. Bell, and A. Webster. 2006. Herd health 
planning: farmers' perceptions in relation to lameness and mastitis. Vet. Rec. 
159:699-705. 
Bennett, R. M., K. Christiansen, and R. S. Clifton-Hadley. 1999. Estimating the costs 
associated with endemic diseases of dairy cattle. J. Dairy Res. 66:455-459. 
Bergsten, C., P. Greenough, J. Gay, W. Seymour, and C. Gay. 2003. Effects of biotin 
supplementation on performance and claw lesions on a commercial dairy farm. J. 
Dairy Sci. 86:3953-3962. 
Bewley, J., M. Boehlje, A. W. Gray, H. Hogeveen, S. Kenyon, S. Eicher, and M. Schutz. 
2010. Stochastic simulation using @Risk for dairy business investment decisions. 
Agr. Finance Rev. 70:97-125. 
Bicalho, R., S. Cheong, G. Cramer, and C. Guard. 2007. Association between a visual 
and an automated locomotion score in lactating Holstein cows. J. Dairy Sci. 
90:3294-3300. 
Booth, C., L. Warnick, Y. Gröhn, D. Maizon, C. Guard, and D. Janssen. 2004. Effect of 
lameness on culling in dairy cows. J. Dairy Sci. 87:4115-4122. 
Bruijnis, M., H. Hogeveen, and E. Stassen. 2010. Assessing economic consequences of 
foot disorders in dairy cattle using a dynamic stochastic simulation model. J. 
Dairy Sci. 93:2419-2432. 
Cha, E., J. Hertl, D. Bar, and Y. Gröhn. 2010. The cost of different types of lameness in 
dairy cows calculated by dynamic programming. Prev. Vet. Med. 97:1-8. 
 
136 
 
Charfeddine, N. and M. A. Pérez-Cabal. 2017. Effect of claw disorders on milk 
production, fertility, and longevity, and their economic impact in Spanish 
Holstein cows. J. Dairy Sci. 100:653-665. 
Collick, D., W. Ward, and H. Dobson. 1989. Associations between types of lameness and 
fertility. Vet. Rec. 125:103-106. 
Cook, N. B. and K. V. Nordlund. 2009. The influence of the environment on dairy cow 
behavior, claw health and herd lameness dynamics. Vet. J. 179:360-369. 
Costa, J. H. C., D. M. Weary, and M. A. G. v. Keyserlingk. 2017. Prevalence of lameness 
and leg injuries on US freestall dairies. J. Dairy Sci. 100 (Suppl. 2): 26. (Abstr.). 
Cramer, G., K. D. Lissemore, C. L. Guard, K. E. Leslie, and D. F. Kelton. 2009. The 
association between foot lesions and culling risk in Ontario Holstein cows. J. 
Dairy Sci. 92:2572-2579. 
DeFrain, J., M. Socha, and D. Tomlinson. 2013. Analysis of foot health records from 17 
confinement dairies. J. Dairy Sci. 96:7329-7339. 
Del Río, N. S., S. Stewart, P. Rapnicki, Y. Chang, and P. Fricke. 2007. An observational 
analysis of twin births, calf sex ratio, and calf mortality in Holstein dairy cattle. J. 
Dairy Sci. 90:1255-1264. 
Dhuyvetter, K. C., T. L. Kastens, M. Overton, and J. Smith. 2007. Cow Culling 
Decisions: Costs or Economic Opportunity? Pages 173-187 in Proc. of the 
Western Dairy Management Conference. Reno, NV. 
Dijkhuizen, A., R. Huirne, and A. Jalvingh. 1995. Economic analysis of animal diseases 
and their control. Prev. Vet. Med. 25:135-149. 
Dobson, H. and R. Smith. 2000. What is stress, and how does it affect reproduction? 
Anim. Reprod. Sci. 60:743-752. 
Dolecheck, K. A., G. Heersche, Jr., and J. M. Bewley. 2016. Retention payoff-based cost 
per day open regression equations: Application in a user-friendly decision support 
tool for investment analysis of automated estrus detection technologies. J. Dairy 
Sci. 99:10182-10193. 
Döpfer, D., M. Holzhauer, and M. van Boven. 2012. The dynamics of digital dermatitis 
in populations of dairy cattle: Model-based estimates of transition rates and 
implications for control. Vet. J. 193:648-653. 
Enting, H., D. Kooij, A. Dijkhuizen, R. Huirne, and E. Noordhuizen-Stassen. 1997. 
Economic losses due to clinical lameness in dairy cattle. Livest. Prod. Sci. 
49:259-267. 
Espejo, L., M. Endres, and J. Salfer. 2006. Prevalence of lameness in high-producing 
Holstein cows housed in freestall barns in Minnesota. J. Dairy Sci. 89:3052-3058. 
Esslemont, R. and E. Peeler. 1993. The scope for raising margins in dairy herds by 
improving fertility and health. Brit. Vet. J. 149:537-547. 
Esslemont, R. J. 2005. The costs of lameness in dairy herds. UK Vet Livestock 10:41-49. 
Ettema, J., S. Østergaard, and A. R. Kristensen. 2010. Modelling the economic impact of 
three lameness causing diseases using herd and cow level evidence. Prev. Vet. 
Med. 95:64-73. 
Ettema, J. F. and S. Østergaard. 2006. Economic decision making on prevention and 
control of clinical lameness in Danish dairy herds. Livest. Sci. 102:92-106. 
FAPRI. 2017. U.S. Baseline Briefing Book: Projections for Agricultural and Biofuel 
Markets. Food and Agricultural Policy Research Institute (FAPRI) at the 
 
137 
 
University of Missouri, https://www.fapri.missouri.edu/wp-
content/uploads/2017/03/FAPRI-MU-Report-01_17.pdf. 
Fjeldaas, T., Å. Sogstad, and O. Østerås. 2006. Claw trimming routines in relation to 
claw lesions, claw shape and lameness in Norwegian dairy herds housed in tie 
stalls and free stalls. Prev. Vet. Med. 73:255-271. 
Gernand, E., P. Rehbein, U. Von Borstel, and S. König. 2012. Incidences of and genetic 
parameters for mastitis, claw disorders, and common health traits recorded in 
dairy cattle contract herds. J. Dairy Sci. 95:2144-2156. 
González, L., B. Tolkamp, M. Coffey, A. Ferret, and I. Kyriazakis. 2008. Changes in 
feeding behavior as possible indicators for the automatic monitoring of health 
disorders in dairy cows. J. Dairy Sci. 91:1017-1028. 
Gould, B. W. and M. Bozic. 2017. Understanding Dairy Markets. University of 
Wisconsin-Madison and University of Minnesota, http://future.aae.wisc.edu/. 
Green, L. E., V. J. Hedges, Y. H. Schukken, R. W. Blowey, and A. J. Packington. 2002. 
The Impact of Clinical Lameness on the Milk Yield of Dairy Cows. J. Dairy Sci. 
85:2250-2256. 
Groenendaal, H., D. Galligan, and H. Mulder. 2004. An economic spreadsheet model to 
determine optimal breeding and replacement decisions for dairy cattle. J. Dairy 
Sci. 87:2146-2157. 
Guard, C. 2008. The costs of common diseases of dairy cattle. In Proceedings of the 
California Veterinary Conference, pp. 695-700. Advanstar Communications, 
Lenexa, KS, USA. 
Harris, D., C. Hibburt, G. Anderson, P. Younis, D. Fitspatrick, A. Dunn, I. Parsons, and 
N. McBeath. 1988. The incidence, cost and factors associated with foot lameness 
in dairy cattle in south‐western Victoria. Aust. Vet. J. 65:171-176. 
Hernandez, J. A., E. J. Garbarino, J. K. Shearer, C. A. Risco, and W. W. Thatcher. 2005. 
Comparison of the calving-to-conception interval in dairy cows with different 
degrees of lameness during the prebreeding postpartum period. J. Am. Vet. Med. 
Assoc. 227:1284-1291. 
Hogeveen, H., K. Huijps, and T. Lam. 2011. Economic aspects of mastitis: New 
developments. N. Z. Vet J. 59:16-23. 
Horseman, S., H. Whay, J. Huxley, N. Bell, and C. Mason. 2013. A survey of the on-farm 
treatment of sole ulcer and white line disease in dairy cattle. Vet. J. 197:461-467. 
Huxley, J. 2013. Impact of lameness and claw lesions in cows on health and production. 
Livest. Sci. 156:64-70. 
Hyde, J. and P. Engel. 2002. Investing in a robotic milking system: A monte carlo 
simulation analysis. J. Dairy Sci. 85:2207-2214. 
Ito, K., M. Von Keyserlingk, S. LeBlanc, and D. Weary. 2010. Lying behavior as an 
indicator of lameness in dairy cows. J. Dairy Sci. 93:3553-3560. 
Kaneene, J. B. and H. S. Hurd. 1990. The national animal health monitoring system in 
Michigan. III. Cost estimates of selected dairy cattle diseases. Prev. Vet. Med. 
8:127-140. 
Kertz, A., L. Reutzel, B. Barton, and R. Ely. 1997. Body weight, body condition score, 
and wither height of prepartum Holstein cows and birth weight and sex of calves 
by parity: A database and summary. J. Dairy Sci. 80:525-529. 
 
138 
 
Kleinhenz, K., P. Plummer, J. Danielson, R. G. Burzette, P. J. Gorden, J. Coetzee, J. A. 
Schleining, V. Cooper, B. Leuschen, and A. Krull. 2014. Survey of veterinarians 
and hoof trimmers on methods applied to treat claw lesions in dairy cattle. Bovine 
Pract. 48:47-52. 
Kossaibati, M. and R. Esslemont. 1997. The costs of production diseases in dairy herds in 
England. Vet. J. 154:41-51. 
Laven, R. and H. Hunt. 2002. Evaluation of copper sulphate, formalin and peracetic acid 
in footbaths for the treatment of digital dermatitis in cattle. Vet. Rec. 151:144-
146. 
Leach, K. A., H. R. Whay, C. M. Maggs, Z. E. Barker, E. S. Paul, A. K. Bell, and D. C. 
Main. 2010a. Working towards a reduction in cattle lameness: 1. Understanding 
barriers to lameness control on dairy farms. Research in Veterinary Science 
89:311-317. 
Leach, K. A., H. R. Whay, C. M. Maggs, Z. E. Barker, E. S. Paul, A. K. Bell, and D. C. 
Main. 2010b. Working towards a reduction in cattle lameness: 2. Understanding 
dairy farmers' motivations. Research in Veterinary Science 89:318-323. 
Liang, D., L. M. Arnold, C. J. Stowe, R. J. Harmon, and J. M. Bewley. 2017. Estimating 
US dairy clinical disease costs with a stochastic simulation model. J. Dairy Sci. 
100:1472-1486. 
Lucey, S., G. Rowlands, and A. Russell. 1986. The association between lameness and 
fertility in dairy cows. Vet. Rec. 118:628-631. 
McConnel, C., J. Lombard, B. Wagner, C. Kopral, and F. Garry. 2015. Herd factors 
associated with dairy cow mortality. Animal 9:1397-1403. 
McInerney, J. 1996. Old economics for new problems‐Livestock disease: presidential 
address. J. Agric. Econ. 47:295-314. 
McInerney, J., K. Howe, and J. Schepers. 1992. A framework for the economic analysis 
of disease in farm livestock. Prev. Vet. Med. 13:137-154. 
Melendez, P., J. Bartolome, L. Archbald, and A. Donovan. 2003. The association 
between lameness, ovarian cysts and fertility in lactating dairy cows. 
Theriogenology 59:927-937. 
Mill, J. and W. Ward. 1994. Lameness in dairy cows and farmers' knowledge, training 
and awareness. Vet. Rec. 134:162-164. 
Miller, G. Y. and C. R. Dorn. 1990. Costs of dairy cattle diseases to producers in Ohio. 
Prev. Vet. Med. 8:171-182. 
Morris, M., K. Kaneko, S. Walker, D. Jones, J. Routly, R. Smith, and H. Dobson. 2011. 
Influence of lameness on follicular growth, ovulation, reproductive hormone 
concentrations and estrus behavior in dairy cows. Theriogenology 76:658-668. 
Morris, R. 1969. Assessing the economic value of veterinary services to primary 
industries. Aust. Vet. J. 45:295-300. 
NAHMS. 2014. Dairy Cattle Management Practices in the United States. USDA-APHIS-
VS, ed. National Animal Health Monitoring System, Fort Collins, CO. 
NMPF. 2016. Animal Care Reference Manual for the Farmers Assuring Responsible 
Management National Dairy Farm Program.  Retreived on 7 July 2017, from  
http://www.nationaldairyfarm.com/sites/default/files/Version-3-Manual.pdf. 
Norman, H., J. Wright, M. Kuhn, S. Hubbard, and J. Cole. 2007. Genetic and 
environmental factors that affect gestation length. J. Dairy Sci. 90:264. 
 
139 
 
NRC. 2001. Nturient Requirements of Dairy Cattle. 7th Rev. Ed. Natl. Acad. Press, 
Washington, DC. 
Pecsok, S. R., M. L. McGilliard, and R. L. Nebel. 1994. Conception Rates. 1. Derivation 
and Estimates for Effects of Estrus Detection on Cow Profitability. J. Dairy Sci. 
77:3008-3015. 
Peeler, E., M. Otte, and R. Esslemont. 1994. Inter-relationships of periparturient diseases 
in dairy cows. Vet. Rec. 134:129-132. 
Pritchard, T., M. Coffey, R. Mrode, and E. Wall. 2013. Genetic parameters for 
production, health, fertility and longevity traits in dairy cows. Animal 7:34-46. 
Rollin, E., K. Dhuyvetter, and M. Overton. 2015. The cost of clinical mastitis in the first 
30 days of lactation: an economic modeling tool. Prev. Vet. Med. 122:257-264. 
Rutten, C. J., W. Steeneveld, C. Inchaisri, and H. Hogeveen. 2014. An ex ante analysis on 
the use of activity meters for automated estrus detection: To invest or not to 
invest? J. Dairy Sci. 97:6869-6887. 
Sanders, A., J. Shearer, and A. De Vries. 2009. Seasonal incidence of lameness and risk 
factors associated with thin soles, white line disease, ulcers, and sole punctures in 
dairy cattle. J. Dairy Sci. 92:3165-3174. 
Skidmore, A. L. 1990. Development of a simulation model to evaluate effectiveness of 
dairy herd management. Cornell University, Aug. 
Sood, P., A. Singh Nanda, and N. Singh. 2009. Effect of lameness on follicular dynamics 
in postpartum anestrous crossbred cows. Vet. Arhiv. 79:531-542. 
Thomsen, P. T., A. M. Kjeldsen, J. T. Sørensen, and H. Houe. 2004. Mortality (including 
euthanasia) among Danish dairy cows (1990–2001). Prev. Vet. Med. 62:19-33. 
USDA. 2007. Dairy 2007 Part I: Reference of dairy cattle health and management 
practices in the United States.  Retrieved 7 July 2017 from, 
https://www.aphis.usda.gov/aphis/ourfocus/animalhealth/monitoring-and-
surveillance/nahms/nahms_dairy_studies. 
USDA. 2017a. Agricultural Marketing Service - Market News Custom Report.  Accessed 
June 20, 2017.  https://www.ams.usda.gov/market-news/custom-reports. 
USDA. 2017b. Dairy Data: Milk cows and production by state and region (Annual).  
Accessed Oct. 16, 2017. https://www.ers.usda.gov/data-products/dairy-data.aspx. 
Van Nuffel, A., I. Zwertvaegher, L. Pluym, S. Van Weyenberg, V. M. Thorup, M. 
Pastell, B. Sonck, and W. Saeys. 2015a. Lameness detection in dairy cows: Part 1. 
How to distinguish between non-lame and lame cows based on differences in 
locomotion or behavior. Animal 5:838-860. 
Van Nuffel, A., I. Zwertvaegher, S. Van Weyenberg, M. Pastell, V. M. Thorup, C. Bahr, 
B. Sonck, and W. Saeys. 2015b. Lameness detection in dairy cows: Part 2. Use of 
sensors to automatically register changes in locomotion or behavior. Animal 
5:861-885. 
Vanegas, J., M. Overton, S. Berry, and W. Sischo. 2006. Effect of rubber flooring on 
claw health in lactating dairy cows housed in free-stall barns. J. Dairy Sci. 
89:4251-4258. 
VanRaden, P. M. and J. B. Cole. 2014. Lifetime Net Merit 2014. USDA. Accessed July 
3, 2017. http://aipl.arsusda.gov/reference/nmcalc-2014.htm. 
Von Keyserlingk, M., A. Barrientos, K. Ito, E. Galo, and D. Weary. 2012. Benchmarking 
cow comfort on North American freestall dairies: Lameness, leg injuries, lying 
 
140 
 
time, facility design, and management for high-producing Holstein dairy cows. J. 
Dairy Sci. 95:7399-7408. 
Von Keyserlingk, M., J. Rushen, A. M. de Passillé, and D. M. Weary. 2009. Invited 
review: The welfare of dairy cattle—Key concepts and the role of science. J. 
Dairy Sci. 92:4101-4111. 
Walker, S., R. Smith, D. Jones, J. Routly, and H. Dobson. 2008. Chronic stress, hormone 
profiles and estrus intensity in dairy cattle. Horm. Behav. 53:493-501. 
Whay, H. R., A. E. Waterman, A. J. F. Webster, and J. K. O'Brien. 1998. The influence 
of lesion type on the duration ofhyperalgesia associated with hindlimb lameness 
in dairy cattle. Vet. J. 156:23-29. 
Willshire, J. and N. Bell. 2009. An economic review of cattle lameness. Cattle Pract. 
17:136-141. 
Zinpro. 2014. Cattle lameness claw lesions: Identify, Prevent, Control. Zinpro 
Corporation, Eden Prairie, MN. 
 
  
 
141 
 
VITA 
 
Karmella Ann Dolecheck 
 
Education 
2014    Master of Science in Animal Sciences 
University of Kentucky, Lexington, USA 
    Specialization: Dairy Systems Management   
Thesis: Assessment of the technical and economic potential 
of automated estrus detection technologies for dairy cattle 
Major Professors: Jeffrey M. Bewley and William J. Silvia  
  
2012 Bachelor of Science in Animal, Dairy, and Veterinary Sciences 
Utah State University, Logan, USA 
    Specialization: Animal and Dairy Sciences 
Minor: Agribusiness Management 
Undergraduate Honors Thesis: Effects of supplementing 
Propionibacteria in lactating dairy diets on ruminal 
fermentation in continuous cultures 
Honors Thesis Advisor: Jong-su Eun 
 
Professional Positions 
2012 - 2018 Graduate Student Researcher and Teaching Assistant at the 
Department of Animal Sciences, University of Kentucky, 
Lexington, USA 
 
2015 Visiting Researcher at the Department of Large Animal Sciences, 
University of Copenhagen, Copenhagen, Denmark 
 
Scholastic and Professional Honors 
2017  Outstanding PhD Student Award 
   Gamma Sigma Delta, University of Kentucky, Lexington, USA 
2016 Top 25 Students, Staff, Faculty, and Alumni within the College of 
Agriculture, Food and Environment contributing to the Empowerment of 
Women 
University of Kentucky, Lexington, USA 
2015   National Dairy Leadership Scholarship 
   National Milk Producers Federation, Arlington VA, USA 
2015  Best Paper Award 
7th European Conference on Precision Livestock Farming, Milan, 
Italy 
 
Peer Reviewed Publications 
1. Dolecheck, K.A. and J.M. Bewley. Accepted for publication in February 2018.  
Invited review: Dairy cow lameness expenditures, losses, and total cost. Animal.  
 
 
142 
 
2. Stygar, A.H., K.A. Dolecheck, A.R. Kristensen.  2018.  Analyses of body weight 
patterns in growing pigs - A new view on body weight in pigs for frequent 
monitoring. Animal 12: 295-302. 
 
3. Dolecheck, K.A., G. Heersche, Jr., and J.M. Bewley.  2016.  Retention pay-off 
based cost of days open regression equations: Application in a user-friendly 
decision support tool for investment analysis of automated estrus detection 
technologies.  Journal of Dairy Science 99: 10182-10193. 
 
4. Dolecheck, K.A., W.J. Silvia, G. Heersche, Jr., C.L. Wood, K.J. McQuerry, and 
J.M. Bewley.  2015.  A comparison of timed artificial insemination and automated 
activity monitoring with hormone intervention in three commercial dairy herds.  
Journal of Dairy Science 99: 1506-1514. 
 
5. Dolecheck, K.A., W.J. Silvia, G. Heersche, Jr., Y.M. Chang, D.L. Ray, A.E. Stone, 
B.A. Wadsworth, and J.M. Bewley.  2015.  Behavioral and physiological changes 
around estrus events identified using multiple automated monitoring technologies.  
Journal of Dairy Science 98: 8723-8731.  
 
6. Lawson, B.D., A.H. Shahzad, K.A. Dolecheck, E.L. Martel, K.A. Velek, D.L. Ray, 
J.C. Lawrence, and W.J. Silvia.  2014.  A pregnancy detection assay using milk 
samples: Evaluation and considerations.  Journal of Dairy Science 97: 6316-6325. 
 
